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Abstract 
 
The process of implantation begins with the attachment of the embryo to the uterine lumen. 
This event is followed by the development of the implanted blastocyst in the differentiated 
endometrium. Decidualization, a signatory event during this process is characterized by the 
deciduous transformation of fibroblast endometrial stromal cells to morphologically and 
functionally unique decidual cells along with the formation of extensive neo-angiogenic 
networks that play pivotal role in nourishing the developing embryo. Steroid hormones 
estrogen (E) and progesterone (P) acting through their cognate nuclear receptors critically 
modulate this maternal-fetal interaction that entails the initial success of procreation. While E 
is primarily involved in cell proliferation and acquisition of epithelial receptivity, P critically 
governs stromal differentiation in addition to contributing to E action in preparing the uterus 
prior to the attachment reaction. Thus, a thriving implantation is the manifestation of 
complementary steroid hormone action both during the proliferation and differentiation 
phases. The role of E in decidualization however remained elusive. Our studies indicated that 
the decidual uterus harbors steroid biosynthetic machinery driving the local production of 
intra-uterine E in both mouse and human endometrium. This local steroid acting through the 
estrogen receptor alpha (ER) plays a major role in sustaining decidualization and uterine 
vascularization, absence of which resulted in embryo resorption. To identify the downstream 
signaling pathway(s) and molecular candidate(s) that mediate the action of local E, we 
performed gene expression profiling, using decidual tissues obtained from mice treated with 
or without letrozole, a specific inhibitor to the key biosynthetic enzyme, cytochrome P450 
aromatase. Of the number of molecules identified from the microarray analysis likely to be 
involved in cell differentiation, the c-Fos family member Fos related antigen-1 (FRA-1), was 
significantly regulated by local E. Our studies further revealed that FRA-1 is a direct target of 
the E/ER signaling in the decidual uterus and plays a major role in sustaining the stromal 
differentiation process. FRA-1, which exhibits strong nuclear expression in the uterine 
decidual cells, also governed the extent of embryo invasion by modulating the stromal cell 
migration and remodeling. Additionally gene profiling experiments indicated that uterine E 
regulated the development of vascular network via the expression of cytokines and paracrine 
factors from the differentiated stroma. To understand the direct implication of this study in 
reproductive health of adult individuals, we next monitored the presence of endogenous E 
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signaling in the human endometrium using primary stromal cells isolated from endometrial 
biopsies of healthy females. In this in vitro model system, decidualization can be induced by 
administering a cocktail of steroid hormones and cAMP. We were able to demonstrate 
significant induction of aromatase in the differentiating cells which resulted in local 
biosynthesis of E. Further, siRNA mediated gene silencing of aromatase or ER expression 
led to a significant down regulation of human endometrial decidual bio-markers, indicating a 
major contribution of this intra-uterine E signaling in mediating stromal cell differentiation. 
Together, this study has helped us to gain novel insights of steroid hormone regulation of 
endometrial stromal cell differentiation and angiogenesis in mouse and human implantation.  
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Introduction 
 
Infertility and altered reproductive health in adult women are some of the leading concerns of 
today’s society. Although modern medicine led to tremendous technological advancements in 
developing assisted reproductive techniques, the success rates amongst infertile individuals 
remain fairly low. One of the major causes of the failed conception is impaired endometrial 
modification to support the development of a healthy and competent blastocyst. The study of 
implantation focuses on understanding the maternal physiology that coordinates embryo 
sustenance before placentation. Decidualization, the major event during this process is 
characterized by differentiation of stromal cells to the decidual cells accompanied by 
extensive development of vascular networks. Identification of the signaling pathway(s) and 
molecular candidate(s) regulating the uterine preparation for pregnancy would thus 
effectively contribute to the development of therapeutics for treating implantation failure and 
pathological situations like endometriosis.  
 
    Steroid hormones estrogen (E) and progesterone (P) orchestrate the implantation process 
by regulating the terminal differentiation of uterine fibroblast stromal cells to epitheloid 
decidual cells. While the pivotal role of P in inducing decidualization is widely established, 
the role of E is primarily focused on acquisition of uterine epithelial receptivity and embryo 
attachment. The contribution of the later in stromal differentiation process however, remains 
unclear. Recent studies in our laboratory have revealed that cytochrome P450 aromatase, the 
cardinal enzyme regulating E biosynthesis, is expressed and results in synthesis of E in the 
uterus during decidual phase of pregnancy. To analyze the functional significance of this 
local steroid action, the goal of this overall dissertation project is centered on the question: 
“Does E signaling play a role in decidualization?”   
 
    A detailed overview of the established molecular mechanisms during implantation, 
primarily in the decidualization phase has been reviewed in Chapter 1 of the dissertation 
while Chapters 2 to 5 address the role of E signaling in the regulation of decidual program in 
mice and human.  
 
    Letrozole, a specific enzyme inhibitor to aromatase action, disrupts E biosynthetic 
machinery. By implementing this phenomenon we first addressed the role of decidual E 
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during early pregnancy in mice. We observed that letrozole treatment had a severe 
consequence in sustaining stromal differentiation and blastocyst development. To identify the 
possible downstream targets involved in mediating this effect, we subjected uterine RNA 
treated with or without the inhibitor drug to microarray-based gene expression profiling. In 
Chapter-2 we detail the signaling mechanisms that mediate endogenous E action during 
stromal cell differentiation. The primary objective was to identify critical down stream targets 
of uterine E that mediate stromal differentiation process.  
 
    Gene profiling experiments identified an early inducible gene that belongs to the c-FOS 
family of transcription factors, Fra-1, as a potential downstream target of aromatase-derived 
E. FRA-1 signaling is critical for cell differentiation in several systems including osteoblast 
differentiation. Our studies showed prominent expression of this molecule in the 
decidualizing stromal bed during early pregnancy. Employing an in-vitro decidualization 
approach and siRNA mediated blockade of gene expression, we evaluated the functional 
contribution of FRA-1 in the endometrium. In Chapter 3 we have discussed our results 
showing the critical role of this transcription factor in governing stromal cell decidualization.  
 
    Angiogenesis, the development of new vascular network from pre-existing structures is a 
critical physiological process characterizing decidualization. Additionally, the decidua-
derived paracrine factors play a major role in regulating this neo-vascularization process. 
Inhibition of aromatase expression in the uterus resulted in a severe defect in the development 
of endometrial vasculature during early pregnancy. Letrozole treatment downregulated the 
expression of several angiogenic factors in the decidual uteri. In Chapter 4, the candidate 
molecules that mediate local E action in controlling uterine vascular growth is addressed. 
Further, to identify the endothelial cell specific E target molecules, which contribute to 
decidual vascularization, differential expression of these regulatory molecules in blood vessel 
rich mesometrial region of the uterus in control and aromatase inhibitor treated animals was 
analyzed.  
 
    Although insights from the murine research-models are important in understanding of 
human physiological processes, direct analysis of human tissues undoubtedly gives us a 
better understanding of the actual scenario. The final part of this dissertation thus focused on 
identifying the contribution of E signaling during human endometrial stromal cell 
decidualization. Stromal cells isolated from endometrial biopsies of healthy individuals 
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undergo in-vitro decidualization in response to steroid hormone P and cAMP. The cellular 
differentiation is demarcated by transition of the fibroblast morphology to an epitheloid 
shape. Interestingly, we observed a significant induction of P450 aromatase expression in 
these differentiating stromal cells, indicating that similar to the rodent model, local E 
signaling might contribute to human decidualization. In Chapter 5, we focused on the 
importance of local E signaling via its predominant receptor ER in mediating human 
endometrial stromal cell differentiation.  
 
    In summary, this dissertation study has focused on the critical role of stertoid signaling in 
the regulation of uterine function during implantation. The experiments performed have 
significantly contributed to this goal by testing the hypothesis that intrauterine E signaling 
and its downstream target molecules critically regulate endometrial stromal differentiation 
and uterine neovascularization during implantation in mouse and humans. 
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Literature Review- 
Molecular regulators of stromal 
differentiation and angiogenesis 
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1.1. ABSTRACT 
 
The close association of the fertilized embryo and the receptive maternal uterus during the 
“window of implantation” governs the initial success of procreation. Although, the extent of 
trophoblast invasion differs between species, yet this event universally regulates a thriving 
conception. The overall implantation process is defined by a series of physiological events 
initiated with the attachment of the embryo to the uterus followed by deciduous 
transformation of a non-pregnant uterine tissue to a specialized chamber supporting embryo 
growth. As stromal cell proliferation and differentiation proceed modifying the uterine 
cellular mass, new blood vessels originate to support the growth of the developing embryo. 
Unlike rodents, in humans, differentiation of stromal cells is initiated in regular menstrual 
cycles through a process known as pre-decidualization. Steroid hormone orchestration 
critically regulates the implantation process. In addition to the ovarian source of estrogen (E) 
and progesterone (P) that prepares the uterine cells for embryo receptivity, recent studies 
have identified an intrauterine origin of E significantly contributing to the decidualization 
process. This hormone action regulates uterine cellular differentiation, vascular permeability 
and angiogenesis to sustain embryo growth and thereby the successful initiation of 
pregnancy. In this chapter we will focus on the major findings in the field of implantation 
biology that pictures the interplay of steroid hormone signaling paradigms during early 
pregnancy.  
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1.2. Extensive uterine remodeling characterizes implantation 
 
Implantation is initiated in mouse when the blastocyst enters the uterine cavity 4 days after 
fertilization. Embryo attachment to the uterine wall initiates apoptosis of the adjacent luminal 
epithelial cells and proliferation of the surrounding stromal population. With the progression 
of pregnancy, a subset of these proliferating cells enters the differentiation route to form 
polyploid and secretory decidual cells (1, 2). Subsequently, the wave of differentiation 
progress to the deeper layers of the implantation chamber forming the secondary decidual 
zone (Fig. 1.1). Stromal cell decidualization has been assessed by monitoring the enzymatic 
activity of alkaline phosphatase and the expression of prolactin related protein, two most well 
characterized markers of decidualization (Fig. 1.2). By day 10 of pregnancy, the terminally 
differentiated stromal cells undergo apoptosis to accommodate the growing embryo and 
placentation ensues to maintain the conceptus till term. The morphological transition of 
isolated stromal cells during differentiation can be well appreciated in vitro primary mouse 
stromal cell cultures. Stromal cells enzymatically isolated from day 4 pre-implantation mouse 
uterus differentiate when cultured in the presence of steroid hormones (Fig 1.3). As the cell 
decidualizes, they form multinucleated giant cells that exit from the cell cycle and enter 
endoreduplication resulting in the polyploid nucleus with a DNA content as much as n=64 
(3).  
 
    In the human endometrium, decidualization is however initiated independent of a 
blastocyst in the superficial endometrial stromal layer surrounding the spiral arteries during 
the mid-secretory phase of every menstrual cycle. In the event a blastocyst invades through 
the uterine epithelium, steroid hormone regulated stromal differentiation involves the entire 
endometrium accompanied by growth of uterine spiral arteries and infiltration of the uterine 
stroma by macrophages, lymphocytes and natural killer cells (4). In the absence of a 
blastocyst, the hormone level declines, the endometrium is sloughed off and the menstrual 
cycle repeats.  
 
    Formation of an extensive angiogenic network during the decidual transformation of 
stromal cells is a key physiological consequence that supports early pregnancy and the initial 
embryo development. At this time a large population of cytokines, growth factors and other 
angiogenic cues are locally released in the uterus that drives proliferation and maturation of 
nascent vascular structures to mature blood vessels. In humans, the cyclical change of the 
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endometrium is accompanied by the proliferation, growth and coiling of the spiral arteries to 
develop the angiogenic network as the stromal cells undergo pre-decidualization in the mid-
secretory phase.  
 
 
1.3. Steroid hormone action regulate implantation 
 
Steroid hormones estrogen (E), progesterone (P) and their downstream signaling players are 
pivotal in coordinating the physiological events during implantation. The schematic 
representation of the hormonal profiles during implantation are represented in Fig 1.5A 
(mouse) and B (human). The biological effects of these steroids are classically known to be 
mediated by the respective nuclear receptors ER and PR, which act like ligand inducible 
transcription factors (5). E mediates its action through two different receptors, ER alpha 
(ER) and ER beta (ER). While it has been widely documented that the ER is the critical 
receptor governing uterine proliferation and embryo attachment, studies have addressed the 
important role of ER in the growth and differentiation of uterine epithelium (6). Ligand 
bound ER undergoes a conformational change and binds to the E response elements of target 
gene as a receptor dimer. This mechanism of action is referred to as the classical pathway. 
Alternatively in some cases ER can also regulate gene expression through the non-canonical 
pathway by interacting with AP-1 or Sp1 protein complexes (7).  P mediates its effect 
through the two isoforms PRA and PRB; PRA is the major isoform involved in the regulation 
of uterine physiology. The mechanism of PR action also involves the classical response 
element mediated signaling, where in the presence of ligand, PR dissociates from the heat 
shock chaperone proteins, dimerizes and binds to P response elements, recruit co-regulators 
and govern the transcriptional fate of target genes. PR can also act through the non-classical 
pathway, when it undergoes ligand independent activation and translocates to the nucleus to 
regulate gene expression (8). Gene silencing studies have been instrumental in understanding 
the importance of these proteins during implantation, as will be discussed shortly. Fig 1.4 
depicts the expression profile of the steroid receptors ER (A) and PR (B) during early 
pregnancy. 
 
1.3.1. P signaling during implantation 
 8
P signaling through PR plays an authoritative role throughout implantation governing the 
transformation of the stromal cells to the decidual cell mass. The role of PR in regulating 
decidualization has been widely addressed by several laboratories including ours. Absence of 
PR obliterates the implantation process with severe impairment in uterine receptivity, embryo 
attachment and decidualization (9). Administration of the well known PR antagonist RU486 
also exhibited a severe defect in implantation, similar to the knock out model. Gene 
expression analysis of mouse uterus treated with this inhibitor drug revealed a large repertoire 
of genes with pivotal role in maintenance of the implantation process (10). Some of these 
molecules have been widely explored and will be discussed briefly in this chapter.  
 
1.3.1.a. Regulation of PR expression  
PR remains protected by a cohort of chaperone proteins in the absence of endogenous ligand. 
These constitute a 90kd heat shock protein (Hsp 90), a co-chaperone and an immunophilin 
with tetratricopeptide repeat (TPR) domain, FKBP52 or FKBP51 also known as FKBP4 and 
FKBP5, respectively. The uterine localization of FKBP52 exhibits maximal similarity to the 
pattern of PR expression during decidualization and is considered as the major chaperone 
protein involved in maintaining the functional form of the nuclear receptor competent for 
hormone binding. Knockout studies have indicated that while FKBP51 null animals are 
fertile, the FKBP52 null mice develop normally to the adult stage but exhibit a severe defect 
in implantation. Further, these null mice are also unable to respond to experimentally induced 
decidualization (11). PR activity in these mice is severely impaired along with the inhibition 
of target genes amphiregulin, IHH and HOXA10. Further, lack of PR activity also reversed P 
dependent antagonism of E actions resulting in enhanced E mediated proliferation of uterine 
epithelial cells in the knockout animal along with the increased expression of E responsive 
epithelial marker lactotransferrin. Together the study indicated that FKBP52 plays a major 
role in regulating PR function in the decidual uterus and thereby significantly contributes to 
the maintenance of implantation.  
 
1.3.1.b. Downstream mediators of P action  
Indian hedgehog (IHH) 
A member of the hedgehog morphogens, IHH is a P regulated gene localized in the uterine 
luminal and glandular epithelium during the implantation window (12). Conditional ablation 
of Ihh in the PR responsive cells of the uterus resulted in uterine infertility (13). The 
blastocyst is unable to attach to the uterine wall in the absence of IHH due to an increased 
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expression of MUC-1. Additionally administration of an artificial decidual stimulus failed to 
elicit a response, indicating complete failure of the implantation process. The receptor, 
Patched homolog 1 (Ptch1), a known target of hedgehog action is expressed in the uterine 
stromal cell compartment along with other downstream targets of IHH signaling like the 
Hedgehog interacting protein (Hip) and Chicken Ovalbumin Upstream Promoter-
Transcription Factor II (COUP-TF II). Ablation of IHH expression in the uterus impaired the 
expression of Ptch1 and COUP-TF II in the stromal compartment, indicating IHH signaling is 
an effective mediator of epithelial-stromal communication. The hedgehog pathway in the 
uterus also regulates uterine cell proliferation by governing the EGFR signaling (13). In 
addition to a defect in cell proliferation and differentiation, ablation of IHH in the uterus 
impaired development of the angiogenic network due to the down regulation of Tie2, a well 
characterized receptor mediating angiopoeitin action.  
 
    In order to understand the mechanism through which P regulates IHH expression in the 
uterus, a recent study addressed the involvement of PR in bringing about this effect (14). PR 
is expressed both in the epithelial and stromal compartment in the uterus. Since IHH was 
confined to the epithelial cell type, a direct PR regulation from the same compartment was 
obvious. The regulation of IHH expression by the specific PR population was addressed by 
tissue recombination experiments. Interestingly, reciprocal recombination of the wild type 
epithelium and PR knock out (PRKO) stroma indicated that PR expressed in the stromal 
compartment alone regulates IHH expression in the epithelial layer. Further, this epithelial 
morphogen acts through its stromal receptor Ptch1 to regulate the expression of target 
molecules like COUP-TF II in the stroma. Identification of the PR-IHH-COUP-TF II 
signaling during implantation unveiled a unique stromal-epithelial inter compartmental 
crosstalk and its pivotal contribution to stromal cell differentiation.  
 
Chicken ovalbumin upstream transcription factor –II (COUP- TF II)  
COUP-TF II is an orphan nuclear receptor with known function in regulating epithelial 
mesenchymal cross talk in many tissue systems. Global knockout models of COUP-TF II are 
embryonic lethal due to severe defects in cardiovascular and angiogenic development. The 
importance of this molecule in adult uterus has been addressed by conditional knock out 
mouse models. COUP-TF II is expressed in the uterine stromal cell compartment during 
implantation. Uterine stromal cell specific silencing of COUP-TF II impaired embryo 
attachment and decidualization (15). At the molecular level, this defect in implantation has 
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been accounted to decreased PR expression in the stroma. During early pregnancy, stromal 
PR attenuates the ER activation in the epithelium, antagonizes E regulated epithelial 
proliferation and further governs down regulation of ER regulated glycoproteins like 
MUC1, a prerequisite for embryo attachment. In the absence of this orphan nuclear receptor, 
low levels of PR releases the epithelial inhibition resulting in high ER expression and 
increased ER activity in the epithelium leading to a complete implantation failure. Exogenous 
administration of BMP2 can ameliorate this defect, indicating the critical role of the TGF 
family morphogen in mediating the effect of COUP-TF II action in decidualizing uterus. 
 
Bone morphogenetic protein 2 (BMP2)  
Bone morphogenetic proteins (BMP) are well characterized mediators of differentiation in 
the development and organization of various tissue systems. BMP2 and its receptor BMPRII, 
belonging to the TGF family, are two well characterized targets of P signaling in mouse 
uterus, expressed particularly in the stromal cell compartment during the early phase of 
decidualization. With the advancement of cell differentiation BMP2 expression sequentially 
progresses to the neighboring secondary decidual zone, indicating a pivotal role of this 
morphogen in decidualization. The importance of BMP2 during decidualization has been well 
characterized by in vitro mouse primary stromal cell cultures and by silencing BMP2 
expression in the uterine stromal cells through the PR driven cre recombinase in vivo. 
Embryo attachment remains unaffected after the conditional deletion of BMP2 however the 
differentiation of stromal cells to the decidual phenotype is greatly impacted by the 
attenuation of this molecule (16). Stromal cells isolated from day 4 morning pre-implantation 
mouse uterus, in the presence of exogenous steroids undergo in vitro differentiation. In 
addition to the morphological change of the stromal cells, the expression of decidual markers 
like alkaline phosphatase (Alkp) and prolactin related protein (Prp) are significantly induced 
over time. Studies employing this in vitro primary cell culture model indicated that 
administration of recombinant BMP2 accelerated the differentiation of stromal cells with a 
significantly enhanced the expression of the bio-markers of decidualization (17).  
 
    BMP2 action in cell differentiation has been shown to be coordinated by a member of the 
Wingless (Wnt) family of glycoprotein, Wnt4. Wnt proteins are highly conserved secreted 
molecules that regulate cell-cell interactions during organ development. They bind to the Fzd 
receptors on cell membrane and act either through the canonical beta catenin or the non-
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canonical signaling through the calcium pathway. Over-expression of BMP2 significantly 
enhanced Wnt4 expression in primary stromal cell cultures, while silencing the morphogen 
suppressed it. Attenuation of Wnt4 expression by siRNA mediated gene silencing exhibited a 
marked impairment of stromal cell differentiation in vitro indicating that it might be the key 
regulator of BMP2 mediated decidualization (17). 
 
Homeobox gene: HOXA10 
The AbdominalB-like homeobox gene, HOXA10 is expressed in the uterine stromal cells 
during decidualization and is a target of P signaling mediated through PR. HOXA10 is 
involved in the development of genitourinary and adult female reproductive tracts. Null 
mutation of Hoxa10 results in a severe defect in decidualization (18). Mechanistic studies 
have revealed that this defect in implantation is caused by the altered cell proliferation in 
response to exogenous steroids. Although the expression of certain differentiation related 
molecules are unchanged, the expression of the PGE2 receptor subtypes EP3 and EP4 are 
aberrantly expressed in the null uterus. It is concluded that HOXA10 signaling acts to 
mediate P response and thus the activation of the steroid targets EP3 and EP4. The expression 
of COX2 and the co-chaperone FKBP52 is altered in the HOXA10 deficient mouse uterus 
which further contributes to the implantation defect (18) (19).   
 
CCAAT/ enhancer-binding protein beta (C/EBP)  
The transcription factor C/EBP is a critical mediator of steroid hormone action in the 
decidual uterus. It belongs to the family of basic leucine zipper domain proteins that is 
important in regulating cellular processes like proliferation, differentiation, inflammation and 
apoptosis. The expression of C/EBP is induced in the mouse uterus at the time of 
implantation and is under the dual regulation of both E and P, thereby contributing to the 
differential regulation of cellular functions in the two uterine cell types. Studies in our 
laboratory involving the global knock out of C/EBP have identified that it plays a critical 
role in uterine epithelial and stromal cell proliferation and in the differentiation of stromal 
cells, absence of which leads to a complete failure of the implantation process and a steroid 
unresponsive uterus (20).  
 
 
1.3.2. E signaling during implantation  
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Epithelial cell proliferation is an important event coordinating uterine preparation for 
implantation. E plays the predominant role in this process by controlling the expression of 
cyclin and cyclin dependent kinases (CDK) (21). Epithelial cell proliferation in response to E 
and its stromal receptor ER is mediated by the nuclear localization of cyclin D and 
activation of the corresponding CDK4 and CDK6. In a recent study, Zhu and Pollard 
identified the signaling pathway that regulates this inter-compartmental crosstalk in 
governing cell proliferation. E/ER mediated activation of insulin like growth factor 1 (IGF-
1) pathway activates epithelial PI3-kinase/AKT signaling (22). In the scheme of events, 
activated PI3K regulates phosphorylation of the inhibitory domain of GSK3 rendering it 
unstable, which further governs the nuclear expression of cyclin D1 and thus progression of 
cell cycle. P antagonizes this pathway by inhibiting the phosphorylation of PI3kinase 
resulting in stabilization of GSK3 and thus the subsequent degradation of cyclin D and lack 
of cell proliferation (23). Thus, a balance in these two steroid dependent regulatory 
mechanisms is critical in preparing the epithelial receptivity prior to blastocyst attachment.  
 
    Classical studies using the delayed model of implantation have established that E is also 
critical in mediating the attachment of the dormant blastocyst in the P primed ovariectomized 
pregnant mouse uterus (24, 25).  In addition, studies by Lubahn et. al. identified that absence 
of ER in mouse results in a hypoplastic uterus with severe impairment to exogenous 
hormone treatment and a uterus refractory to embryo attachment (26).  
 
    Following blastocyst attachment, decidualization is the most essential prerequisite 
governing the implantation success. It requires a controlled orchestration of the two steroids 
to mediate the cell differentiation. P from the corpora lutea becomes the predominant 
hormone regulating decidualization while the role of E in this phase remained unclear. 
Although administration of ER antagonist ICI obliterated stromal decidual response in mice, 
the uteri of the ER knockout animals did respond to an artificial stimulus inducing 
decidualization (27, 28). However, studies have later identified the presence of a truncated 
but functional ER transcript in these knock out mouse capable of mediating DNA binding 
activity in the uterus (29). In order to address the possibility that the decidualization observed 
in this global knock out model might be a consequence of residual ER activity, we generated 
a conditional ER knock out mouse using the Cre-loxP technology. Ablation of ER in the 
stromal cells revealed a severe defect in uterine decidual response and thus established the 
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pivotal role of this hormone receptor in stromal cell differentiation (Laws M.J and Bagchi 
I.C, unpublished observation). The obvious importance of ER during decidualization 
thereby questioned the probable mechanism of its action when the circulatory level of the 
ovarian steroid is almost undetectable.  
 
1.3.2.a Intrauterine E is critical during decidualization - emerging concepts 
In a recent study from our laboratory, we identified that during the decidual phase of early 
pregnancy, the uterus harbors the entire steroid biosynthetic machinery resulting in the 
biosynthesis of local E. Further, as will be discussed further in the following chapters, this 
intra-uterine E plays pivotal role in mediating stromal cell differentiation and uterine neo-
angiogenesis to critically sustain implantation.  
  
    The intrauterine E from differentiating stromal cells drives ER function during 
decidualization (30). In addition to the expression of the major enzymes like side chain 
cleavage (P450 SCC), StAR protein, 3 hydroxysteroid dehydrogenase (3HSD) and 17 
lyase, the key enzyme regulating the conversion of testosterone to E, P450 aromatase is also 
induced in decidual uterus. Blockade of aromatase activity impaired intrauterine E action 
resulting in a severe decidualization defect and embryo resorption. The altered stromal 
differentiation was identified by significant reduction of the decidual mass and down 
regulation of known bio-markers of decidualization like Alkp and Prp.  
 
1.3.2.b. Intrauterine E regulates angiogenesis during decidualization 
During early pregnancy while the implantation chamber undergoes morphological 
transformation, neo-angiogenesis becomes essential for the sustenance of the embryo. 
Initially, the microvascular permeability occurs at specific regions of the uterine horn to 
demarcate the implantation sites in rodents. With the progression of decidualization, new 
blood vasculature begins to accumulate primarily at the mesometrial end. Steroid hormones 
are well characterized regulators of vasculogenesis in pregnant uterus. Ovarian E is a known 
enhancer of the vascular permeability at the site of blastocyst attachment. However, hormonal 
regulation of blood vessel formation in ovariectomized mice have pointed that E might be a 
negative regulator of angiogenesis, while P mediates it positively (31). Recent studies from 
our laboratory have identified that the local E is critical in sustaining the decidual blood 
vasculature by regulating the expression of a large repetoire of angiogenic modulators (30).   
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1.3.2.c. Downstream mediators of E action 
Progesterone receptor 
PR, the critical mediator of the implantation process, is regulated by E signaling. Prior to 
implantation, ovarian E acting through ER governs the expression of stromal PR and 
mediates the downstream signaling events. Following blastocyst attachment the declining 
level of ovarian E switches with the uterine source and sustains PR expression to regulate the 
decidualization process. Consequently, ablation of aromatase enzymatic activity altered PR 
expression and thus inhibited a cohort of differentiation responsive genes downstream of PR 
action. These included known markers like BMP2 and Wnt4. 
   
Connexin 43 (CX43) 
The gap junction protein CX43 is a well characterized E regulated gene in the uterus (32). 
Close association of this membrane protein with the differentiating stromal cells indicated a 
predominant role in decidualization. Recent studies in our lab have identified that disruption 
of CX43 expression in mouse uterus by conditionally deleting the protein in PR positive 
stromal cells results in altered cell differentiation. The expression of Prp is significantly de-
regulated in CX43 conditional knockout mice compared to the wild type littermate. Further, 
the expression of two well characterized molecules of decidualization, BMP2 and HOXA10 
are also significantly impaired after silencing of CX43 gene.  CX43 plays a pivotal role in 
decidual cell communication by regulating the passage of small molecules, ions and second 
messenger signaling candidates. Disruption of this cellular crosstalk resulted in altered 
stromal cell differentiation as observed in the null uteri. This defect in the decidual response 
further regulated the release of angiogenic modulators like VEGF, HIFs and angiopoetins to 
contribute to the uterine vascular growth. Accordingly, deletion of CX43 in decidual cells 
had a severe consequence in the endothelial cell maturation. This defect in vascular 
networking in the knockout animals resulted in embryo resorption by day 8 of pregnancy and 
the consequent infertility (33).  Administration of letrezole impairing aromatase enzymatic 
activity had a severe effect in regulating uterine vascular growth. The down regulation of 
CX43 in the aromatase inhibitor treated uterus indicated that this molecule is one of the prime 
mediators of the local E action contributing to the development of uterine angiogenic network 
indirectly via the decidual cell regulation.  
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VEGF signaling 
Vascular endothelial growth factor (VEGF) is the most potent mitogen for endothelial cells 
and a key regulator of angiogenesis (34). Extensive analyses on the expression of VEGF, its 
steroid hormone regulation and the involvement of specific receptors during implantation, has 
been extremely informative in understanding the functioning of the VEGF system in pregnant 
uterus (35). VEGF, a heparin binding homodimeric glycoprotein, mediates its action through 
the tyrosine kinase receptors namely VEGFR1 (Flt-1), VEGFR2 (Flk-1) and the glycoprotein 
co-receptor Neuropilin-1 (NRP1). VEGFR-2 is the predominant receptor mediating VEGF 
action in the uterus (36).  Angiopoeitins are another class of angiogenic regulators that 
complement the VEGF signaling for the development of angiogenesis. It mediates its action 
through the tyrosine kinase receptor Tie2. Angiopoietin 2 collaborates with VEGF in front of 
invading vascular sprouts to promote vascular remodeling during implantation (37). Pregnant 
uterus exhibits prominent expression of Ang-1, Ang-2, Ang-3 in differentiating stromal cells 
along with the expression of Tie2. Hypoxia inducible factors (HIFs) are major transcriptional 
regulators of VEGF. HIFs are primarily involved in governing the physiological balance of 
oxygen tension and are closely associated with angiogenesis. HIF2 complements the action 
of HIF1 to regulate VEGF expression (38). Our studies indicated that angiopoeitins and 
HIF2 are regulated by the local E during decidualization thereby contributing to VEGF 
regulation and vasculogenesis.  
 
Adrenomedullin (ADM) 
ADM is a 52 aminoacid vasodialator peptide with major role in uterine vascular 
development. ADM binds to the G protein coupled receptor calcitonin receptor like receptor 
(CL) which is associated with a receptor activity modifying protein (RAMP). During early 
pregnancy, ADM exhibits strong expression in the stromal cells at the immediate vicinity of 
the embryo, while its receptor proteins are restricted to the endothelial cell layers (39, 40). 
Heterozygote mice lacking one functional allele of ADM exhibited impaired implantation 
due to uterine receptivity failure. The localization pattern of the ADM signaling components 
strongly suggests the indirect mechanism of endothelial cell maturation during 
decidualization. ADM and RAMP2 are known regulators of E action in uterus. The 
regulation of ADM by the intrauterine E indicated its major contribution in the development 
of vascular structures in the decidual uterus.  
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1.4. Additional regulators critical for stromal cell differentiation 
 
Interleukin-11 (IL-11)  
IL-11 is a pleiotropic cytokine with predominant role in inflammation and wound repair. IL-
11 action is mediated by its receptor alpha chain IL11R and gp130. Expression of both the 
ligand and the receptor is induced following embryo attachment during stromal 
differentiation. While the expression of the ligand in the uterus is restricted to the primary 
decidual region, IL-11R is confined to the secondary zone. The precise expression pattern 
indicated that induction of IL-11 adjacent to the embryo acted on the concentric outer layer 
expressing the receptor to regulate progression of stromal differentiation. Deletion of IL-
11R disrupts IL-11 signaling and renders mice infertile with a severe defect in 
decidualization (41, 42). Vascular permeability surrounding the implantation sites on day 4 
was reduced in these receptor null mice indicating reduced capillary permeability and blood 
flow at the site of blastocyst apposition. Although the attachment reaction did occur in the 
null uteri, the formation of the secondary decidual bed was significantly impaired. By day 8.5 
of pregnancy, the blastocysts in the null uterus were nectrotic and the decidual mass was 
infiltrated by inflammatory cells resulting in regression of the decidual mass and blastocyst 
resorption.  
 
Cyclooxygenase-2 (COX-2)  
Prostaglandins are biosynthesized from arachidonic acid via the cyclooxygenase (COX) 
pathway. The COX enzymes govern the conversion of arachidonic acid to prostaglandin H2, 
which is acted upon by various prostaglandin synthases to form prostaglandins. The two 
isoforms of COX enzymes, COX-1 and COX-2, are expressed in the mouse uterus during 
implantation. While ablation of the first isoform does not exhibit a fertility defect, mutation 
of the later has severe consequences in blastocyst attachment and decidualization (43). COX-
2 is expressed in the luminal epithelium and subepithelial stroma at the time of blastocyst 
attachment and initiation of decidualization. Administration of the prostacyclin analogue 
PGI2 restores the decidualization defect in the COX-2 null uteri, indicating that it might be 
the major functional prostaglandin during implantation. Although COX-2 expression was 
induced after E treatment surrounding the embryo during delayed implantation, in the ovex 
model the steroid regulation of COX-2 expression was not apparent (44). Recent studies have 
identified that the COX enzymes are post-transcriptionally regulated by two microRNAs 
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(miRNA) mmu-miR-101a and mmu-miR-199a, expressed in the uterus during the 
implantation window (45).  
 
 
1.5. Additional regulators critical for angiogenesis 
 
Uterine dendritic cells  
During the implantation a special population of hematopoietic cells known as uterine 
dendritic cells (uDc) are involved in the coordination of innate, adaptive immune responses 
and induction of immunologic tolerance (46). In recent studies the function of these uDc were 
analyzed by conditional depletion of these cells during implantation. In addition to impaired 
decidualization, the study reported that this cell population controlled the vessel maturation 
during uterine angiogenesis. The parallel expression of an angiogenic agonist (TGF1) and 
antagonist (sFlt1) in these cell population indicated that uDcs are involved in controlling the 
extent of vascular growth during decidualization (47). Removal of uDCs suppressed 
angiogenic networking in the decidual uterus. Modulation of uterine vasculature by uDcs 
suggested a parallel regulatory mechanism in addition to the steroid hormones.  
 
COX-2 
As decidualization progresses the COX-2 localization switches from the antimesometrial to 
the mesometrial pole, suggesting a probable role of the enzyme in angiogenesis. Studies in 
the knockout model have identified that COX-2 regulates the vasculogenic development 
during early decidualization. This effect is primarily brought about by regulating the VEGF 
expression in the mesometrial region and to a lesser extent by governing the expression of 
molecules involved in the angiopoeitin system (48). 
       
 
1.6. Decidualization in human endometrial stromal cells 
 
The molecular cross talk between the human endometrium and the conceptus directs a 
comprehensive stromal differentiation program in pregnant women. During every menstrual 
cycle, however, the orchestrations of cell differentiation independent of pregnancy are 
governed by local molecular cues from the epithelial compartment and the steroid hormones. 
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The increasing exposure of the endometrium to cytokines, local endocrine factors like 
prostaglandin E2, relaxin and corticotrophin releasing hormone (CRH) stimulates the 
production of a second messenger cyclic adenosine mono-phosphate (cAMP). Activation of 
the PKA pathway through cAMP is an obligatory signaling event driving the differentiation 
of human endometrial stromal cells. Consequently it has been observed that elevated levels of 
cAMP resulting in sustained activation of the PKA pathway and cAMP induced sensitization 
of cells to steroid action are an absolute necessity to drive these stromal cells differentiation 
(4).  
 
In vitro human stromal cell decidualization 
Undifferentiated stromal cells isolated from endometrial biopsies of healthy individuals at the 
proliferative stage of the menstrual cycle can be differentiated in vitro in response to a 
hormone cocktail containing E (10nM) P (1μM) and a membrane permeable analogue of 
cAMP, 8Br-cAMP (0.5mM). The induction of differentiation is observed by a distinct 
transition of the cellular morphology from spindle like fibroblast appearance to terminally 
differentiated plump epitheloid shape. Additionally the expression of the various markers of 
human stromal differentiation like prolactin (PRL), insulin like growth factor binding protein-
1 (IGFBP-1), cytokine interleukin-11 (IL-11), vascular endothelial growth factor (VEGF) are 
progressively induced as differentiation progresses in response to steroid hormones and 
cAMP.  
 
1.6.1. Bio-markers of human stromal cell decidualization 
Insulin like growth factor binding protein-1 (IGFBP-1) 
Regulation of insulin like growth factor (IGF) signaling by the IGF binding proteins 
(IGFBPs) is a critical aspect of human endometrial differentiation. As stromal cells begin to 
differentiate it secretes increasing amount of IGFBP-1 and this protein is undoubtedly 
considered as the major regulator of the human endometrial decidualization (49). At the 
molecular level, several signaling pathways converge in inducing IGFBP-1 expression during 
stromal cell differentiation in humans and other primates. Steroid hormone receptor PR 
directly regulates IGFBP-1 expression by binding to the PRE in a ligand dependent manner. 
Downstream target of PR, the Forkhead transcription factor, FOXO-1 interacts with HOXA-
10 to regulate IGFBP-1 expression (50). Activation of PKA pathway further accentuates the 
expression level of this secretory protein. 
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Prolactin (PRL) 
PRL is a peptide hormone and cytokine, involved in regulating growth and differentiation of 
a number of epithelio-mesenchymal organs. Secretion of PRL under the control of the tissue 
specific decidual PRL (dPRL) promoter indicates the extent of stromal cell differentiation in 
human endometrium (51). PRL secretion is induced by P, insulin, IGF-1 and PRL releasing 
factor (52). Activation of the PKA pathway through cAMP further enhances the expression of 
this decidual marker. PR indirectly regulates PRL expression by activating FOXO-1, which 
potently enhances the PKA dependent activation of decidual PRL promoter. FOXO-1 
interacts with a CCAAT family transcription factor C/EBP beta and subsequently binds to the 
proximal promoter of dPRL to regulate PRL expression during stromal cell differentiation 
(53).  
 
Interleukin-11 (IL-11) 
IL-11 is a cytokine with pleiotropic actions on various tissues. During the mid-secretory 
phase, the differentiating stromal cell expresses increasing concentration of IL-11 in response 
to cAMP. It has also been observed that addition of exogenous IL-11 in vitro endometrial 
cultures induces the expression of decidual markers, PRL and IGFBP-1(54).   
 
Vascular Endothelial Growth Factor (VEGF) 
VEGF is another cytokine and angiogenic factor with prominent expression in the 
differentiating stromal cells. Since the expression of VEGF is induced during stromal 
differentiation in response to steroid hormones and cAMP, this molecule is also considered as 
a major marker of decidualization (55).  
 
1.6.2. Hormonal regulation of the human menstrual cycle 
The cyclical change of the endometrium is coordinated by a series of hormone action. 
Activation of the anterior pituitary by the gonadotropin releasing hormone (GnRH) from the 
hypothalamus elicits the release of follicle stimulating hormone (FSH) and leuteinizing 
hormone (LH) that acts on the ovarian follicles to initiate its maturation and the subsequent 
release of the ovarian steroids. E released from these mature follicles in turn regulates the LH 
surge by a feedback mechanism that organizes the follicular rupture. The circulating levels of 
E reach around 300pg/ml in the follicular phase and it actively participate in governing the 
growth and proliferation of the endometrium. Following ovulation, the newly formed corpus 
luteum releases high level of P and to a lesser extent E. Under the influence of P, stromal 
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cells transform to decidual cells thereby demarcating the secretory phase of the cycle. During 
the early to mid secretory phase, the level of E remains around 150pg/ml while the levels 
decreases dramatically in the late secretory phase to around 50pg/ml (56). This decline in the 
E level at a stage when cells are actively involved in differentiation indicates a possible 
replenishment of E level through other mechanisms. Studies by Tseng et al. have identified 
increasing aromatase enzymatic activity in differentiating cultured human endometrial 
stromal cells in response to forskolin and P.  
 
    Steroid hormones in human reproductive cycle mediate their effect both through the 
classical and non classical pathway. P which is the major steroid during decidualization 
mediates its action through PR. Human endometrium has predominant expression of PR-A 
and is considered as the major functional nuclear receptor in vivo and in vitro (57). In 
response to cAMP signaling, PR-A directly recruits other activated transcription factors like 
STAT 5, CEBP, FOXO1 to mediate stromal decidualization. E mediates its action though 
the ER and ER. Although ER is the functional form regulating E action in the 
proliferative phase, the secretory phase has prominent expression of both ER and ER. 
 
    Differentiating human endometrial stroma expresses the major enzyme regulating E 
biosynthesis P450aromatase resulting in picogram/ml levels of endogenous E production. 
Silencing of aromatase expression in cultured stromal cell identified its contribution in 
mediating cell differentiation and regulation of VEGF expression. Endogenous E drives ER 
function during human decidualization. siRNA mediated silencing of ER resulted in a 
severe defect in decidualization. In addition to an obvious defect in cell shape indicating 
more fibroblast morphology compared to decidual, there was a significant impairment in the 
expression of the markers of stromal differentiation like IGFBP-1, PRL, IL-11, VEGF, 
FOXO1 and others.  
 
1.6.3. Molecules governing human stromal cell decidualization 
Of the several signatory molecules that define human differentiation program, the major ones 
are discussed below.  
 
CCAAT/ enhancer-binding protein beta (C/EBP) 
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C/EBP is involved in regulating the expression of both PRL and IGFBP-1. These decidual 
markers have prominent C/EBP binding sites in their promoter. C/EBP associates with PR-
A and regulates promoter interaction. It exhibits strong nuclear localization in the stromal 
cells of the late secretory phase. Additionally in vitro differentiation of stromal cells in 
response to P and cAMP also induces C/EBP expression, indicating that this transcription 
factor might play a central role in mediating human endometrial stromal cell decidualization.  
 
Transforming growth factor  (TGF) family  
The TGF family of proteins including the sub-families of TGF, activin, BMP and GDF have 
known contribution in apoptosis, proliferation, differentiation and tissue remodeling. The 
expression profiles of these molecules have been widely studied in the endometrium to 
address their probable role in human stromal cell differentiation.   
 
    Activins constituting the  subunits A and B, dimerize to form activin A, B or AB. This 
 subunit is expressed in the glandular epithelium of human endometrium in the proliferative 
phase. Their expression in the stromal cells is particularly induced in the mid-late secretory 
phase when the cells enter the differentiation program. In-vitro differentiation of endometrial 
stromal cells in response to cAMP also induces activin A indicating a predominant role of the 
molecule during decidualization (58). Further, exogenous administration of recombinant 
activin to cultured stromal cells undergoing decidualization enhanced the secretion of known 
decidual markers PRL and IGFBP1. The effect of activin A in cell differentiation can be 
attenuated by administration of follistatin, a naturally occurring activin antagonist (59). Thus 
parallel expression of these two antagonistic molecules regulates the extent of stromal 
differentiation in human endometrium.  
 
    Bone morphogenetic proteins, (BMPs) play a critical role in stromal cell differentiation. 
The differentiating cells in the secretory phase exhibit high expression of BMP2 and BMP4, 
although the expression of the latter is not induced but constitutively expressed in the stromal 
cells (60). BMP2 is a phylogenetically conserved morphogen important in both mouse and 
human endometrium. Early induction of BMP2 during in vitro differentiation suggested a 
possible steroid regulation of this molecule. Administration of recombinant BMP2 in cultured 
stromal cells also enhances the expression of decidual markers PRL and IGFBP1 indicating 
this morphogen is a major mediator of endometrial stromal cell differentiation (17).  
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    In addition to activin and BMPs, TGF1 and GDF 5, 8 and 11 are expressed in the stromal 
cells with prominent induction in decidualizing cells of the secretory phase. The strong 
expression of these molecules further confirmed their role in coordinating the endometrial 
decidualization process in humans.  
 
Forkhead transcription factor forkhead box O1 (FOXO1)  
The winged helix/Forkhead class of transcription factors constituting the FOXO proteins 
have important role in cell fate decisions in response to environmental factors and hormonal 
signals. In the human endometrium several FOXO proteins are induced during the stromal 
cell decidulization in the secretory phase. The major ones include FOXO1, FOXO3a and 
FOXO4. FOXO1 is significantly induced in the secretory phase of the menstrual cycle in 
vivo. FOXO1 expression in cultured human stromal cells is under the direct regulation of the 
PKA pathway. P accentuates this induction however P alone is unable to mediate an 
enhanced expression of the transcription factor (61). FOXO1 regulates the expression of the 
two major differentiation markers PRL and IGFBP-1 (62). Biochemical analysis of the PRL 
promoter has indicated that FOXO1 in cooperation with CEBP enhances the dPRL promoter 
activity (53). FOXO1 also stimulates IGFBP-1 expression by a direct interaction with 
HOXA10. Additionally in a recent study by (63), it was shown that in association with PR, 
FOXO1 regulates cell cycle molecules and differentiation in cultured stromal cell 
decidualization. These observations indicate that FOXO1 plays a major role in mediating 
human stromal cell decidualization.  
 
Signal transducer and activation of transcription-5 (STAT5)  
The STAT family of proteins also plays an important role by regulating genes involved in 
growth and differentiation. Receptor associated activation of janus kinases further induces the 
phosphorylation of a tyrosine residue in STAT protein and its subsequent activation. 
Activated STAT dimerizes and translocates to the nucleus to mediate the regulation of its 
target genes. In the human endometrium, STAT5 is induced in the glandular epithelium. 
During the secretory phase however, it shows predominant expression in the stromal cells 
that express the PRL receptor. In vitro cultured stromal cells indicated a strong induction of 
STAT5 expression followed by the activation and nuclear localization of STAT5 in response 
to cAMP (64). STAT5 interacts with PR and plays a major role in activating PRL promoter.  
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v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (SRC)  
SRC is a non-receptor tyrosine kinase associated with integrins and G protein coupled surface 
receptors. It plays an important role in converting extracellular stimuli to intracellular signals. 
Activation of SRC in the presence of ligands involves dephosphorylation of the tyrosine 
residues at the carboxy terminal. Recent in vitro studies in human endometrium identified 
SRC as an important candidate mediating stromal cell differentiation. SRC expression is 
regulated by the cAMP and PKA signaling pathways. Additionally, P also induces 
SCR/MAPK activity by direct or indirect interaction of SRC with the ligand bound PR. 
Administration of a dominant negative mutant of SRC kinase in cultured stromal cells 
completely impaired the transformation of the fibroblast cells to the decidual cell type. The 
mechanism of SRC action in the human endometrial cultures involved STAT 5 activation 
another important regulator of stromal differentiation. Activation of STAT5 by 
phosphorylation of a specific tyrosine residue is governed by SRC and in the presence of a 
dominant negative SRC mutant this active form was absent (65).  
 
p53 
The transcription factor p53 is induced in decidualizing stromal cells in vitro in response to 
cAMP treatment. p53 also shows strong nuclear expression in the stromal cells of the 
secretory endometrium, indicating a possible role in stromal differentiation. Classically the 
cell cycle repressor is involved in apoptosis however a similar possibility in differentiating 
stromal cells is remote considering very minute fraction of cells undergoes cell death. The 
major function of p53 in stromal decidualization remains unclear, although studies have 
identified a direct physical interaction and transrepression between p53 and CEBP (66). In 
mouse stromal cell differentiation, p53 is involved in regulating the transcription of LIF, a 
major cytokine governing embryo reception (67). In a recent study, it has been shown that 
high incidence of single nucleotide polymorphisms in the p53 pathway is more prevalent 
among infertile individuals with unsuccessful in vitro fertilization (68).  
 
1.6.4. Angiogenesis and development of spiral arteries during human menstrual cycle 
 
The blood supply to the uterus is furnished by the arteries from ovarian and uterine origin. 
The uterine arteries that enter the myometrium gives rise to the arcuate arteries which further 
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branch to form the radial arteries. The radial artery bifurcates to the basal arteries that supply 
blood to the basal portion of the endometrium and governs endometrial regeneration after 
menstruation; the other half forms the spiral arteries that supply blood to the superficial 
functional endometrium (69). The spiral arteries eventually form subepithelial capillary 
plexeus that plays a critical role in regulating blood supply to the endometrium and is the 
initial site of stromal cell differentiation during the mid-secretory phase.  
 
    A functional interface between the maternal and fetal circulations is extremely critical for 
the maintenance of pregnancy. This involves major physiological changes in the maternal 
vasculature as the endometrium prepares itself for the blastocyst during each mid-secretory 
phase of the menstrual cycle. Angiogenic development in the cyclical uterus sequentially 
occurs during the (a) regeneration of blood vessel after menstrual sloughing, (b) the 
proliferative phase when endometrium grows predominantly under the influence of E, and 
finally during (c) the secretory phase, when the development of the spiral arteries becomes 
important for the initiation of stromal cell transformation. Some of the known mediators of 
the angiogenic signals in the human endometrium include VEGF, its receptors Flk-1, Flt-1, 
bFGF and angiogenin.  
 
    VEGF is the major cytoine regulating angiogenic network in the cycling human 
endometrium. While the superficial stromal cells express high levels of VEGF, its high-
affinity tyrosine kinase receptors receptors Flk-1 and Flt-1 are expressed in the endothelial 
cells, indicating a probable paracrine interaction between the two cell compartments (70). 
VEGF expression in the human endometrium is cyclical with strong expression in the late 
proliferative phase that coincides with the edema and hypervascular permeability. VEGF 
expression is also significantly induced in the mid-to late secretory phase and aids in 
regulating the angiogenesis and development of the spiral arteries in this phase (55). The gap 
junction protein CX43 also regulates the VEGF expression in human endometrium and 
significantly contributes to cell differentiation (33).  
 
    Basic FGF is a18kd peptide belonging to the heparin-binding family of growth factors with 
known mitogenic properties. Along with VEGF it also plays major role in angiogenesis in 
vitro and in vivo. In the human endometrium, bFGF is induced in the proliferative phase, but 
the expression is persistent in the secretory phase and contributes towards capillary 
angiogenesis (71).   
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    Angiogenin (Ang) is another characteristic polypeptide with predominant role in vascular 
growth. In the human endometrium, Ang is induced in the secretory phase. In vitro studies 
have also identified that the expression of Ang is regulated by P, which accentuates the 
polypeptide expression as the stromal cells undergo differentiation. Ang is involved in the 
convulation and thickening of arterioles in the secretory phase (72).  
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1.7. FIGURES 
 
Figure 1.1: Morphological structure of uterine cross-sections during implantation 
 
 
 
 
 
 
 
 
Figure 1.1: Morphological structure of uterine cross-sections during implantation 
 
Uterine cross-sections from pregnant CD-1 females were obtained. Sections from day 2, and 
implantation sites on day 4 midnight, day 5, day6, day7 and day8 were stained with 
hematoxylin and eosin and the representative images are shown at the same magnification.  
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Figure 1.2: Major hallmarks of implantation 
 
 
Figure 1.2: Major hallmarks of implantation  
 
Frozen uterine cross sections isolated on day7 of pregnancy were subjected to alkaline 
phosphatase enzymatic activity assay (panel A) and immunostaining for PECAM-1 (panel B) 
to monitor the extent of cell differentiation and angiogenesis, respectively. 
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Figure 1.3: Mouse in vitro stromal cell culture 
 
 
Figure 1.3: Mouse in vitro stromal cell culture 
 
Stromal cells isolated from pre-implantation pregnant mouse were cultured in complete 
medium. Decidualization was induced by the addition of P. Cells were collected at 5 hrs and 
24hr intervals thereafter to monitor A: the morphological changes. Cultured cells were 
stained with phallodin (green), counter stained with DAPI (nucleus) and images were 
procured at the same magnification. B: the expression profile of the differentiation markers 
alkaline phosphatase (upper) and Prp (lower).  
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Figure1.4: Steroid hormone nuclear receptor during implantation 
 
 
 
 
 
 
Figure 1.4: Steroid hormone nuclear receptor during implantation-ER 
 
Estrogen receptor alpha expression in the pre-implantation (day 1 and day 2) and 
implantation uterus (day 4 at 0:00hrs, day 5, day 6, day 7 and day 8 at 9:00hrs). Strong 
nuclear expression is predominantly observed in the luminal epithelium in day 1. The stromal 
expression is prominent from day 2 along with strong glandular expression. By day 5, wide 
spread expression of ER is observed over the entire uterine stroma, while day 6 onwards it 
becomes more restricted to the mesometrium. The figure shows the low (4X) and high (40X) 
magnification of a representative field from each pregnant sample.  
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Figure1.4: Steroid hormone nuclear receptor during implantation 
 
 
 
 
 
 
 
 
 
Figure 1.4: Steroid hormone nuclear receptor during implantation-PRA 
 
Progesterone receptor A expression in the pre-implantation (day 1 and day2) and 
implantation uterus (day 5, day 6, day 7 and day 8 at 9:00hrs). Strong nuclear expression is 
predominantly observed in the stromal cells surrounding the embryo on day 5. The 
expression remains persistent at the antimesometrial end on days 7 and 8 of pregnancy. 
Strong expression surrounding the blood vessels is prominent on day 8 at the mesometrial 
end. The figure shows the low (4X) and high (20X and 40X) magnification of a 
representative field from each pregnant sample.  
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Figure 1.5: Steroid hormone profile during implantation 
 
 
 
 
 
 
Figure 1.5: Steroid hormone profile during implantation 
 
Schematic representation of the hormonal profile during early pregnancy. A: High levels of 
ovarian E and rising level of P are exhibited during the pre-implantation phase. On day 4, a 
transient surge of ovarian E is occurs specifically in mice. Following attachment, the P level 
rises significantly and predominates the differentiation phase, while the level of E declines to 
very low levels. B: The human menstrual cycle is dominated by high E levels in the 
proliferative phase. Following ovulation, the P levels become dominant along with low levels 
of E in the secretory phase. 
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Chapter-2 
 
De Novo synthesis of estrogen in pregnant 
uterus is critical for stromal cell 
decidualization  
 
 
 
 
 
 
 
 
 
______________________________________ 
A part of this chapter has been published as “De novo synthesis of estrogen in pregnant uterus is critical for 
stromal decidualization and angiogenesis”, authored by Amrita Das, Srinivasa Raju Mantena, Athilakshmi 
Kannana, Dean B. Evans, Milan K. Bagchi and Indrani C. Bagchi in the Proceedings of National Academy of 
Sciences, July 28, 2009, doi: 10.1073/pnas.0901647106 
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2.1. ABSTRACT 
 
Implantation is initiated when the embryo attaches to the uterine luminal epithelium during 
early pregnancy. Following this event, uterine stromal cells undergo steroid hormone-
dependent transformation into morphologically and functionally distinct decidual cells in a 
unique process known as decidualization. An angiogenic network is also formed in the 
uterine stromal bed, critically supporting the early development of the embryo. The steroid-
induced mechanisms that promote stromal differentiation and endothelial proliferation during 
decidualization are not fully understood. Although the role of ovarian progesterone (P) as a 
key regulator of decidualization is well established, the requirement of ovarian estrogen (E) 
during this process remains unresolved. Here we show that the expression of P450 aromatase, 
a key enzyme that converts androgens to E, is markedly induced in mouse uterine stromal 
cells undergoing decidualization. The aromatase then acts in conjunction with other steroid 
biosynthetic enzymes present in the decidual tissue to support de novo synthesis of E. This 
locally produced E is able to support the advancement of the stromal differentiation program 
even in the absence ovarian E in an ovariectomized, P-supplemented pregnant mouse model. 
Administration of letrozole, a specific aromatase inhibitor, to these mice blocked the stromal 
differentiation process. Collectively, these studies identified the decidual uterus as a novel 
site of E biosynthesis and uncovered E-regulated maternal signaling pathways that critically 
control uterine differentiation and angiogenesis during early pregnancy. 
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2.2. INTRODUCTION 
 
Implantation involves a series of complex interactions between the developing embryo and 
the uterus, leading to the establishment of pregnancy (1, 2, 73, 74). Although the details of 
the implantation process vary between species, the basic features of blastocyst attachment 
and penetration of the uterine surface epithelium are common to many mammals. In mice, 
implantation is initiated four days after fertilization when the blastocyst reaches the uterus. 
The concerted actions of the steroid hormones estrogen (E) and progesterone (P) via their 
cognate receptors orchestrate the changes in the uterine tissue that make it competent to 
attach to the blastocyst and initiate the process of implantation. 
 
    In the mouse, an experimentally induced delayed implantation model provided the 
evidence that E plays an essential role in triggering the attachment of the embryo to the 
uterine luminal epithelium (24, 25). In these mice, which have undergone ovariectomy on day 
4 of gestation, implantation does not occur in the absence of ovarian E. continued 
administration of p allows the blastocysts to remain viable within the uterus but they fail to 
attach to the luminal epithelium in the absence of E. administration of E to these 
ovariectomized pregnant mice allows attachment of the blastocyst trophectoderm to the 
luminal epithelium within 12-24 hours, demonstrating a critical function of e-dependent 
signaling in initiating the implantation process (3, 4).  
 
    Once the embryo attaches itself to the uterine epithelium, the underlying stromal cells start 
to proliferate and then differentiate into unique decidual tissue that form the implantation 
chamber. Paracrine factors secreted by the decidual cells are critical regulators of uterine 
remodeling, maternal immune response, uterine angiogenesis and early embryonic growth. 
Decidualization is thus a prerequisite for successful implantation and establishment of 
pregnancy. 
 
    Previous studies established that P acting via its receptor plays a central role in regulating 
decidualization (5). In contrast, a functional requirement of E beyond the embryo attachment 
step remained ambiguous. An earlier study showed that administration of P alone to 
ovariectomized mice sustained the decidual response during experimentally induced 
decidualization, indicating a non-obligatory role of exogenous E in regulating this process 
(27). Conversely, it was reported that administration of ICI 182780, an estrogen receptor 
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(ER) antagonist, to mice severely impairs the formation of the decidual tissue, hinting that E 
acting via ER regulates this process (75). These apparently contradictory reports prompted us 
to further investigate the role of E in the uterus during decidualization. 
 
    In this study, we demonstrate, for the first time, that the decidual uterus is a novel site of de 
novo synthesis of E. The expression of P450 aromatase, a key enzyme that converts 
testosterone into E, is markedly induced in the pregnant mouse uterus during decidualization 
and plays an essential role in this process. Even in the absence of ovarian E, this locally 
synthesized E is able to support the advancement of the stromal differentiation program in an 
ovariectomized, P-supplemented pregnant mouse model.  
 
 
2.3. EXPERIMENTAL PROCEDURES 
Reagents- 
Progesterone and 17--estradiol were purchased from Sigma Chemical Co., St. Louis, MO. 
Letrozole was synthesized in laboratories of Novartis Pharma AG, Basel, Switzerland.  
 
Animals and Tissue Collection- 
All experiments involving animals were approved by the Animal Care Committee at the 
University of Illinois at Urbana-Champaign and the studies were conducted in accordance with 
the National Institutes of Health standards for the use and care of animals. Female mice (CD-1 
from Charles River, Wilmington, MA), in proestrus, were mated with adult males. The presence 
of a vaginal plug after mating was designated as day 1 of pregnancy. The animals were killed at 
various stages of gestation and the uteri were collected. The uteri were freed of embryos by 
repeated flushing.  
 
In some experiments, mice were ovariectomized on day 5 (morning) of pregnancy and injected 
daily with P or P in combination with letrozole (20 mg/kg body weight) from days 5-8. Mice 
were killed 6 h after the last injection and uteri were isolated. 
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Artificial Decidualization- 
Decidualization was experimentally induced in non-pregnant mice as described previously 
(76). Mice were ovariectomized and 14 days later were subcutaneously injected with E (2 
g/kg body weight) in 0.1 ml of sesame oil for three consecutive days. This was followed by 
daily injections of P (40 mg/kg body weight) for three consecutive days. Decidualization was 
then initiated in one horn by injection of 20l oil. The other horn was left unstimulated. The 
animals were treated with P or P plus letrozole for additional three days following decidual 
stimulation and then killed to collect the uterine tissue.  
 
Laser Capture Micro dissection RTPCR- 
Sections of uteri collected on d 4, 5, and 6 of pregnancy were subjected to LCM. Frozen 
sections (10 m) containing the implantation sites were placed on polyethylene naphthalate 
membrane slides (Molecular Devices) and dehydrated serially in ethanol and xylene. Using 
the Veritas microdissection instrument (Molecuar Devices), the mesometrial and anti-
mesometrial regions were excised and the decidual tissues were obtained. RNA was isolated 
from these tissues using a Pico Pure RNA isolation kit according to the manufacturer’s 
instructions. cDNA was synthesized from the isolated RNA using the Sensiscript reverse 
transcriptase kit (Qiagen) and subjected to real-time PCR using gene-specific primers. 
 
Immunohistochemistry- 
Polyclonal antibodies against aromatase (Abcam Inc, Cambridge, MA), Ki67 (BD Pharmingen, 
San Jose, CA), connexin-43 (Zymed Laboratories INC, Carlsbad, CA), and PECAM-1 (BD 
Pharmingen, San Jose, CA) were used for immunohistochemistry. Paraffin-embedded uterine 
tissues were sectioned at 4 µm and mounted on slides. Sections were washed in PBS for 20 min 
and then incubated in a blocking solution for 40 min before incubation with primary antibody 
overnight at 40C. Immunostaining was performed using an Avidin-Biotin kit for rabbit primary 
antibody (Vector Laboratories, Burlingame, CA). Sections were counterstained with 
hematoxylin, mounted, and examined under bright field. Red deposits indicate the sites of 
immunostaining. 
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Microarray Analysis- 
Mice were treated with or without letrozole and subjected to experimentally induced 
decidualization. Uteri were collected from untreated or treated animals at 72 h following the 
application of decidual stimulus (n=5). Total RNA was prepared from these tissues and subjected 
to microarray analyses using Affymetrix mouse arrays (GeneChip® Mouse Genome 430 2.0 
Array) following the Affymetrix protocol as described previously (58). 
 
Assay of Aromatase Activity- 
The aromatase activity in uterine and ovarian homogenates was determined by the tritiated water 
release assay as described previously (77). Briefly, 250 l of uterine or ovarian homogenates was 
incubated with 300 pmol of [1-3H] androstenedione for 6 h at 37 C. The results were calculated 
as fmol of [3H] water released per 24 h per mg of tissue. The aromatase activity was expressed as 
meanSEM of data derived from three independent experiments.  
 
Estradiol Measurement in Uterine Homogenates- 
The measurements of estradiol in uterine homogenates were performed by the Center for 
Research in Reproduction Ligand Assay and Analysis Core of the University of Virginia, 
Charlottesville, VA.  
 
 
2.4. RESULTS 
 
2.4.1. Ovarian E is not essential for decidualization 
In the mouse, attachment of the embryo to the uterine epithelium occurs on day 4 (midnight) 
of pregnancy. This event initiates the process of decidualization, which proceeds through 
progressive phases during days 5-8 of gestation. To assess the role of ovarian E during 
decidualization, mice were ovariectomized on the morning (6 AM) of day 5, approximately 6 
h following the attachment of the embryo to the uterine epithelium and then treated with 
exogenous P for three consecutive days (Fig. 2.1A). We found that administration of P alone 
to the ovariectomized pregnant mice maintained the decidualization process, and the growth 
and development of the implanted embryos (Fig. 2.1B). In these P-treated ovariectomized 
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uteri, the spatio-temporal expression of known markers of decidualization, such as 
progesterone receptor (PR) and prolactin-like protein type B (PLP-B), was found to be 
similar to that seen in normal pregnant uterus, indicating that P is sufficient to sustain 
decidualization in the absence of exogenous E (Fig. 2.1C). Collectively, these results 
indicated that ovarian E is not essential for maintenance of decidual response.  
 
2.4.2. Evidence for biosynthesis of E in the decidual uterus 
We next considered the possibility that production of E from an extra-ovarian source, such as 
the uterus itself, may contribute to the decidualization process. To investigate whether the 
uterus has the capacity to synthesize E de novo, we monitored the expression of various 
steroid biosynthetic enzymes in this tissue during early pregnancy. Total RNA was obtained 
from pregnant uteri on day 4 (morning) preceding implantation and on different days during 
the decidualization phase. The RNA samples were analyzed by reverse-transcription-coupled 
polymerase chain reaction (RT-PCR) to monitor the expression of various steroidogenic 
factors (Fig. 2.2A). We observed prominent expression of StAR (steroidogenic acute 
regulatory protein), P450SCC (P450 side chain cleavage enzyme), P450C17 (17lyase), 3 HSD 
(3beta-hydroxysteroid dehydrogenase), and 17-HSD-1 (17beta-hydroxysteroid 
dehydrogenase type 1) in the pregnant uterus in both preimplantation (day 4 morning) and 
decidualization (days 6 and 7) stages (Fig. 2.2B). Interestingly P450 aromatase, the product 
of the CYP19 gene, which converts testosterone to biologically active E exhibited markedly 
altered expression in pregnant uterus. The expression of aromatase mRNA was undetectable 
in the preimplantation uterus on day 4. However, a robust induction of this mRNA was 
observed in the decidual uterus on days 6 and 7 of pregnancy. Further analysis by Northern 
blotting confirmed that the expression of aromatase mRNA is initiated on day 5 of pregnancy 
and increases further on day 6 as decidualization progresses. It was diminished significantly 
on day 10 with the cessation of the decidual phase of gestation (Fig. 2.2C).  
 
    To further establish that the decidual cells are the actual sites of aromatase mRNA 
expression during pregnancy, we performed laser capture microdissection (LCM) to isolate 
these cells from uterine sections. Total RNA was prepared from the excised tissue and the 
expression of mRNAs corresponding to aromatase and alkaline phosphatase, a well-
established biomarker of decidual cells (8), was assessed by real-time PCR. A significant rise 
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in the level of aromatase mRNA expression, relative to its level on day 4 of pregnancy, was 
observed in the stromal tissue excised from the antimesometrial region on day 5 of gestation 
(Fig. 2.2D). A dramatic increase (~12 fold compared to day 4) in the level of both aromatase 
and alkaline phosphatase mRNAs was seen in the decidual cells collected from the 
antimesometrial area of uterine sections on day 6 of pregnancy. Collectively, these results 
confirmed that decidual cells are the actual sites of aromatase mRNA expression in the 
pregnant uterus.  
 
    We next examined the spatial expression of the P450C17 and aromatase proteins in normal 
pregnant mouse uterus using immunohistochemistry (Figs. 2.2E and 2.2F). The P450C17 
antibody, as expected, showed specific immunostaining in the Leydig cells of testis (Fig. 
2.2E panel a). Probing of uterine sections on day 6 of pregnancy with this antibody revealed 
prominent expression of P450C17 in decidual cells surrounding the implanted embryo (panel b 
and c). The authenticity of the aromatase antibody was first confirmed by immunostaining of 
sections of ovaries obtained from mice treated with pregnant mare serum gonadotropin 
(PMSG) (Fig. 2.2F panel a). As expected, intense aromatase expression was observed in the 
granulosa cells of the ovarian follicles stimulated with PMSG. Sections of ovaries collected 
from mice treated with human chorionic gonadotropin (hCG), which induces follicular 
rupture, luteinization, and suppression of aromatase expression, showed very little aromatase-
specific immunostaining (panel d). Immunohistochemical analysis of uterine sections showed 
no detectable aromatase immunostaining on day 4 (morning) of pregnancy prior to embryo 
attachment (panel b). However, on day 5 (panel c) and day 6 (panels e and f) of pregnancy, 
prominent expression of this enzyme was seen in decidualizing stromal cells at both 
antimesometrial and mesometrial regions surrounding the implanted embryo. Additionally, 
when primary stromal cells were isolated from pregnant uteri (preimplantation stage, day 4) 
and subjected to steroid-induced decidualization in vitro, the cytoplasmic staining of 
aromatase was clearly evident in the decidual cells (right panel).  
 
    The finding that aromatase is expressed in the decidual uterus raised the possibility that 
this tissue acquires the ability to produce E locally as it undergoes differentiation. We, 
therefore, assessed the enzymatic activity of aromatase in the uterus during decidualization. 
Mice were ovariectomized on day 5 (morning) of pregnancy, and treated with P in the 
presence or absence of letrozole, a well-known aromatase inhibitor. The uteri were collected 
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on day 6 and tissue extracts were prepared. As shown in Table I, extracts of day 6 pregnant 
uteri exhibited significant aromatase activity. Treatment of mice with letrozole resulted in a 
drastic reduction of this activity. We also determined the intrauterine levels of E (17-
estradiol) by radioimmunoassay. A significant amount of E (12 pg per ml) was detected in the 
extracts of decidual uteri on day 6. When the ovariectomized pregnant mice were treated with 
letrozole, the E (17-estradiol) level was undetectable in the uterine extracts. Taken together, 
these results confirmed that a functionally active aromatase enzyme is present in the decidual 
uterus and it catalyzes the production of E within this tissue. 
 
2.4.3. Uterine aromatase activity is critical for successful implantation 
We next investigated whether the intrauterine E produced by aromatase is necessary for the 
maintenance of pregnancy. Mice were ovariectomized on day 5 (6 AM) of pregnancy and 
given daily injections of P in the presence or absence of letrozole. Uteri were collected on 
days 8 and 10 of pregnancy and analyzed for the presence of implanted embryos. 
Morphological and histological analyses of letrozole-treated and untreated uteri revealed that 
administration of this drug severely impaired embryo implantation. Inhibition of aromatase 
activity led to a significant reduction in decidual mass and the majority of the implanted 
embryos failed to develop properly and were resorbed by day 10 (Fig. 2.3). This result 
indicated that the aromatase activity and local E production is essential for endometrial 
functions that support embryonic development during early pregnancy. 
 
2.4.4. Inhibition of uterine aromatase activity blocks stromal differentiation 
To determine whether the locally produced E controls endometrial functions independent of 
embryonic development, we subjected mice to experimentally induced decidualization in 
which a mechanical stimulation of the steroid-primed uteri triggers a decidual response in the 
absence of the implanting embryo (10). This artificial stimulus mimics the embryonic signal 
during implantation and sets in motion the decidualization program. 
 
Following this uterine stimulation, the mice were treated with P alone or P plus letrozole for 
three consecutive days (Fig. 2.4A). Uterine response was assessed at 72 h following the 
decidual stimulation. As shown in Fig. 2.4B, the uterine horns of the P-treated animals 
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exhibited a robust decidual response (left panel). In contrast, decidualization was severely 
compromised in mice that received P plus letrozole (right panel). Treatment with letrozole 
strongly inhibited the uterine wet weight gain, a classical hallmark of uterine decidual 
response (Fig. 2.4C).  
 
    We further assessed the impact of the loss of aromatase activity on decidual response by 
monitoring the uterine expression of alkaline phosphatase and decidual prolactin-related 
protein (PRP, 11), well-established biochemical markers of uterine stromal differentiation, in 
the presence or absence of letrozole. We also examined the expression of two additional 
factors: bone morphogenetic protein 2 (BMP2), a morphogen, and connexin 43 (Cx43), a gap 
junction protein, which are induced in stromal cells during decidualization and are known to 
play critical regulatory roles during this process (10, 12, 13). We found that the expression of 
mRNAs encoding alkaline phosphatase, PRP, BMP2, and Cx43 was markedly reduced in the 
letrozole-treated uteri (Fig. 2.4D). Consistent with these results, we observed a drastic 
reduction in the intensity of Cx43 immunostaining in the uterine sections of letrozole-treated 
mice (Fig. 2.4E). In contrast, the expression of ER mRNA was not significantly altered in 
response to the inhibitor. Taken together, these results indicated that aromatase-driven 
intrauterine E synthesis plays an important regulatory role in stromal cell differentiation.  
 
 
2.5. DISCUSSION 
 
In cycling rodents, the circulating E and P are produced and secreted by the concerted actions 
of ovarian granulosa and theca cells (78). The adrenal glands in rodents are incapable of 
synthesizing significant levels of these steroid hormones (79). In pregnant mice, the corpora 
lutea develop fully by day 3 of pregnancy and start to produce P, the level of which rises and 
remains elevated until mid-gestation (80). In contrast, the level of serum E, which is high on 
day 1 of pregnancy due to the preovulatory hormonal surge, declines and reaches ~15 pg/ml 
on days 2 and 3. The serum E level rises transiently to ~22 pg/ml on day 4 of pregnancy and 
plays a critical role in embryo attachment. Once the embryo attaches to the uterus, the 
ovarian E synthesis declines. During the decidualization phase, which lasts from days 5 
through 8 of gestation, the circulating level of E remains low at ~15 pg/ml (80). When the 
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ovaries were removed after embryo attachment, administration of exogenous P was found to 
be sufficient to sustain decidualization in pregnant mice (Fig. 2.1). The ovarian E, therefore, 
has no evident role in regulating uterine functions following the embryo attachment step. The 
present study reveals that the mouse uterus is able to carry out de novo synthesis of E during 
decidualization and it is this locally produced hormone, not the ovarian E, which critically 
supports the stromal differentiation process. 
 
    It was previously documented that during early pregnancy mouse endometrial stromal cells 
acquire the ability to express the steroidogenic enzymes required for the synthesis of P 
starting from cholesterol (81, 82). These factors are StAR, P450scc, and 3 HSD. The 
maximal activity of 3 HSD, which catalyzes the conversion of pregnenolone to progesterone, 
was detected in decidual tissue on days 6.5-7.5 of pregnancy (83, 84). Although these earlier 
reports provided evidence for the potential de novo production of P in the decidua, the 
physiological significance of this locally produced hormone remained unclear in the face of 
high serum levels of P originating from the corpora lutea during early phases of pregnancy. 
The expression of 17-HSD in the decidual tissue was also described previously (21). Our 
present study extends these earlier observations to demonstrate that the decidua expresses 
additional steroidogenic enzymes P450C17 and P450 aromatase. Therefore, a full complement 
of steroidogenic enzymes is expressed in the decidual tissue, which allows conversion of P to 
the androgenic precursors and their eventual aromatization to E. 
 
    The P450 aromatase, encoded by the CYP19 gene, is the key enzyme that catalyzes the 
conversion of C19 steroids to E (22, 23). Previous studies have shown that E is synthesized in 
a number of extragonadal sites such as breast, brain, and bone (85). This extragonadal E acts 
locally within the tissue in a paracrine or intracrine fashion. Although only a small amount of 
E is synthesized at these extragonadal sites, it is possible to attain high local concentrations of 
the hormone, which then exerts important biological effects within the tissue. It is noteworthy 
that aromatase expression in the pregnant uterus is initiated in the decidua on day 5 of 
gestation, immediately following implantation, and continues to increase as the stromal 
differentiation program advances during days 6 and 7. Our study is the first report 
documenting the expression of a functionally active aromatase in the maternal decidua. Since 
the ovarian E secretion drops to very low levels during decidualization, the local production 
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of this hormone in the decidual tissue at the implantation sites assumes high physiological 
significance.  
 
    Previous studies using the aromatase-null mice provided important insights into the role of 
E in various reproductive tissues. As expected, the homozygous mutant females were infertile 
(86). Histology of the reproductive tract of these mice demonstrated evidences of follicular 
depletion and the presence of hemorrhagic follicles in the ovaries, and diminution of uterine 
weight. Supplementation with E rescued the development of ovarian follicles and allowed the 
recovery of uterine weight, but did not ameliorate the reproductive failure in the mutant 
females (86, 87). Interestingly, transplantation of wild-type ovaries into aromatase-null 
female mice, which produces a circulating hormonal profile similar to that in wild-type mice, 
resulted in only a poor rescue of the pregnancy outcome (27). These results hinted at 
additional reproductive abnormalities in the mutant females, presumably at the level of the 
uterus, and are consistent with our current findings demonstrating a critical functional role of 
local E produced by uterine aromatase during implantation. 
 
    Our study revealed that the aromatase-driven intrauterine E plays an important role in 
decidualization. The expression of alkaline phosphatase and PRP, two well-characterized 
biomarkers of decidual response, was compromised when ovariectomized pregnant mice 
were treated with letrozole (8, 11). Furthermore, the expression of BMP2 and Cx43, critical 
regulators of stromal differentiation, were severely reduced in the presence of letrozole, 
indicating that decidualization is impaired when this inhibitor blocks aromatase activity. 
Previous studies reported that conditional ablation of BMP2 expression in the mouse uterus 
leads to infertility due to lack of decidualization (16). Recently we have shown that 
conditional loss of expression of Cx43, a major gap junction component in uterine stromal 
cells, impairs decidualization and angiogenesis during early pregnancy (88). The uterine 
expression of Cx43 is regulated by E (32, 89). It is, therefore, conceivable that the local E 
produced by the aromatase in the decidua controls Cx43 expression, which in turn contributes 
to the progression of decidualization by promoting gap junction communication between the 
stromal cells. 
 
    Another major finding of this study is that de novo production of E plays a novel and 
central role in the regulation of uterine neovascularization during early pregnancy. Although 
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a functional link between steroid hormone action and uterine angiogenesis in rodents has long 
been speculated, the precise nature of this regulation remained unclear. The detailed 
molecular candidates which are involved in modulating this decidual angiogenesis have been 
discussed in Chapter 4 of the dissertation.  
 
    Our study, therefore, uncovers important pathways regulated by local E signaling to 
regulate endometrial stromal differentiation and promote the establishment of new vascular 
structures within the decidual tissue, thereby critically sustaining decidualization during early 
pregnancy.  
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2.6. FIGURES 
 
Figure 2.1: Ovarian E is not necessary for decidualization 
 
 
 
Figure 2.1: Administration of exogenous P sustains decidualization in ovariectomized 
pregnant mice. 
 
A: Experimental scheme. Pregnant mice were ovariectomized on day 5 (D5) morning 
following the attachment of the embryo to the uterine epithelium on day 4 mid night. Mice 
were then treated with P (40 mg/kg bodyweight) for three days and uteri were collected on 
day 8 (D8). B: Gross morphology indicating the implantation sites in normal D8 uterus (left 
panel) and ovariectomized P-treated pregnant uterus (right panel). C: Sections of 
ovariectomized P-treated D8 and normal D8 uteri were subjected to immunohistochemical 
analysis using antibodies specific for progesterone receptor (PR, upper panel) and prolactin 
like protein type B (PLP-B, lower panel). am, m, and D denote antimesometrial, mesometrial, 
and decidua, respectively.  
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Figure 2.2: P450 aromatase is induced in the decidual uterus 
 
Figure 2.2: Evidence for local E biosynthesis in decidual uterus.  
 
A: Schematic representation of the Estradiol biosynthetic machinery. B: Total uterine RNA 
obtained on day 4 (D4), day 6 (D6) and day 7 (D7) of pregnancy were analyzed by RT-PCR 
for the expression of StAR, P450SCC, P450C17, 3 HSD, 17-HSD-1, and P450 aromatase. C. 
RNA from d 2 to d 10 of pregnancy was analyzed by Northern blotting with cDNA probes 
specific for P450 aromatase (Upper) and 36B4 (Lower). 
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Figure 2.2 (cont.) 
 
 
 
 
Figure 2.2: Evidence for local E biosynthesis in decidual uterus (cont). 
 
D: Top panel: Sections of uteri collected on days 4, 5, and 6, are shown before and after laser 
capture micro dissection (LCM). Bottom panel: Quantitation of the results of real-time PCR 
using gene-specific primers for aromatase and alkaline phosphatase. AM, M, E corresponds 
to antimesometrium, mesometrium and embryo respectively. (n=3, p<0.01) 
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Figure 2.2 (cont.) 
 
 
 
 
 
 
 
 
Figure 2.2: Evidence for local E biosynthesis in decidual uterus. 
E. Immunohistochemical analysis using the P450C17 antibody (Santa Cruz Biotech); sections 
of testes from male mice and uteri obtained from day 6 pregnant mice (panels a and b, 
respectively). F. Immunohistochemical analysis using the P450 aromatase antibody (Abcam); 
sections of ovaries collected 48 h after PMSG treatment and 16 h after hCG treatment (panels 
c and d, respectively), sections of uteri collected on day 4 (panel e), day 5 (panels f and g), 
and day 6 (panels h and i) of pregnancy. Panel j shows aromatase immunostaining in decidual 
cells when primary stromal cells isolated from uteri of day 4 pregnant mice were subjected to 
in vitro decidualization for 72 h. E, denote embryo. 
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Figure 2.3: Blockade of aromatase function leads to loss of pregnancy. 
 
 
 
 
 
 
Figure 2.3: Blockade of aromatase function leads to loss of pregnancy.  
Pregnant mice (day 5 morning) were ovariectomized and treated with exogenous P in 
combination with or without letrozole, an aromatase inhibitor (AI). The uteri were collected 
on day 10 of gestation (D10). The sections of D10 uteri treated with P only (Panel Day10-P) 
or P and AI (Panel D10-P+AI) were analyzed with eosin and hematoxylin stain. E, AM and 
M denote embryo, antimesometrial and mesometrial, respectively. 
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Figure 2.4: Inhibition of aromatase activity impairs uterine decidualization. 
 
 
 
 
 
Figure 2.4: Inhibition of aromatase activity impairs uterine decidualization. 
A: The hormonal regimen used in the artificial decidualization protocol is shown. Mice were 
treated with or without letrozole (20 mg/kg body weight). Uteri were collected 72 h after the 
application of stimulus. B: The extent of decidual response in ovariectomized mice treated 
with P (left panel) and P plus letrozole (P+AI, right panel) is shown. “s” and “us” denote 
stimulated and unstimulated uterine horns, respectively. C: The quantitative analysis of the 
average weight gain of stimulated relative to unstimulated horns in mice (n=5) subjected to 
artificial decidualization with or without letrozole treatment. The data are represented as 
meansSEM. 
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Figure 2.4 (cont.) 
 
Figure 2.4: Inhibition of aromatase activity impairs uterine decidualization (cont.) 
D: Uterine RNA was isolated 72 h after the initiation of decidualization and subjected to 
quantitative PCR analysis using gene-specific primers for ER, alkaline phosphatase (Alk), 
BMP2, connexin 43 (Cx43) and prolactin-related protein (PRP). P and P+AI represent uterine 
RNA from ovariectomized mice treated with P and P plus letrozole, respectively. E: 
Immunolocalization of Cx-43 protein in control (panels a and b) and letrozole treated (panels 
c and d) decidual uterus.   
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Table 2.1: Measurement of aromatase activity in the uterus during early pregnancy. 
 
The tissue homogenates were incubated with [1-3H] androstenedione for 6 h at 37 C to 
estimate the water release per mg of tissue. The intrauterine levels of estrogen were analyzed 
by radioimmunoassay. 
 
 
 
 
 
 
 
 
 
 
 
 
Tissue                                    fmol [H3] water                       Estradiol 
released/mg net wt/24 h (pg/ml
uterine extract)
------------------------------------------------------------------------------------------------
Uterus (Day 6) 243.2 12.123.22
Uterus (Day 6+AI) 8.71.5 Undetectable
Ovary 455.4                                     Not analyzed            
Table ITable 2.1 
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Chapter-3 
 
Fos-related antigen 1 (FRA-1) is an 
estrogen regulated transcription factor 
playing a critical role in mediating uterine 
decidualization 
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3.1. ABSTRACT 
 
During early pregnancy, the concerted actions of steroid hormones estrogen (E) and 
progesterone (P) via their cognate receptors orchestrate changes that make the uterine 
epithelium competent to blastocyst attachment and initiate implantation. Following this event, 
uterine stromal cells undergo steroid hormone-dependent transformation into 
morphologically and functionally distinct decidual cells in a unique process known as 
decidualization. An angiogenic network is also formed in the uterine stromal bed, critically 
supporting early development of the embryo. Our recent studies in the mouse have revealed 
that, following embryo attachment, de novo synthesis of E by the uterus drives stromal cell 
differentiation and neovascularization during the decidual phase of pregnancy. To address the 
mechanism of local E action in mediating this physiological process, we performed gene 
expression profiling and identified Fos-related antigen 1 (FRA-1), a member of the Fos 
family of transcription factors, as a downstream target of intrauterine E signaling. Further 
analysis using chromatin immunoprecipitation (ChIP) indicated direct recruitment of E 
receptor alpha (ER) to the Fra-1 promoter. Our study also revealed that signaling by 
ERK/MAPK pathway activates FRA-1 protein in differentiating endometrial stromal cells. 
To investigate the role of FRA-1 in decidualization, we attenuated Fra-1 expression by 
administering small interfering RNA (siRNA) in primary cultures of endometrial stromal 
cells. Our study demonstrated that signaling by ER regulates Fra-1 expression in the 
decidual uterus which plays a critical role in stromal differentiation and migration during 
early pregnancy. 
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3.2. INTRODUCTION 
 
Implantation, a critical event in early pregnancy, is initiated by attachment of the blastocyst to 
the wall of the uterine lumen. Subsequently, as the embryo invades through the luminal 
epithelium, the underlying stroma undergoes dramatic remodeling to form the specialized 
implantation chamber. Fibroblastic stromal cells proliferate and then differentiate to form the 
secretory decidual cells that support embryo growth until placentation ensues (2, 73, 74, 76). 
In addition, uterine endothelial cells proliferate forming an extensive vascular network in the 
decidual tissue to nourish the embryo and sustain its development (90, 91). This 
morphological and functional transformation of the pregnant uterus is regulated by concerted 
action of the steroid hormones estrogen (E) and progesterone (P) and their cognate nuclear 
receptors E receptor (ER) and P receptor (PR), respectively (2, 73, 92).  
 
    Ovarian E, along with P, regulates epithelial receptivity and embryo attachment during the 
pre-implantation period. Following embryo attachment, the role of progesterone (P) as a 
critical regulator of decidualization is well established but the effect of ovarian estrogen (E) 
during this process is not clear. Our recent studies, however, have shown that the decidual 
uterus expresses P450 aromatase, a key enzyme converting androgens to E, and is a novel site 
of E biosynthesis (8). This locally produced intrauterine source of E is able to support 
advancement of stromal differentiation even in the absence of ovarian E in an 
ovariectomized, P-supplemented pregnant mouse model. Administration of letrozole (a 
specific aromatase inhibitor) to these mice blocked stromal differentiation and impaired 
development of the angiogenic network during decidualization (8). 
 
    To further understand the mechanism of E action and to identify the downstream targets of 
intrauterine E during decidualization, we performed gene expression profiling of uterine 
tissue in the presence or absence of letrozole (8). Our study revealed Fos-related antigen 1 
(Fra-1) as one of the genes whose expression was significantly down-regulated in the 
letrozole-treated decidual uteri, indicating Fra-1 as a potential target of intrauterine E 
regulation during decidualization. FRA-1 belongs to the FOS family of transcription factors 
that includes c-FOS, FOS B, and FRA-2 as its other members. FRA-1 exhibits maximum 
homology to c-FOS, a known target of E/ER signaling in various cell types (93, 94). 
Activation of FOS proteins is mediated by mitogen-activated protein kinase (MAPK) 
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pathways. Phosphorylation of FRA-1 initiates its activation and heterodimerization by the 
highly conserved leucine zipper domains with the JUN proteins to constitute activator 
protein-1 (AP-1). Previously regarded as the negative regulator of AP-1 activity, the FRA-1 
comprising AP-1 complex was subsequently found to have important transforming activities 
in many tissues, governing cell proliferation, differentiation, and remodeling (95-97).  
 
    In this study we address the regulation and functional significance of FRA-1 during 
endometrial stromal cell differentiation. We provide strong evidence that locally produced 
intrauterine E signals via ER to regulate Fra-1expression, which is then activated by the 
ERK/MAPK pathway in differentiating uterine stromal cells. To elucidate the function of 
FRA-1 in decidualization, we utilized a primary culture system in which undifferentiated 
stromal cells isolated from pregnant mouse uterus undergo decidualization. Using this in vitro 
system, we provide evidence that FRA-1 plays a critical role in stromal differentiation and 
cell migration during early pregnancy. Additionally, we demonstrated that VEGFa an 
important regulator of angiogenesis is down regulated by FRA-1 indicating this transcription 
factor might contribute to the development of the decidual vascularization.  
 
 
3.3. EXPERIMENTAL PROCEDURES 
 
Reagents-  
Progesterone and 17--estradiol were purchased from Sigma Chemical Co. (St. Louis, MO). 
Antibodies against FRA-1, p-ERK1/2, ERK1/2, ERand Calnexin were obtained from Santa 
Cruz Biotechnology Inc., (Santa Cruz, CA).  
 
Animals and Tissue Collection-  
All experiments involving animals were approved by the Animal Care Committee at the 
University of Illinois at Urbana-Champaign and the studies were conducted in accordance 
with the National Institutes of Health standards for the use and care of animals. Female mice 
(CD-1 from Charles River, Wilmington, MA), in proestrus, were mated with adult males. The 
presence of a vaginal plug after mating was designated as day 1 of pregnancy. The animals 
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were killed at various stages of gestation and the uteri were collected after removal of the 
embryos by repeated flushing.  
 
Artificial Decidualization-  
Decidualization was experimentally induced in hormone primed mice as described previously 
(98). Briefly, mice were first ovariectomized and two weeks following ovariectomy, animals 
were injected with 100 ng of E in 0.1 ml of sesame oil for three consecutive days. This was 
followed by daily injections of 1 mg of P for three consecutive days. Decidualization was 
then initiated in one horn by injection of 50 l oil. The other horn was left unstimulated. The 
animals were treated with P for additional 3 days post stimulation and then killed to collect 
the uterine tissue.  
 
Mouse primary stromal cell culture-  
Isolation of mouse primary stromal cells was performed as discussed before (99). Briefly, day 
4 pregnant mouse uterus in the pre-implantation phase was subjected to enzymatic digestion 
using pancreatin and dispase enzymes for 1 hr at room temperature. The reaction was 
neutralized with 10% fetal bovine serum (FBS) and the supernatant containing the epithelial 
cell clumps were discarded. The partially digested tissue was then incubated with collagenase 
at 37C for 45 mins. The reaction was again neutralized with 10% FBS and vortexed to 
dispense stromal cells in the suspension. The resultant solution was passed through a 80m 
sieve to obtain a pure stromal cell population. Stromal cells obtained were cultured in 
complete medium containing 2% serum, and differentiation was induced by adding P.  
 
Immunohistochemistry-  
Polyclonal antibodies against FRA-1 (1:500 dilution) was used for immunohistochemistry as 
discussed before (100). Briefly, paraffin-embedded uterine tissues were sectioned at 4 µm 
and mounted on slides. Sections were washed in PBS for 20 min and then incubated in a 
blocking solution containing 10% normal goat serum for 30 min before incubation in primary 
antibody overnight at 40C. Immunostaining was performed using avidin-biotin kit for rabbit 
primary antibody (Vector Laboratories, Burlingame, CA). Sections were counterstained with 
hematoxylin, mounted, and examined under bright field. Red deposits indicate the sites of 
positive immunostaining. 
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Western Blotting-  
Whole cell extracts were prepared from mouse primary stromal cell cultures undergoing in 
vitro differentiation. Briefly, cells were washed with ice-cold balanced solution and lysed 
with the RIPA buffer (0.1% SDS, 0.5% Na-deoxycholate, 1% NP-40 in PBS) containing 
protease inhibitor cocktail, phenylmethylsulfonylfluoride (PMSF 0.1 mg/ml), and 
phosphatase inhibitor (1:1000; Sigma-Aldrich). This was followed by passing the cells 
through a 25 gauze syringe and centrifugation at 12000 rpm for 10 mins to remove the cell 
debri. Typically 20-50g of the protein extract was analyzed by SDS-PAGE and transferred 
to polyvinylidene fluride membrane (Amersham Biosciences Inc., Piscataway, NJ). The 
membrane was blocked with 5% milk in Tris buffered saline with 0.1% Tween 20 for 1 hr at 
room temperature, followed by incubation with a primary antibody against FRA-1, p-Erk1/2, 
Erk1/2, ER or calnexin. The blot was then incubated with HRP-conjugate secondary 
antibody for 45 mins at room temperature. The HRP was detected by chemiluminescence.  
  
Alkaline Phosphatase Activity Assay-  
For detecting alkaline phosphatase activity, cultured stromal cells were fixed in 4% 
formaldehyde for 10 mins and were incubated in the dark at 37 C for 60 m in 2 mM a-
Napthyl phosphate and 4 mM Fast violet in 0.1 M Tris HCl, pH 8.7. In the presence of 
substrate a-Napthyl phosphate, the uterine alkaline phosphatase activity releases 
orthophosphate and napthol derivatives from the substrate. The napthol derivatives are 
simultaneously coupled with the diazonium salt present in the incubating medium to form a 
dark dye marking the site of enzyme action. The slides were rinsed in water to terminate the 
enzymatic reaction and visualized under a microscope. 
 
siRNA transfection-  
siRNA corresponding to mouse FRA-1 (5'-3' sense GGAAGGAACUGACCGACUUtt, and 
antisense AAGUCGGUCAGUUCCUUCCtc), ER(5’-3’ sense 
GGGAGAAUGUUGAAGGCACAtt, and antisense UGUGCUUCAACAUUCUCCCtc) and 
a scrambled negative control were obtained from Ambion (Ambion Inc., Austin, TX) and 
transfected using the siPORT NeoFX transfection reagent according to the manufacturer’s 
instruction. Briefly, the annealed oligonucleotide was complexed with the transfecting 
reagent in Opti MEM I reduced serum medium. The complex containing 20nM of siRNA in 
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5l of the reagent was dispersed into culture plates while the primary cells were attaching. 
The cells were again subjected to a second silencing hit after 36 hrs with the Silent Fect 
reagent (Bio-Rad Inc., Hercules, CA) and cultured for an additional 24 to 48 hrs before 
analyzing gene expression.  
 
Chip Assays-  
Primary stromal cells isolated from day 4 pregnant mouse uterus were cultured for 24 hrs in 
the presence of steroid hormones and ChIP was performed using a commercially available kit 
from Upstate Biotech according to the manufacturer’s instruction (Millipore Inc, Billerica, 
MA). Briefly, 1.5x10^7 to 2x10^7 primary stromal cells were isolated from day 4 pregnant 
mouse uterus and cultured in 15cm plates in the presence of P. After 24hrs, the chromatin 
was crosslinked by adding 1% formaldehyde to the tissue culture medium for 10 mins at 
room temperature followed by adding 1M of glycine for 5 mins. The crosslinked chromatin 
was sonicated using a sonic Dismembrator Model 100 (Fisher Scientific) at power 4 and 5 
pulses (each for 12 seconds) to shear the DNA and obtain fragments from 200bp-1kb. The 
sonicated chromatin was diluted in ChIP dilution buffer and pre-cleared using protein G 
agarose. The input sample is 1% of the pre-cleared supernatant. Immunoprecipitation was 
performed over night at 4C with 5g of ER antibody (Santa Cruz Biotechnology Inc., Santa 
Cruz, CA) and 1g of each RNAPolII and the non specific anti mouse IgG antibodies. The 
immune complexes were further precipitated using protein-agarose beads and washed several 
times using different buffers, followed by elution of the protein/DNA complexes. Reverse 
crosslinking was then performed at 65C for 5 hrs and the DNA was purified using spin 
columns. Quantitative and regular PCR was performed on these purified DNA samples using 
the specific primers.  
 
Gel shift assay-  
Primary stromal cells were treated with DMSO or the ERK inhibitor for 2 hrs and subjected 
to EMSA following the manufacturer’s instruction (Thermo Scientific Inc., Rockford, IL). 
Briefly, nuclear extract was obtained using the NE-PRE nuclear and cytoplasmic extraction 
reagent kit from Pierce (Thermo Scientific Inc., Rockford, IL). EMSA was performed using 
equal amount (2-3g) of the nuclear extract in 20l of binding buffer (containing 50% 
glycerol, 1% NP40, 1M Kcl, 100mM Mgcl2 and 200mM EDTA) on ice for 10 mins before 
adding the biotinylated double stranded AP-1 probe (5’-CGCTTGATGAGTCAGCCGGAA-
 60
3’). After incubating for an additional 20 mins at room temperature, the samples were 
resolved on a 4% polyacrylamide gel. After the gel separation, the samples were transferred 
to a Nylon membrane (Ambion Inc., Austin TX) and crosslinked at 120 mJ/cm2 using a 
commercial UV-light cross-linker instrument. The biotin labeled DNA was then detected by 
chemiluminescence. To demonstrate the specificity of the DNA:protein complex, the nuclear 
extract was incubated for 10 mins with a 200 fold molar excess of unlabeled oligo before 
adding the labeled probes. To further demonstrate the presence of a specific protein in the 
complex, the nuclear extracts were mixed with 2g of anti-FRA-1 antibody and incubated for 
20mins on ice prior to adding the labeled probe.  
 
Wound healing assay –  
Primary stromal cells were cultured in the presence of steroid hormones to induce 
differentiation. FRA-1 expression was silenced in these cells using siRNA transfection. The 
confluent monolayer of mouse stromal cells were uniformly scratched with a 10l sterile 
pipette tip, the cell debris washed and the remaining cells were further cultured in fresh 
medium for an additional 48hrs. Wound width was monitored by phase contrast microscopy 
at regular intervals. The extent of migration was analyzed by calculating the wound closure 
and expressed as a percentage of the initial wound. 
 
 
3.4. RESULTS 
 
3.4.1. Intrauterine E regulates FRA-1 expression  during decidualization 
Our previous studies have shown that the mouse uterus is able to carry out de novo synthesis 
of E during decidualization, and it is this locally produced hormone that critically supports 
stromal differentiation (8). To identify potential downstream targets of intrauterine E that 
contribute to decidualization, we examined changes in uterine mRNA expression profiles in 
response to letrozole, which inhibits aromatase activity and thereby blocks estrogen 
synthesis. Uteri were collected from control or letrozole-treated mice 72 h following 
administration of the decidual stimulus. Total RNA isolated from these tissues was subjected 
to microarray analysis using Affymetrix murine GeneChip arrays. We identified several 
mRNAs whose expression was altered significantly in the decidual uterus in response to 
letrozole. One of the mRNAs whose level was markedly down-regulated encoded FRA-1, a 
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member of the FOS family of transcription factors that regulates a wide variety of biological 
processes such as cell proliferation, differentiation, and migration (101). 
 
    We verified the results of the microarray analysis by performing q-PCR analysis of RNA 
obtained from uteri of control and letrozole-treated mice. While significant down-regulation 
of Fra-1 mRNA was observed in the absence of intrauterine E, expression of ER remained 
unaltered in either treatment (Fig. 3.1A upper panel). Regulation by endogenous E was 
further confirmed by monitoring the expression of FRA-1 protein in uterine sections of mice 
treated with or without the inhibitor (Fig. 3.1A lower panel). A high nuclear accumulation of 
FRA-1 protein surrounding the site of decidual stimulation was observed in the control 
uterine sections (left panel). However, uterine expression of FRA-1 was significantly down-
regulated after letrozole treatment (right panel). We also confirmed intrauterine estrogenic 
regulation of FRA-1 by employing a well-established in vitro decidualization system. We had 
previously shown that primary cultures of stromal cells isolated from pregnant uteri (pre-
implantation, day 4) and subjected to P-induced decidualization exhibit strong aromatase 
expression; inhibition of this aromatase activity by letrozole severely impairs decidualization 
(8). As shown in Fig. 3.1B, administration of letrozole to primary cultures of stromal cells 
impaired FRA-1 expression in a dose-dependent manner, indicating that FRA-1 is a novel 
target of intrauterine E action during early pregnancy. 
 
3.4.2. Induction of FRA-1 during decidual phase of pregnancy 
We next studied the spatial expression of FRA-1 in pregnant mouse uterus using 
immunohistochemistry (Fig 3.2A, panel a-f). The nuclear expression of FRA-1 was induced 
in the stromal cells surrounding the embryo on day 4 midnight (panel a). As decidualization 
progressed, FRA-1 expression became prominent at the antimesometrial end on day 5 of 
pregnancy (panel b). The expression intensified in the decidual cells surrounding the embryo 
on day 6 (panel c and d) and gradually progressed from the antimesometrial end to the 
mesometrial region on day 7 (panel e and f). The nuclear FRA-1 expression was finally 
restricted in the mesometrial decidua by day 8 (Fig S1). We further monitored the expression 
of FRA-1 during experimentally induced decidualization in mouse uterus (Fig 3.2B, panel a-
c). Consistent with the expression profile during pregnancy, nuclear FRA-1 was initially 
observed surrounding the lumen 24hrs after stimulus (panel a) and the expression expanded 
to the surrounding layers by 64 and 72 hrs (panel b and c). These observations indicated that 
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the precise pattern of FRA-1 expression in the decidual cells is not induced by the embryo 
derived signals but a possible prerequisite for the uterine transformation during 
decidualization. 
 
3.4.3. E/ ER signaling regulates FRA-1 expression in differentiating stromal cells 
To further investigate steroid hormone regulation of FRA-1 in the uterus, we subjected mice 
to ovariectomy and treated them with E (100 ng) or P (2 mg) or vehicle for three days. 
Uterine stromal cells isolated from these animals were subjected to q-PCR analysis. As 
shown in Fig. 3.3A, the expression of P receptor (PR), a well-characterized E target, was 
significantly induced after E treatment, while ER expression remained unchanged in 
response to hormone treatments. E administration also led to marked induction of Fra-1, 
while P had no effect on Fra-1 expression. Immunohistochemical analysis of FRA-1 in the 
uterine sections from mice treated with steroid hormones revealed that E treatment led to 
strong nuclear localization of FRA-1 in the stromal compartment as well as in the epithelial 
cells (Fig. 3.3B, middle panel). In contrast, vehicle- or P-treated uterine sections exhibited 
markedly reduced, as well as cytoplasmic, expression of FRA-1 in stroma and luminal 
epithelium (left and right panels, respectively).  
 
    Using an in vitro decidualization system, we next investigated whether regulation of Fra-1 
by E in endometrial stromal cells is mediated via ER. We first monitored expression of Fra-
1 in stromal cell cultures from 24 h to 72 h, and found marked induction of Fra-1 by 24 h in 
culture (Fig. 3.4A, upper panel). Fra-1 expression was also observed at 48 h to 96 h, although 
at a reduced level. Immunolocalization studies indicated that nuclear expression of FRA-1 
protein was induced as early as 5 h in culture and then intensified by 24 h to 48 h of culture 
(Fig. 3.4A, lower panel). Consistent with the early induction of FRA-1, expression of ER 
mRNA and protein was induced significantly in endometrial stromal cells by 24 h of culture 
and declined by 72 h (Fig. 3.4B).  
 
    Using this in vitro primary cell culture model we wanted to address E mediated FRA-1 
regulation during decidualization. E action in the uterus is primarily mediated through the 
predominant intercellular nuclear receptor ER, thus we first wanted to examine if the E 
induced FRA-1 expression is regulated by the stromal ERs. A well characterized ER 
antagonist, ICI 182 780 was administered to primary mouse stromal cells undergoing in vitro 
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decidualization. 48 hrs after ICI treatment, the cells were harvested and the isolated RNA was 
subjected to real time PCR analysis. We observed a significant down regulation of the Fra-1 
transcript after treating cells with the ER antagonist (Fig 3.4C). We next investigated the role 
of ER in regulating Fra-1 expression by employing an RNAi-mediated gene knockdown 
strategy. Cultured endometrial stromal cells were treated with control scrambled siRNA or 
ER-specific siRNA for 48 h. We observed that cells transfected with ER siRNA exhibited 
more than 80% reduction in ER mRNA expression compared to cells transfected with 
scrambled siRNA (Fig. 3.4D, top panel). Down-regulation of ER also led to more than 60% 
reduction in Fra-1 mRNA expression in ER siRNA-treated cells compared to cells treated 
with scrambled siRNA. The expression of GAPDH remained unaltered in either treatment 
condition (Fig. 3.4D, top panel). Consistent with the mRNA expression profile, the protein 
levels of ER and FRA-1 were significantly down-regulated in the ER siRNA-treated cells 
(Fig. 3.4D, bottom panel). Taken together, these results indicate that E signaling via ER 
regulates expression of FRA-1 in differentiating uterine stromal cells.  
 
    To examine the possibility that FRA-1 is a direct target of ER action during mouse 
stromal cell decidualization, we first analyzed the region from -2000 to +200 bp in the Fra-1 
gene promoter using a bioinformatic tool (Transcription Element Search System 
http://www.cbil.upenn.edu/cgi-bin/tess/tess) and observed six potential ER binding sites. Fig. 
3.5A shows the location of these sites. We then performed a ChIP experiment to identify the 
predominant ER binding site in the Fra-1 promoter. Mouse primary stromal cells were 
fixed after 24 h of culture and the sheared chromatin was immunoprecipitated with antibodies 
against ER, RNA Pol II, and IgG. The precipitated and reverse cross-linked DNA was 
purified and subjected to RT-PCR followed by agarose gel analysis using six different primer 
sets, each flanking a potential ER binding site in the Fra-1 promoter. The pre-cleared 
supernatant served as the input control for each antibody. RNA Pol II and IgG were used as 
positive and negative controls for the ChIP experiment, respectively. As shown in Fig. 3.5B, 
amplicon 3, which encompassed an E response element (ERE) at about -1400 bp, exhibited a 
robust signal, indicating a potential ER binding site in the Fra-1 promoter (Fig. 3.5B upper 
panel). Q-PCR analysis from a number of independent experiments further confirmed this 
site for predominant ER occupancy in the Fra-1 promoter (lower panel). 
 
3.4.4. ERK-MAPK pathway dependent activation of FRA-1 in differentiating stromal cells 
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FRA-1 is known to be activated by the ERK1/2-regulated MAPK pathways in many cell 
types (102). To investigate whether MAPK pathways are involved in regulating FRA-1 
activity during endometrial stromal cell differentiation, we first monitored activation status of 
the ERK/MAPK pathway in mouse stromal cells. Protein extracts were prepared at regular 
intervals from cultured stromal cells undergoing in vitro differentiation and subjected to 
Western blot analysis using antibodies against the phosphorylated and total forms of ERK 
protein. As shown in Fig. 3.6A, the level of total ERK remained unaltered for the duration of 
culture. However, a marked elevation in the level of phospho-ERK1/2 was observed 12 h 
after initiation of culture and was sustained until 96 h. Consistent with the phospho-ERK 
status, we observed a similar expression profile of FRA-1, raising the possibility that FRA-1 
is activated by the ERK1/2 pathway during in vitro endometrial stromal differentiation. 
 
    To investigate whether FRA-1 activation is linked to the ERK pathway, we performed a 
gel shift assay to investigate whether the ERK pathway affects DNA binding activity of FRA-
1 (Fig. 3.6B). Nuclear extracts isolated from mouse primary stromal cells treated or untreated 
with the ERK inhibitor, UO126, were incubated with the biotinylated oligonucleotide-
containing FRA-1 binding site, the AP-1 probe. The protein-DNA complexes were analyzed 
by gel electrophoresis. In the presence of nuclear extract and the probe an intense signal was 
detectable, indicating formation of a protein-DNA complex (lanes 2-7), while no signal was 
detected in the absence of nuclear extract (lane 1). Complex formation was significantly 
reduced in response to a 200-fold molar excess of unlabeled AP-1 probe (compare lanes 2, 3 
to 4, 5) or after addition of anti-FRA-1 antibody (compare lane 2 to 6 and lane 3 to 7), 
indicating that the protein-DNA complex formation is specific to the AP-1 probe and to 
binding of FRA-1 protein to the AP-1 probe, respectively. Addition of ERK inhibitor, 
UO126, further reduced the signal intensity, suggesting that binding activity of FRA-1 is 
compromised in the presence of ERK inhibitor (compare lane 6 to 7). Together, these 
experiments indicated that the ERK1/2 pathway is important in activating FRA-1 in 
endometrial stromal cells undergoing decidualization. 
 
3.4.5. Fra-1 is a critical mediator of stromal cell decidualization 
We next addressed the role of FRA-1 in stromal differentiation by RNA interference-
mediated knockdown of its gene expression. Primary stromal cells were isolated from uteri of 
day 4 pregnant mice as described previously and transfected with siRNA targeted specifically 
to the Fra-1 mRNA. Control cells were transfected with a scrambled siRNA (NC). Cells 
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transfected with Fra-1 siRNA exhibited a remarkable decrease in Fra-1 mRNA expression 
(Fig. 3.7A, upper panel) and FRA-1 immunostaining (Fig. 3.7A, lower panel), whereas 
transfection with NC siRNA did not affect Fra-1 expression. We next investigated the 
functional consequences of this blockade of Fra-1 expression during stromal differentiation. 
The siRNA-mediated down-regulation of Fra-1 in stromal cells led to a significant decline in 
the level of alkaline phosphatase (ALP) (Fig. 3.7B) and PRP (Fig. 3.7C), the well-
characterized markers of stromal decidualization. In contrast, the ER level remained 
unaltered in cells treated with either Fra-1 or NC siRNA. These results indicated that Fra-1 
expression is critical to successful progression of stromal differentiation during 
decidualization. VEGFa, a known cytokine mediating the development of angiogenesis 
during decidualization was also significantly repressed after FRA-1 attenuation (Fig 3.7C).  
Additionally, impairment of FRA-1 activity by disrupting ERK phosphorylation through the 
administration of UO126 also altered stromal cell decidualization in vitro (Fig 3.7D). The 
defect was again addressed by examining enzymatic activity of Alkp (upper panel) and Prp 
expression (lower panel) after inhibitor treatment in stromal cells. 
 
3.4.6. Fra-1 regulates stromal cell remodeling through extracellular matrix proteins  
Invasion of an embryo into the uterine stroma necessitates extensive remodeling of the 
differentiated decidual cells to accommodate the growing embryo. Because FRA-1 is known 
to regulate cell migration and motility in a variety of cell types, we next investigated the role 
of FRA-1 in stromal cell remodeling, using an in vitro wound-healing assay. As shown in 
Fig. 3.8A, stromal cells transfected with Fra-1 siRNA displayed a significant decrease in cell 
motility compared to cells transfected with NC siRNA. Quantification of wound closure 
demonstrated that cells treated with the NC siRNA exhibited more than 80% wound closure 
at 24 h and almost complete closure by 48 h, while those treated with Fra-1 siRNA exhibited 
less than 30% wound closure even after 48 h of culture (Fig. 3.8A and Fig. 3.8B). 
 
    To further clarify this impairment in wound closure in Fra-1-silenced cells, we assessed 
proliferation of these cells. Stromal cells transfected with control NC or Fra-1 siRNA were 
fixed at 48 h after the wound-healing assay and subjected to immunocytochemical analysis 
using the anti-Ki67 antibody. Drawing from five independent fields of NC and Fra-1 siRNA 
transfected cells, the cells that displayed positive Ki67 staining were then analyzed by paired 
t-tests (Fig. 3.8C). We failed to observe any significant difference (P = 0.132) in cell 
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proliferation between the two siRNA-treated cell populations, indicating that the defect in 
wound healing in Fra-1-silenced cells might instead be due to impaired cell migration. 
 
    To identify possible downstream mediators of Fra-1 involved in stromal cell migration and 
remodeling, cells treated with NC- and Fra-1-specific siRNAs were subjected to a wound-
healing assay, followed by RNA extraction and q-PCR analysis to measure expression of 
several matrix metalloproteinases (MMPs). We observed significant down-regulation in the 
expression of MMP7, MMP9, and MMP13, while expression of MMP2 remained unaltered 
(Fig. 3.8D). CD44, a glycoprotein molecule involved in cell migration and a well-
characterized target of FRA-1 in various cell types, was also significantly down-regulated in 
cells transfected with Fra-1 siRNA compared to cells treated with NC siRNA (Fig. 3.8D). 
Collectively these results indicated that FRA-1 plays a critical role in stromal cell migration 
by influencing expression of extracellular matrix modulators, thereby controlling invasion of 
the embryo during decidualization.  
 
 
3.5. DISCUSSION 
 
During early pregnancy in the mouse, E along with P plays a pivotal role in preparing the 
uterus for embryo implantation. While ovarian E is critical during the pre-implantation 
period, we recently reported that a local source of intrauterine E driven by the presence of 
P450 aromatase in decidual uterus contributes significantly, after embryo attachment, to 
sustaining stromal differentiation and uterine neovascularization (30). To identify 
downstream targets of this local intrauterine E, we disrupted the functional E biosynthetic 
pathway by administering letrozole, a potent aromatase inhibitor, and performed gene 
expression profiling. Expression of the transcription factor Fra-1 in the decidual uterus was 
significantly repressed in response to letrozole, indicating Fra-1 as a possible mediator of E 
action. Our study also showed that during decidualization FRA-1 is localized primarily in the 
nuclear compartment of differentiating stromal cells, which also express high levels of ER 
(Fig. 3.2). Therefore, it is reasonable to speculate that, with the onset of differentiation, FRA-
1 is induced in response to E/ER signaling in decidual cells. In the classical signaling 
pathway, ER regulates gene expression by binding to EREs in the upstream regulatory 
regions of target genes. So far, PR is the only factor that has been identified as a direct target 
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of ER in endometrial stromal cells. We are now reporting that ER regulates Fra-1 in 
uterine stroma by binding to the ERE located 1400 bp upstream in the Fra-1 promoter (Fig. 
3.5B).  
 
    FRA-1 undergoes phosphorylation at the serine and threonine residues to achieve its 
activation and sustained nuclear expression (103). ERK/MAPK regulates activation of FRA-1 
by phosphorylation and also governs the stabilization of this nuclear protein by preventing its 
proteasomal degradation (102, 104). In the uterus during implantation, induction of ERK 
could result from a variety of stimuli such as growth factors, mitogens, or cytokines. E is 
known to regulate EGF and IGF signaling in mouse uterus, which might govern the 
activation status of ERK1/2 (22, 105, 106). Our study revealed that ERK signaling is 
significantly induced while stromal cells differentiate, and thereby activates FRA-1 and 
sustains its nuclear expression during decidualization (Figs 3.6A). Activated FRA-1 
dimerizes with members of the JUN family of proteins to constitute the AP-1 transcription 
factor complex, and binds to AP-1 consensus sites in the target gene promoter. Gel shift 
analysis showed binding activity of FRA-1 and specific complex formation during stromal 
cell differentiation. Because ERK regulates activation of FRA-1, disruption of the ERK 
pathway inhibited the DNA binding activity of FRA-1 and severely impacted complex 
formation (Fig. 3.6B). It is, however, possible that inhibition of the ERK pathway may 
additionally alter the activation status of the JUN partner, resulting in decreased DNA 
binding and complex formation.  
  
    FRA-1 is important in regulating cell proliferation, differentiation, and migration in 
various cell types. Previous studies indicated that mice lacking c-FOS develop osteoporosis 
due to a defect in osteoclast lineage. This defect in differentiation could be rescued by over-
expression of FRA-1, suggesting overlapping functions of c-FOS and FRA-1 in osteoclast 
differentiation (107). Additionally, accelerated differentiation of osteoprogenitors to form 
mature osteoblasts occurs in response to ectopic expression of FRA-1 (108). Consistent with 
these observations, studies employing a conditional knockout model of Fra-1 clearly 
established the critical role of FRA-1 in osteoblast differentiation (109). While expression of 
c-FOS and JUN proteins in the uterus had been previously reported, the expression and 
function of FRA-1 in stromal differentiation was not investigated until now (110, 111). In this 
study we observed robust induction of FRA-1 in differentiating endometrial stromal cells 
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(Fig. 3.7A). Attenuation of FRA-1 expression in these cells severely influenced the 
expression of decidualization biomarkers, indicating a critical role of Fra-1 in stromal cell 
differentiation (Fig. 3.7B).  
 
    Decidualization is accompanied by an extensive uterine neo-vascularization (35, 112). 
Abundant VEGF expression in the differentiating stromal cells critically regulates the 
angiogenic growth, reduction of which results in a severe impairment of the vascular 
structure development (33). FRA-1 is known to be involved in angiogenesis during tumor 
progression by regulating VEGF expression (113). In our studies we observed that FRA-1 
also governs VEGF expression in endometrial differentiating stromal cells. Additionally, 
during decidualization, the gradual shift in FRA-1 expression from the antimesometrium to 
the mesometrial decidua further supports the previous observation, indicating a probable role 
of the transcription factor in the development of uterine angiogenesis (Fig. 3.9). We speculate 
that FRA-1 in the decidual cells at the mesometrial pole regulate the VEGF production which 
acts on the surrounding endothelial population to modulate the uterine angiogenic 
development. Further, these studies also indicated FRA-1 as one of the mediators of 
intrauterine E action in regulating the decidual vasculature.  
 
    Our study also revealed the critical role of Fra-1 in stromal cell migration during 
decidualization. During decidualization, invasion of the embryo through the maternal 
endometrium requires extensive uterine remodeling, particularly near the site of embryo 
attachment. This remodeling involves reorganization of the differentiating stromal cells to 
accommodate the growing embryo. A recent study in a co-culture of human blastocyst on a 
monolayer of endometrial stromal cells used time-lapse microscopic images to capture the 
migration of stromal cells away from the site of the embryo (114). It is likely that such 
remodeling is also operational during implantation in the mouse; however, the regulators of 
stromal cell migration during decidualization remain poorly understood. This study used the 
wound-healing assay, a well-established experimental read-out of cell migration and 
remodeling, to assess the role of Fra-1 in cellular migration. Quantification of wound closure 
in stromal cells transfected with Fra-1 siRNA revealed significant impairment in cell 
mobility compared to the control siRNA-treated stromal cells (Fig. 3.8). Furthermore, our 
studies showed that the migration defect of FRA-1-deficient stromal cells is due to improper 
expression of factors that critically regulate cellular remodeling and motility. 
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    Previous studies in various cell types have shown that MMPs and the tissue inhibitors of 
metalloproteinases (TIMP) play active roles in cell migration and remodeling (37, 38). 
Interestingly, it has been reported that administration of hydroxamic acid, an inhibitor of 
metalloproteinases, to pregnant mice severely impacts the progress of decidualization 
indicating a critical role of MMPs in maintaining the implantation chamber (115). CD44, a 
principal hyaluronic receptor with known functions in cell adhesion, trafficking, and 
migration, is another strong candidate for regulating endometrial remodeling, and prominent 
expression of CD44 has been reported in decidual cells surrounding the embryo (116). 
Previous studies have also reported that FRA-1 governs the expression of MMP9, MMP13, 
and CD44 in various cell types and in pathological situations such as mesothelioma (117-
119). In this study, we found that expressions of several MMPs and CD44 are regulated by 
FRA-1 in differentiating stromal cells. Thus, FRA-1 governs stromal cell migration during 
decidualization by regulating the expression of these molecules. 
 
    In summary, our study indicates that intrauterine E, functioning via ER, regulates the 
expression of transcription factor FRA-1 in the decidual uterus. FRA-1 is then activated by 
ERK/MAPK signaling pathways. The activated FRA-1 plays a pivotal role during early 
pregnancy by regulating gene expression to promote stromal cell differentiation and 
migration during decidualization.    
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3.6. FIGURES 
 
Figure 3.1: Intrauterine Estrogen signaling regulates FRA-1 expression during stromal 
cell decidualization. 
 
 
 
Figure 3.1: Intrauterine Estrogen signaling regulates FRA-1 expression during stromal 
cell decidualization.  
 
Mice were ovariectomized and subjected to artificially induced decidualization as described 
in experimental procedures. Cohorts of these animals were treated with P alone (P) or P along 
with aromatase inhibitor (P+AI) and the uterine horns were separately collected after 72hrs of 
stimulus (n=5). A: Stimulated uterine samples were subjected to RNA isolation and 
quantitative PCR (q-PCR) analysis using Fra-1 and ER specific primers (upper panel) and 
to immunohistochemical analysis using the anti-FRA-1 antibody (lower panel). Lu indicates 
the lumen of the uterus. (n=3, p<0.05) 
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Figure 3.1(cont.) 
 
 
 
 
 
 
 
Figure 3.1: Intrauterine Estrogen signaling regulates FRA-1 expression during stromal 
cell decidualization. 
 
B: Stromal cells isolated from day 4 of pregnancy were subjected to in vitro decidualization 
in the presence of increasing concentration of AI for 72hrs. The RNA was analyzed with q-
PCR to monitor the expression of Fra-1 transcript. (n=3, p<0.05) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1BFigure .1B 
*
 72
Figure 3.2: FRA-1 expression is induced in mouse stromal cells as decidualization 
progresses. 
 
 
Figure 3.2: FRA-1 expression is induced in mouse stromal cells as decidualization 
progresses. 
 
A: Uterine cross sections were obtained from mice on different days of pregnancies (a-f) and 
immunohistochemical analysis was performed against FRA-1 on day 4 midnight (a), day 5 
(b), day 6 (c, d), day 7 (e, f). Higher magnification of days 6 and 7 are shown in d and f 
respectively. B: Sections from mice subjected to experimentally induced decidualization (a-c) 
were obtained and FRA-1 localization at 24hr (a), 64 hrs (b) and 72hrs (c) after application of 
decidual stimulus was monitored. 
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Figure 3.3: FRA-1 is a downstream target of E in mouse uterine stromal cells 
 
 
 
 
 
Figure 3.3: FRA-1 is a downstream target of E in mouse uterine stromal cells 
 
Non-pregnant animals were ovariectomized and treated with vehicle (oil), E or P (n=5). 
Stromal cells were isolated 24 hrs after the last treatment. A: RNA extracted from isolated 
stromal cells was subjected to q-PCR analysis using specific primers for ER, PR and Fra-1. 
B: Immunohistochemical analysis for FRA-1 in the uterine cross sections of mice treated 
with vehicle, E and P. (n=8, p<0.05) 
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Figure 3.4: Fra-1 is directly regulated by E/ERa signaling during decidualization 
 
 
Figure 3.4: Fra-1 is directly regulated by E/ERa signaling during decidualization 
 
Primary stromal cells isolated from day4 pre-implantation mouse uterus were subjected to in 
vitro differentiation in the presence of P. A and B: Cells were isolated at regular intervals to 
analyze the mRNA level of Fra-1(Fig 3.4A) and ER (Fig 3.4B) expression by q-PCR 
(upper panel) and protein by immunocytochemistry (ICC) (lower panel).(n=7, p<0.05) 
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Figure 3.4 (cont.) 
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Figure 3.4 (cont.) 
 
 
 
 
 
 
 
Figure 3.4: Fra-1 is directly regulated by E/ERa signaling during decidualization 
 
C: Stromal cells isolated from the pre-implantation uterus were cultured for 48hrs in the 
presence of vehicle (V) or P plus antiestrogen ICI-182 780 (ICI).  RNA was extracted and the 
transcript level of Fra-1 was analyzed by q-PCR. D and E: The endogenous expression of 
ER was silenced by transfecting a siRNA specific to its transcript in mouse primary stromal 
cells. After 48hrs of transfection, RNA was subjected to q-PCR analysis using gene specific 
primers for ER, Fra-1 and GAPDH. The relative levels of gene expression in the ER 
siRNA treated samples compared to the negative control (NC) siRNA treated samples are 
shown. (average ± SD) (D). Whole cell protein extract obtained from ER siRNA and NC 
siRNA treated cells were subjected to Western blot (WB) analysis against FRA-1, ER and 
the control protein calnexin (E). (p<0.01, n=3) 
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Figure 3.5: Recruitment of ER to Fra-1 promoter 
 
Figure 3.5: Recruitment of ER to the Fra-1 promoter  
A: Schematic representation of the potential E response elements from -2000bp to +200bp of 
Fra-1 gene promoter (accession no: AF017128).  The candidate binding sites comprising of 
half EREs are located at -1829bp (ERE 1), -1677bp (ERE 2), -1408bp (ERE 3), -1114bp 
(ERE 4), -994 bp (ERE 5), -158bp (ERE 6) and the corresponding PCR amplicons are 
amplicon 1 (-1964 to -1729), amplicon 2 (-1694 to -1505), amplicon 3 (-1523 to -1373), 
amplicon 4 (-1204 to -1050), amplicon 5 (-1071 to -931), amplicon 6 (-275 to -118) flanking 
each potential binding site.  B: Mouse primary stromal cells were cultured in presence of P 
for 24 hrs, formaldehyde fixed and subjected to ChIP protocol. Immunoprecipitation (IP) was 
performed using the ER antibody. IP with RNA PolII and IgG antibodies were used as the 
positive and negative control respectively. RT-PCR using 32 cycles was performed to 
amplify the purified DNA. The input lane represents 1 % of each soluble chromatin. IP lane 
represented the amplified PCR product for each amplicon (upper panel). The 
immunoprecipitated promoter-DNA fragments were reverse crosslinked and amplified by q-
PCR using a pair of primers for each amplicon and the fold change was calculated (lower 
panel). The data shown is a representative of 3 independent experiments. 
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Figure 3.6: ERK-MAPK pathway dependent regulation of FRA-1 activation in 
differentiating stromal cells. 
 
 
 
 
 
Figure 3.6: ERK-MAPK pathway dependent regulation of FRA-1 activation in 
differentiating stromal cells.  
 
A: Equal amounts of whole cell protein extract isolated from cultured stromal cells were 
analyzed by Western blotting (WB) with antibodies directed to phosphorylated form of 
ERK1/2 (pERK1/2), total ERK1/2 and FRA-1. Calnexin was used as a loading control.  
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Figure 3.6 (cont.) 
Figure 3.6: ERK-MAPK pathway dependent regulation of FRA-1 activation in 
differentiating stromal cells. 
 
B: Equal amount of the nuclear extract treated with vehicle DMSO (lanes 2, 5 and 6) and the 
inhibitor UO126 (lanes 3, 4, and 7) were subjected to gel shift assay to analyze the protein 
binding to the biotinylated labeled probe containing AP-1 elements. The representative image 
illustrates the formation of a protein-DNA complex to the biotinylated free probe. Lane 1 
serves as a control showing no complex formation in absence of the nuclear extract. Presence 
of 200-fold molar excess of unlabeled AP-1 probes competed out the biotinylated probe 
binding indicating that the complex formation is specific to AP-1 (lanes 4 and 5). Incubation 
with anti-FRA-1 specific antibody (lanes 6 and 7) reduced the extent of complex formation 
indicating FRA-1 complexes with the nuclear extract and in presence of the antibody, it 
reduced the extent of protein-DNA complex formation (compare lane 2 with lane 6). 
Addition of ERK inhibitor UO126 significantly reduced the complex formation indicating 
binding activity of FRA-1 is compromised in the presence of ERK inhibitor (compare lane 6 
to lane 7). 
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Figure 3.7: FRA-1 is a critical regulator of mouse stromal cell decidualization 
 
Figure 3.7: FRA-1 is a critical regulator of mouse stromal cell decidualization 
Primary mouse stromal cells transfected with FRA-1 and NC specific siRNA, were collected 
48hrs after transfection. A: Down regulation of Fra-1 mRNA (upper panel) and protein 
(lower panel) was assessed by qPCR, ICC and WB respectively. B: Alkaline phosphatase 
(Alkp) activity in NC (a) and FRA-1(b) siRNA treated cultured cells. C: Expression of 
decidualization markers like Alkp, Prp and VEGF. D: Mouse cultured stromal cells were 
treated with vehicle or ERK1/2 inhibitor UO126 for 48hrs and assessed for enzymatic 
activity of Alkp (upper panel) and transcript levels of the decidualization markers Alkp and 
Prp (lower panel). (n=3, p<0.05) 
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Figure 3.7 (cont.) 
 
 
 
 
 
 
 
 
 
 
Figure 3.7: FRA-1 is a critical regulator of mouse stromal cell decidualization 
 
D: Inhibition of FRA-1 activity further impaired stromal cell differentiation as indicated by 
the decreased enzymatic activity of Alkp (left panel) and expression of decidual biomarkers 
(right panel). (n=3, p<0.05) 
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Figure 3.8: FRA-1 modulates uterine stromal cell mobility through extracellular matrix 
proteins 
 
Figure 3.8: FRA-1 modulates uterine stromal cell mobility through extracellular matrix 
proteins. 
 
Primary mouse stromal cells were transfected with FRA-1 specific siRNA and NC siRNA or 
incubated with a transfection reagent serving as a mock control. siRNA transfected confluent 
monolayers of primary stromal cells were subjected to wound healing assay to monitor the 
cell migration. A: Cells were photographically recorded under phase contrast microscopy 
after 0hr, 24hr and 48hr of the wound. B: Quantitative representation of stromal cell 
migration after scratching from three independent experiments are shown *p<0.01, 
**p<0.001. 
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Figure 3.8 (cont.) 
 
 
 
 
 
Figure 3.8: FRA-1 modulates uterine stromal cell mobility through extracellular matrix 
proteins 
 
C: Cells were fixed after 48hrs of the migration assay and subjected to immunocytochemical 
analysis using anti-Ki67 antibody. Left panel: Red dots indicate cells positive for Ki67 and 
undergoing active proliferation after transfection with control (panels a and b) and FRA-1 
siRNA (panels c and d). Right panel: Photomicrographic representation of the staining 
quantitatively expressing the Ki67 positive cells in NC and FRA-1 siRNA treated cells. D: 
RNA isolated was subjected to q-PCR to assess the relative levels of the gene expression of 
MMP2, MMP7, MMP9, MMP13 and CD44 compared to the mock control (average ± SEM). 
(n=3, p<0.05).  
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Figure 3.9: Expression of FRA-1 in the mesometrium on Day 8 
 
FRA-1 expression on day 8 uterus is restricted to the mesometrial end surrounding the blood 
vessels as shown in the right panel (arrow pointing the blood vessels) 
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Chapter-4 
 
Intra-uterine estrogen signaling critically 
regulates decidual angiogenesis 
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4.1. ABSTRACT 
 
During implantation, the development of new blood vessel plays an important role 
contributing to embryo growth and sustaining early pregnancy. Endothelial cells, the major 
cell type in these blood vessels and capillary networks are the primary target of several cues 
in the uterine milieu that modulate active vessel formation. Fluorescence assisted cell sorting 
indicated around 20% of the cells in an isolated deciduoma is endothelial in nature. Although 
the regulation of these cells by the steroid hormones estrogen (E) and progesterone (P) has 
been addressed in previous studies, the underlying mechanism directing uterine neo-
angiogenesis is not well characterized. In a recent study we identified the local biosynthesis 
of E in uterine decidual cells, and its pivotal role in sustaining implantation. Microarray 
analysis after disrupting this E biosynthetic machinery revealed significant population of 
molecules involved in regulating angiogenesis, indicating a significant contribution of this 
steroid in the formation of decidual vasculature. Here, we have addressed the possible 
mechanisms through which local E govern angiogenesis. The regulation primarily involved 
the expression of paracrine factors from decidualized stromal cells that act on the endothelial 
population governing its proliferation and maturation. In addition, we also monitored a subset 
of players that directly regulate endothelial cell growth, down regulated in the absence of E 
signaling. Collectively, this study addressed novel E regulated maternal signaling pathways 
that are critical in governing uterine vascularization and angiogenesis during early pregnancy.    
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4.2. INTRODUCTION 
 
Differentiation of the fibroblast stromal cells to the specialized cell typically characterizes the 
deciduous transformation of the uterine endometrium in early pregnancy. The development of 
blood vessels during this process is considered as a major hallmark event, significantly 
contributing to the formation of an implantation chamber (73, 74). In mouse, the initial 
vasculature is identified early on day 4 evening demarcating the implantation sites in uterine 
horns. Following embryo attachment, with progression of decidualization, a dramatic 
vascular remodeling prepares the uterine endometrium to support embryo growth. Formation 
of this vasculature and capillary network becomes predominant by day 7 of pregnancy at the 
mesometrial pole, also demarcating the future site of placentation (2, 76, 120).  
 
    Development of extensive blood vessels in a relatively a-vascular structure sustains growth 
of a developing tissue. In normal physiological condition such spurious growth of vasculature 
or angiogenesis is characteristic in the adult female reproductive cycles during cyclical 
remodeling of the growing endometrium and during corpus luteum formation in ovary (3, 
121). Vascular network develops by the migration of endothelial cells from pre-existing 
blood vessel structures and their subsequent morphogenesis at a distant site. The process 
requires coordinated execution of a series of cellular events beginning with degradation of the 
endothelial basement membrane and extracellular matrix surrounding the parent vessel. 
Endothelial cells then migrate from the origin and proliferate along the chemo-attractant 
gradient towards an angiogenic signal, resulting in the formation of nascent capillary sprouts 
(17).  
 
    Steroid hormone signaling critically orchestrates the overall implantation process. In 
addition to its contribution in regulating stromal cell differentiation, estrogen (E) and 
progesterone (P) also play major roles in the vascular development and angiogenesis. While 
studies have indicated that the hormonal regulation of blood vessel formation in non-pregnant 
ovariectomized mice is regulated by P (31), during pregnancy, prior to the embryo 
attachment, ovarian E is the known enhancer of the vascular permeability at sites of 
blastocyst attachment (35, 122). Additionally, previous observations in our laboratory have 
identified the major contribution of a E regulated gap junction molecule, Connexin-43 (Cx-
43), in governing uterine angiogenesis (33). Conditional ablation of Cx-43 protein in the 
decidual uterus resulted in a severe impairment of vasculature resulting in embryo resorption 
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and subsequent infertility. During decidualization, the expression of Cx-43 is regulated by the 
intrauterine E source, indicating a plausible mediator of steroid regulation during decidual 
angiogenesis (30).  
 
    In this chapter, we identified the contribution of the local E in regulating uterine vascular 
growth during decidualization. We observed that this regulatory event was mediated either 
through the differentiated stromal cells, by the release of paracrine mediators that modulate 
vascular growth or by a direct governance of the endothelial population by local E. The study 
addresses some of the key observations that establish the significant contribution of E 
signaling in modulating decidual angiogenesis. 
 
 
4.3. EXPERIMENTAL PROCEDURES 
 
Reagents- 
 Progesterone and 17--estradiol were purchased from Sigma Chemical Co. (St. Louis, MO).  
Animals and Tissue Collection-  
All experiments involving animals were approved by the Animal Care Committee at the 
University of Illinois at Urbana-Champaign and the studies were conducted in accordance 
with the National Institutes of Health standards for the use and care of animals. Female mice 
(CD-1 from Charles River, Wilmington, MA), in proestrus, were mated with adult males. The 
presence of a vaginal plug after mating was designated as day 1 of pregnancy. The animals 
were killed at various stages of gestation and the uteri were collected after removal of the 
embryos by repeated flushing.  
 
Artificial Decidualization-  
Decidualization was experimentally induced in hormone primed mice as described previously 
(98). Briefly, mice were first ovariectomized and two weeks following ovariectomy, animals 
were injected with 100 ng of E in 0.1 ml of sesame oil for three consecutive days. This was 
followed by daily injections of 1 mg of P for three consecutive days. Decidualization was 
then initiated in one horn by injection of 50 l oil. The other horn was left unstimulated. The 
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animals were treated with P for additional 3 days post stimulation and then killed to collect 
the uterine tissue.  
 
Mouse primary stromal cell culture-  
Isolation of mouse primary stromal cells was performed as discussed before (99). Briefly, day 
4 pregnant mouse uterus in the pre-implantation phase was subjected to enzymatic digestion 
using pancreatin and dispase enzymes for 1 hr at room temperature. The reaction was 
neutralized with 10% fetal bovine serum (FBS) and the supernatant containing the epithelial 
cell clumps were discarded. The partially digested tissue was then incubated with collagenase 
at 37C for 45 mins. The reaction was again neutralized with 10% FBS and vortexed to 
dispense stromal cells in the suspension. The resultant solution was passed through a 80m 
sieve to obtain a pure stromal cell population. Stromal cells obtained were cultured in 
complete medium containing 2% serum, and differentiation was induced by adding P.  
 
Immunofluorescence-  
Polyclonal antibodies against PECAM-1 (BD Biosciences) was used for 
immunocytochemistry as discussed before (100). Briefly, cultured cells were fixed in 4% 
paraformaldehyde solution and permeabilized with 0.25% Triton X-100. The culture dishes 
were washed in PBS for 20 min and then incubated in a blocking solution containing 10% 
normal goat serum for 30 min before incubation in primary antibody overnight at 40C. 
Immunostaining was performed using a FITC conjugated secondary antibody against the 
primary anti PECAM-1 antibody. Sections were counterstained with 4',6-diamidino-2-
phenylindole (DAPI), mounted, and examined under green fluorescence filter. Bright green 
deposits indicate the sites of positive immunofluorescence. 
 
Immunohistochemistry-  
Paraffin-embedded uterine tissues were sectioned at 4 µm and mounted on slides for 
immunostaining of Ki-67, Ang2 (Santa Cruz Biotech), Claudin 5 (Invitrogen Inc.) and frozen 
sections for PECAM-1 (BD Biosciences Inc). Sections were washed in PBS for 20 min and 
then incubated in a blocking solution containing 10% normal goat serum for 30 min before 
incubation in primary antibody overnight at 40C. Immunostaining was performed using 
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Avidin-Biotin kit for rabbit primary antibody (Vector Laboratories, Burlingame, CA). 
Sections were counterstained with hematoxylin, mounted, and examined under bright field. 
Red deposits indicate the sites of positive immunostaining. 
 
Endothelial cell isolation- 
The isolation of endothelial cells was performed as described before with some modifications 
(123). Briefly, the cells were obtained from day 8 uterus of pregnant CD-1 females by 
mechanical separation, enzymatic digestion and fluorescence activated sorting. Individual 
implantation sites were washed in ice cold hanks solution and the myometrium removed to 
reveal the deciduoma. The embedded blastocyst was carefully removed under microscope 
and the remaining spongy tissue was minced and subjected to enzymatic digestion in 10ml of 
DMEM F-12 medium supplemented with 2% Type IA crude collagenase (Sigma), 1% heat 
inactivated fetal bovine serum and 1% penicillin and streptomycin in for 1hr at 37C with 
intermittent shaking. The reaction was neutralized with 10% FCS in balanced hanks medium, 
and the tissue clumps were sheared by repeated pipeting; the undigested tissue was allowed to 
settle by gravity and the supernatant was collected, this wash was repeated thrice to obtain the 
heterogenous cell population. The supernatant was further digested in 0.25% trypsin EDTA 
solution for 20 mins at 37C to obtain a single cell suspension. After digestion, the solution 
was filtered by passing through a 80m sieve, washed thrice and the cells were cultured in 
gelatin or matrigel coated plates. The culture medium was specific for endothelial cell growth 
containing 2mM glutamine, 1% penicillin streptomycin, 1mM sodium pyruvate, 20mM 
HEPES, 1% non-essential aminoacid, 50mM beta mercaptoethanol, 20% fetal calf serum, 
150m/ml of Endothelial cell growth factor and 12U/ml heparin.  
 
Flow cytometry- 
Dissociated cells in single suspension were incubated in ice with rat anti-mouse PECAM-1 
antibody for 90 mins, followed by a second incubation with FITC conjugated anti-rat IgG for 
30 mins in ice. Cells were washed thrice with 0.1% sodium azide and 1% FBS in balanced 
solution after each incubations and were analyzed and separated using FCS express software 
(De Novo Software Inc). Establishment of the gates was based on the staining profiles of the 
negative controls and cells labeled with propium iodide to eliminate low forward scatter 
signal events, debris and apoptotic cells.  
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LCM RTPCR- 
Laser assisted microdissection was performed as discussed before (30). Briefly, sections of 
uteri collected on day 8 of pregnancy from mice treated with P or P+AI were subjected to 
LCM. Frozen sections (10 m) containing the implantation sites were placed on polyethylene 
naphthalate membrane slides (Molecular Devices) and dehydrated in ethanol and xylene. 
Using the Veritas microdissection instrument, the mesometrial and anti-mesometrial regions 
were excised and the decidual tissues were obtained. RNA was isolated from these tissues 
using a Pico Pure RNA isolation kit according to the manufacturer’s instructions. cDNA was 
synthesized from the isolated RNA using the Sensiscript reverse transcriptase kit (Qiagen) 
and subjected to real-time PCR using gene-specific primers. 
 
 
4.4. RESULTS 
 
4.4.1. Endothelial cell population in decidual uterus 
With progression of pregnancy, the decidual mass recruits several factors that govern uterine 
neo-angiogenesis to nourish embryo growth and survival. As shown in the whole mount day 
8 deciduoma (Fig 4.1A), the mesometrial region exhibits predominant blood vessel formation 
and extensive capillary networks demarcating active site of vascular remodeling. To establish 
a model for studying the hormonal regulation of endothelial cells during decidualization, we 
isolated the uterine cells from day 8 pregnant decidua and cultured them in complete medium 
supplemented by endothelial cell growth factors. 5 days after culture, the endothelial cells 
clumped together forming the specific cobble stone morphology (Fig 4.1B). Immunostaining 
of these cells with Platelet derived endothelial cell adhesion molecule-1 (PECAM-1), an 
endothelial cell specific membrane protein also known as CD-31, exhibited positive cell 
clusters at the immediate vicinity of the decidual cells (Fig 4.1C).  
 
4.4.2. Isolation of endothelial cells from decidual uterus 
In order to quantify the population of uterine endothelial cells during decidualization, we 
separated the deciduoma from the myometrium and the embedded blastocyst. The spongy 
tissue was then enzymatically digested as described in experimental procedures to yield a 
single cell suspension of heterogenous uterine cells and subjected to flow cytometry analysis. 
As shown in Fig 4.2A, the forward vs. side scatter plot indicated three major cell population 
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based on the differential size and granularity. Cells were stained with anti-CD31 antibody, 
further tagged with a fluorescein dye, FITC and subjected to fluorescence assisted cell sorting 
(FACS). Only the live cell population which was gated after staining with propium iodide 
were sorted (Fig. 4.2B). 
 
    A histogram plotting the cell count on the y-axis to the intensity of the fluorescence on the 
x axis represented the CD-31 positive and negative cell populations (Fig.4.3). The total cell 
population (M2) and the cells which exhibit higher than the minimal threshold intensity for 
FITC (M1) were defined. Before sorting majority of the population were FITC negative 
(upper panel), while sorting yielded around 90% pure endothelial cells (lower panel). Further, 
in the control sample stained with fluorophore tagged anti-rat IgG, the M1 population was 
less than 1%, while after staining with anti-CD31 antibody, around 15% of the gated cells 
were M1 positive, representing the endothelial cell population in the decidual uterus (Table 
4.1). We performed 4 independent experiments and observed that endothelial cells comprised 
around 15-20% of the total number of cells in a day 8 pregnant uterus.  
 
4.4.3. Intrauterine E biosynthesis plays a critical role in decidual vascular growth 
A recent study in our laboratory identified the biosynthesis of local E during early pregnancy 
and its pivotal contribution in sustaining implantation. To identify the potential targets of E 
action in mediating this process, we performed a microarray analysis with the uterine RNA 
isolated from the decidual tissue of mice treated with or without the aromatase inhibitor, 
letrozole. We identified more than 6000 mRNA transcripts including ESTs which were 
altered at a fold change of 1.5 fold or more when compared to the vehicle treated control 
decidual uterus. Of the 450 genes with complete coding sequences down regulated in the 
absence of E signaling, a significant population of molecules (about 120 genes) was involved 
in the development of angiogenesis. These putative E regulated genes were involved in 
various aspects of angiogenesis and were broadly classified into factors that contribute to 
endothelial cell proliferation, extracellular matrix remodeling, regulation of VEGF 
expression, migration and maturation of endothelial cells. A quantitative analysis of the 
number of genes involved in each biological function is represented in Fig 4.3A.   
 
    To validate the expression profile of the angiogenic markers in the absence of E signaling, 
we subjected mice to artificially induced decidualization program and treated a subset of 
them with aromatase inhibitor. Q-PCR analysis of the RNA obtained from uterine extracts of 
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the control and inhibitor treated mice confirmed the significant down regulation of several 
angiogenic markers like hypoxia inducible factor (HIF2a), Claudin-5, angiopoeitin-2 and 4 
(Ang-2 and Ang-4) and adrenomedulin (Adm) (Fig. 4.3B).  
 
    The regulation of E action on decidual vascular growth was again confirmed by monitoring 
the expression of PECAM-1. As shown in Fig. 4.3C the control uterine horn exhibited intense 
PECAM-1 expression, demarcating vascular network (panel a and c); treatment with 
aromatase inhibitor resulted in a significant reduction in PECAM-1 expression and intensity, 
indicating that the expansion of the uterine angiogenic network was impaired in the absence 
of local E production (panel b and d).  
 
    Development of vascular network necessitates active proliferation of the endothelial 
population in the mesometrial zone of the pregnant uterus. We next assessed the extent of this 
cell proliferation in the presence of aromatase inhibitor by immunostaining for Ki67 (Fig. 
4.3D). Uterine sections obtained from P-treated mice exhibited robust Ki67 immunostaining 
in endothelial cells, consistent with microvascular proliferation (panel A), while those 
obtained from aromatase inhibitor-treated animals showed greatly reduced Ki67 expression 
(panel B).  
 
4.4.4. Plausible mechanisms of E action in modulating uterine vascular development 
Stromal cells isolated by enzymatic digestion from day 4 morning pre-implantation mouse 
uterus, were cultured in vitro in the presence of steroids to induce decidualization. The 
expression of the angiogenic markers were compared in the P treated control versus 
aromatase inhibitor treated samples (Fig 4.4). A significant inhibition of HIF2a, Adm and 
Ang 2 and 4 were observed along with the other differentiation markers like Alkp, Prp, 
BMP2 and Cx-43 after disrupting the endogenous E biosynthesis, indicating that the release 
of paracrine factors from the decidual cells is regulated by the local source of E. This 
observation was further validated by monitoring the protein expression of some of these 
molecules during normal pregnancy. Pregnant mice were ovariectomized on day 5 early 
morning, 6-8 hrs following the embryo attachment. Pregnancy was sustained with an 
exogenous administration of P. To a subset of these animals, aromatase inhibitor was 
administered to disrupt the local E biosynthesis (Fig 2.1A). Uterine samples collected on day 
8 of these mice were subjected to immunohistochemical analysis using antibodies against 
Ang-2 a critical player in the development of angiogenic network. Ang-2 exhibited intense 
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staining in the mesometrial decidual cells and in the ectoplacental cone in the control uteri 
(Fig 4.5A). Administration of letrozole resulted in the significant down regulation of Ang-2 
expression in the mesometrium, while the expression in the ectoplacental cone was retained, 
further confirming a significant contribution of endogenous E in regulating the expression of 
these molecules and in coordinating endothelial cell growth and maturation. 
 
    From our microarray analysis, we identified certain endothelial cell specific molecules 
which were down regulated in the presence of letrozole. One such molecule was Claudin 5, 
an endothelial cell specific tight junction molecule with major contribution in cell to cell 
communication. The expression of this molecule in the control uterus was restricted to the 
endothelial cell membrane junctions at the mesometrial end of day 8 uterus (Fig 4.6, panels a 
and b). Administration of the inhibitor drug significantly altered Claudin 5 expression, 
indicating a severe impairment in endothelial cell to cell communication (panels c and d). 
Collectively, these results indicated that aromatase-mediated local E in the uterus plays a 
critical role in angiogenesis by governing the expression of stromal cell derived factors and 
endothelial cell specific angiogenic modulators.   
 
4.4.5. Expression of angiogenic markers is concentrated to the mesometrium 
As we observed in Fig. 4.1A, the maximum concentration of uterine blood vasculature is 
restricted to the mesometrial pole, it is thus plausible that the cytokines and other critical 
modulators of uterine angiogenesis are primarily accumulated in that region. To confirm this 
speculation we captured specific uterine zones by laser assisted microdissection (LCM) and 
analyzed the gene expression. Frozen sections collected from d5 ovariectomized-d8 uterus 
were processed in xylene and ethanol and subjected to laser capture. The region of intense 
blood vasculature comprising the zone immediately outside the ectoplacental cone upto the 
beginning of the deep stroma was compared to the decidual cells of the antimesometrium (Fig 
4.7A). The angiogenic markers in the blood vessel concentrated mesometrium exhibited a 
significant high expression compared to the antimesometrial decidual cells in the normal P 
treated d8 uterus (Fig. 4.7B). As expected, treatment with aromatase inhibitor impaired the 
gene expression in the mesometrium, confirming the pivotal role of endogenous E signaling 
in regulating uterine vascular network (Fig.4.7C). 
 
 
4.5. DISCUSSION 
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Decidual vasculature is an essential criterion for sustaining early pregnancy. Endothelial cells 
near the mesometrium undergo extensive remodeling to form nascent capillary network 
demarcating the future site of placentation. While the uterine angiogenesis has been 
established in the field of implantation biology, the molecular mechanisms that underlie this 
physiology remain largely uncategorized. Our previous study identified an intrauterine source 
of E during decidualization. This endogenous steroid is critical in maintaining the 
implantation chamber, absence of which results in embryo resorption (30). It is likely that this 
dramatic consequence on pregnancy outcome is due to an overall impairment of the 
decidualization process. While in the previous chapter the contribution of E in regulating 
stromal cell differentiation was focused, the concentration of the present involves on 
identifying the morphological features of isolated uterine endothelial cells and its regulation 
by the local steroid. The major finding of this study is that de novo production of E plays a 
novel and central role in the regulation of uterine neovascularization during early pregnancy. 
 
Separation of the endothelial population from a heterogenous single cell suspension of the 
uterine cell mass was achieved by FACS. It is a powerful tool that enables simultaneous 
quantification and multiparametric categorization of different populations of cells by labeling 
them with fluorescent conjugated antibodies specific to a particular cell type. Using this 
method of cell separation we were able to sort a pure population of CD-31 positive 
endothelial cells which comprised about 20% of the entire endometrial cellular mass during 
decidualization. FACS sorted endothelial cells when grown in culture did form the long 
cylindrical tube like processes, but owing to the low cell number that survived after the 
sorting process, we were unable to monitor the characteristic cobble stone morphology in 
these isolated cells, later addressed in co-culture experiments. Decidual cell plays a major 
role in morphogenesis and formation of uterine vasculature. Accordingly, in the stromal-
endothelial co-culture experiments, 5 days of culture promoted the aggregation of endothelial 
cells in small clumps and development of their characteristic pavement stone like 
morphology (Fig 4.1B). The experimental method of endothelial cell isolation and separation 
during decidualization can be used as a powerful tool to study the steroid regulation 
specifically to these cell types in future studies.  
 
Steroid hormone regulation is the polar event that organizes endothelial networking during 
pregnancy. Although a functional link between the hormone action and uterine angiogenesis 
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in rodents has long been speculated, the precise nature of this regulation remained unclear. 
Establishment and remodeling of blood vessels during angiogenesis requires the coordinated 
execution of a series of cellular processes. Endothelial cells migrate from the parent vessel 
and proliferate in response to one or more paracrine signal(s), resulting in the formation of 
nascent capillary sprouts (124). Treatment of decidual uterus with aromatase inhibitor 
significantly altered expression of several molecules involved in endothelial cell maturation 
and morphogenesis, broadly categorized into factors that promote endothelial cell 
proliferation, molecules involved in endothelial-extracellular matrix remodeling, important 
players that regulate the expression of VEGF and the associated angiopoeitin-Tie2 signaling 
(125).  
 
During angiogenesis, the tip cell that directs the migration of a large population of endothelial 
cells towards an environmental cytokine has often been compared to an axonal growth cones 
that discerns the direction of axon outgrowth (124). Some of these molecules that regulate the 
migration event include semaphorins, ephexin, ninjurin, netrin, slit and robo proteins and 
other molecules involved in the Notch and Ephrin signaling (125-129). Interestingly, most of 
these factors were found to be down regulated in the absence of intrauterine E signaling 
(Table 4.2). This is a critical observation of steroid regulation on the endothelial population, 
indicated for the first time that local E signaling governs the directionality of blood vessel 
formation during decidualization.  
 
As stromal cells differentiate, they secrete increasing amount of cytokines, transcriptional 
regulators of angiogenic factors and other mitogenic agents that act via paracrine signaling on 
endothelial cells to regulate angiogenesis. We identified that the decidual E critically 
mediated differentiation of stromal cell population which further governed the release of 
these paracrine factors, regarded as the indirect mechanism of E action on vascular 
development. The alternative mechanism would be a direct regulation of endothelial cells by 
E action. We hypothesized that a balanced interplay of these two pathways are responsible in 
governing the angiogenic development of the decidual uterus.  
 
Consistent with this speculation, we have identified a number of stromal factors that are 
induced in response to aromatase-derived E and are likely regulators of neovascularization in 
the decidua. Our study showed that the intrauterine E controls the stromal expression of 
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HIF2, a transcription factor that regulates VEGF production (38). VEGF is a potent mitogen 
for endothelial cells, and is a prime regulator of angiogenesis during implantation and 
decidualization (35, 37). In many tissues, VEGF acts in concert with angiopoietins to regulate 
angiogenesis (37, 130). While angiopoietin 2 collaborates with VEGF to advance the 
invasion by the vascular sprouts and promote vascular remodeling, angiopoetin 4 serves an 
important function during endothelial cell migration (131). We present evidence that 
aromatase-driven E controls the expression of both angiopoetin 2 and angiopoetin 4 in uterine 
stromal cells. The stromal expression of adrenomedullin, a factor involved in angiogenesis 
and important regulator of uterine function during implantation  (40), is also controlled by the 
E generated in the uterus. Another critical regulator of angiogenesis regulated by local E is 
the gap junction molecule Cx-43. Previous studies in our laboratory have shown that Cx-43 
expression in the pregnant uterus is restricted to the decidual population and it significantly 
contributes to neo-vascularization, by modulating the paracrine release of angiogenic factors 
(132).  
 
Endothelial cell to cell communication is critical in mediating the vascular network and 
coordinate endothelial cell migration and growth (133). This communication is primarily 
mediated by a group of cell adhesion molecules forming various adhesion complexes. We 
found that treatment with aromatase inhibitor severely impaired expression of several 
endothelial cell adhesion molecules, indicating a direct regulation of intrauterine E on this 
population. Among the other prominent players we identified Claudin-5, vasculo-endothelial 
cadherins and several independent cell adhesion molecules like PECAM, CeaCAM and 
ICAM, important in controlling endothelial cell communication (134-136). It is possible that 
this direct regulation of intrauterine E is mediated by the expression of ER in mouse uterine 
endothelial cells. Studies in our laboratory are currently underway exploring this direct aspect 
of hormonal regulation in endothelial cells. 
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4.6. FIGURES 
 
Figure 4.1: Extensive endothelial cell population in decidual uterus 
 
 
Figure 4.1: Extensive endothelial cell population in decidual uterus 
 
The implantation sites were isolated from a day 8 pregnant CD-1 mouse and the myometrium 
was removed to reveal the deciduoma. A: Whole mount picture of an isolated day 8 
deciduoma. The figure shows extensive blood vasculature in the mesometrial end compared 
to the antimesometrium. B: Co-culture of endothelial and stromal cells in vitro. The 
deciduoma was enzymatically digested after the removal of the blastocyst and the 
heterogenous population was cultured in endothelial cell specific medium for 5 days. (i) 
Phase contrast microscopy indicating the cobble stone morphology of endothelial cells. (ii) 
Immunostaining with FITC conjugated anti-PECAM-1 antibody further characterized these 
clusters as endothelial cells. The overlay panel clearly indicates strong membrane specific 
expression in endothelial cells. 
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Figure 4.2: Fluorescence activated cell sorting of uterine endothelial cells 
 
 
Figure 4.2: Fluorescence activated cell sorting of uterine endothelial cells 
 
A: 2D Scatter Plot from the day 8 decidua cell extract. The forward vs. side scatter plot 
indicates a heterogenous population with 3 major cell clusters grouped based on their varying 
cell size and internal complexity. B: Cells were stained with propidium iodide and the live 
population is gated to be sorted in the flow. C: The heterogenous cell population isolated 
from normal day 8 pregnant uterus was stained with anti-CD31 antibody conjugated to a 
fluroscein dye FITC. Cells were sorted using the flowcytometer. M1 is defined as the cell 
population that emits fluorescence higher than the threshold intensity, while M2 is the total 
number of cells sorted. Upper panel: The distribution of cell population before sorting. 
Lower panel: Cell population positively sorted for CD-31 cells emitting high fluorescence. 
FACS resulted in a 90% separation of the endothelial cells from the heterogenous mixture. 
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Table 4.1: Percentage of endothelial cells in decidual uterus 
 
The table represents the number of cells present and the percentage of the gated cells positive 
in the M1 and M2 population. In the control sample, stained with the isotype control for 
PECAM-1, less than 1% of the cells exhibited fluorescence, while in the CD-31 sample, 
almost 15% of the cells exhibited fluorescence, indicating the percentage of CD-31 positive 
cells present in the heterogenous population.  
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CD-31 Sample              
Table 4.1le 4.1 
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Figure 4.3: Classification of the angiogenic molecules down regulated after AI 
administration 
 
 
 
 
 
Figure 4.3: Classification of the angiogenic molecules down regulated after AI 
administration 
Mice were ovariectomized and subjected to artificially induced decidualization as described 
in experimental procedures. Cohorts of these animals were treated with P alone (P) or P along 
with aromatase inhibitor (P+AI) and the uterine horns were separately collected after 72hrs of 
stimulus (n=5). The isolated mRNA from the stimulated uterine horns was subjected to 
microarray analysis. The down regulated gene list was analyzed at a threshold cut off of 1.5 
folds. A: The genes likely to be involved in angiogenesis were identified and further sub-
categorized according to their function, as represented in the pie diagram. B:  The factors 
identified in the microarray analysis were further confirmed by their differential mRNA 
expression in the control and AI treated uterine extracts. (n=3, p<0.01) 
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Figure 4.3(cont.) 
 
 
 
 
 
Figure 4.3: Angiogenic network is regulated by intrauterine E  
 
C: Uteri from mice treated with P and the inhibitor drug were collected at 72 h following the 
decidual stimulation and frozen tissue sections were subjected to immunohistochemical 
analysis using an antibody specific for PECAM-1. Panels a and c indicate the PECAM-1 
expression in uteri of mice without letrozole treatment; Panel b and d indicate the PECAM-1 
expression in uteri of mice treated with letrozole. M indicates mesometrial end. 
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Figure 4.3: (cont.) 
 
 
 
 
 
 
Figure 4.3: Endothelial cell proliferation is regulated by local E 
 
D: Pregnant mice were ovariectomized on day 5 morning, 12 hrs following the blastocyst 
attachment. To a subset of these animals, P was administered to sustain pregnancy or treated 
with P along with aromatase inhibitor (P+AI). The uterine horns were collected after 3days 
on day 8 (n=5). Uterine cross-sections containing a well defined embryo from the control and 
AI treated animals were subjected to immunohistochemical analysis using anti Ki-67 
antibody. Expression of Ki-67 in the control (panel a) and letrozole treated (panel b) uterus.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3D
a b
-AI +AI
Figure 4.3D 
 104
Figure 4.4. Stromal cell differentiation induces the release of angiogenic modulators 
 
 
 
 
 
 
 
 
 
 
Fig 4.4: Stromal cell differentiation induces the release of angiogenic modulators 
 
Stromal cells isolated from uteri of day 4 pregnant mice were subjected to in vitro 
decidualization in the presence or absence of letrozole for 72 h. RNA was prepared from 
these cells and subjected to real-time PCR analysis using gene-specific primers to assess the 
expression of ER, aromatase (arom), alkaline phosphatase (Alkp), prolactin related protein 
(PRP), BMP2 and angiogenic regulators: HIF2, angiopoeitin 2 (Ang-2), angiopoeitin 4 
(Ang-4), and adrenomedullin (adm). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ER Alkp           PRP       BMP2      HIF2 Ang2        Ang4        Adm        Arom
Figure 4.4Figure .  
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Figure 4.5: Stromal cell derived factors are modulated by intrauterine E 
 
 
 
 
 
 
 
Figure 4.5: Stromal cell derived factors are modulated by intrauterine E 
 
Angiopoeitin 2 exhibited strong expression in the ecto-placental cone and in the mesometrial 
blood vessels in uterus (upper panel) and in the decidual cells surrounding the lumen in 
samples undergoing artificially induced decidualization (lower panel). Control uteri (panels 
a-c) exhibited strong expression of Ang-2 while those treated with aromatase inhibitor 
exhibited a significant impairment (panels d-f). 
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Figure 4.6: Intrauterine E regulates the expression of endothelial cell specific angiogenic 
molecules 
 
 
 
 
 
Figure 4.6: Intrauterine E regulates the expression of endothelial cell specific angiogenic 
molecules 
 
Pregnant mice were ovariectomized on day 5 morning, 12 hrs following the blastocyst 
attachment. To a subset of these animals, P was administered to sustain pregnancy or treated 
with P along with aromatase inhibitor (P+AI). The uterine horns were collected after 3days 
on day 8 (n=5). Uterine cross-sections containing a well defined embryo from the control and 
AI treated animals were subjected to immunohistochemical analysis using anti-Claudin 5 
antibody. The protein was specifically localized in the endothelial cell junctions at the 
mesometrium region in the control (panels a and b) and the aromatase inhibitor treated uteri 
(panels c and d). 
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Figure 4.7: Expression of the angiogenic markers in specific uterine zones in the presence 
and absence of aromatase inhibitor 
Figure 4.7: Expression of the angiogenic markers in specific uterine zones in the presence 
and absence of aromatase inhibitor 
Uterine cross sections of control and aromatase inhibitor treated samples were subjected to 
LCM RTPCR. The mesometrial blood vessel region and the antimesometrial stromal cell 
population were separately captured by the laser dissection. A: The expression of the 
angiogenic markers were compared in the mesometrial blood vessel compared to the 
antimesometral stroma. B: Comparison of the expression amongst the control and aromatase 
inhibitor treated mesometrial blood vessel regions. 
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Table: 4.2: Molecules involved in axonal guidance also modulates decidual vasculature 
and is regulated by intrauterine E 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mus musculus semaphorin IV 
isoform b 
Semaphorins are important guidance factors in axon guidance. Semaphorin 4 and 
semaphorin 3 are also important in vascular development
Mus musculus galanin receptor 
2 (Galr2)
galanin is a neuropeptide which is upregulated following a nerve injury, GalR2 
expression reduces apoptosis by inducing the Akt pathway, induces neurite outgrowth
Mus musculus ninjurin 1 (Ninj1) axonal guidance and cell migration
Mus musculus neuronal guanine 
nucleotide exchange factor 
(Ngef)
Also known as Ephexin A. governs axonal cell growrh and migration. Ephexins are 
involved in Ephrin signaling pathways
Mus musculus transient 
receptor potential cation
channel, subfamily V, member 2, 
mRNA.
calcium-permeable cation channels with polymodal activation properties, governs 
membrane polarization, present in growth axon cones and directs migration
Mus musculus dynactin 3 
(Dctn3)
axonal migration; dynactin proteins are more aggregated in the axonal growth cones 
and govern the penetration of the microtubules in the peripheral zone of differentiating 
axonal growth cones
Mus musculus chordin (Chrd)
governs neural plate morphogenesis and venous and patterning in cardiovascular 
development
Table 4.2Table 4.2 
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Chapter-5 
 
Estrogen signaling plays a critical role in 
mediating human endometrial stromal cell 
decidualization 
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5.1. ABSTRACT 
 
Implantation, a series of physiological events that entails the initial success of pregnancy is 
initiated with the attachment of the embryo to the uterine wall and is critically involved in 
sustaining the blastocyst growth before onset of placentation. In the human endometrium 
however, pre-decidualization of superficial stromal cells precedes embryo attachment during 
the late-secretory phase of every menstrual cycle, while in the event of a successful 
conception, the cellular differentiation proceeds through the entire endometrium. The cyclical 
modification of the human endometrium is controlled by steroid hormones estrogen (E) and 
progesterone (P). Although E gains prominence in the proliferative and P in the secretory 
phase of the menstrual cycle, the ultimate outcome is the manifestation of a controlled 
interplay of the two steroids. In this study we show that the key enzyme driving the 
conversion of androgens to E, P450 aromatase is significantly induced during human 
endometrial stromal cell differentiation. The biosynthetic machinery results in local 
production of the endogenous steroid in the cultured endometrial stromal cells that reaches 
the maximum concentration with the continued presence of P and cAMP. Disruption of 
aromatase expression markedly impaired intrauterine E production and stromal cell 
differentiation. Further, this local E also drives ER function in coordinating decidualization. 
Using small interfering RNA silencing technology we are able to show that the endogenous 
E/ER signaling plays a critical role in regulating the expression of several critical factors 
mediating stromal differentiation and thereby significantly contributing to endometrial 
preparation during the late-secretory phase of the cycle.  
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5.2 INTRODUCTION 
 
Decidualization is the key physiological event that characterizes implantation across different 
species. While in rodents it is initiated following embryo attachment to uterine luminal 
epithelium, in humans, the endometrium prepares for an incoming blastocyst during every 
menstrual cycle through the differentiation of the superficial stromal cells, a process known 
as pre-decidualization. Since in humans the stromal cell differentiation occur independent of 
pregnancy, the local molecular cues from the epithelial compartment and the steroid 
hormones, play the important role in orchestrating the cellular transformation in each late 
secretory phase (137, 138).  
 
    The cyclical change of the human endometrium is coordinated by a series of hormone 
action. Activation of the anterior pituitary by the gonadotropin releasing hormone (GnRH) 
from the hypothalamus elicits the release of follicle stimulating hormone (FSH) and 
leutenizing hormone (LH) which acts on the ovarian follicles to initiate its maturation and the 
subsequent release of steroids. Estrogen (E) released from these mature follicles in turn 
regulates the LH surge by a feedback mechanism that regulates follicular rupture. The 
cyclical release of steroid hormones from the ovary defines the ovarian follicular cycle that 
corresponds to the endometrial growth phases, regarded as the menstrual cycle or endometrial 
cycle. During the follicular phase, also known as the endometrial proliferative phase, the 
circulating concentration of E reaches high levels and it actively participates in the 
regeneration of the endometrium by extensive proliferation of the stromal cells and growth of 
the blood vessels (56). Following ovulation, the newly formed corpus luteum releases high 
level of P and to a lesser extent, E. Under the influence of these steroid hormones endometrial 
stromal cells transforms to the decidual cells which release cytokines, growth factors, and 
other signaling molecules, demarcating the secretory phase of the cycle.  
 
    The increasing exposure of the endometrium to cytokines, local endocrine factors like 
prostaglandin E2, relaxin and corticotrophin releasing hormone (CRH) together stimulates 
the production of a second messenger, cyclic adenosine mono-phosphate (cAMP) that 
induces the PKA pathway. It has thus been observed that elevated levels of cAMP leading to 
sustained activation of the PKA pathway and cAMP induced sensitization of cells to steroid 
action are absolutely critical for inducing decidualization in the human endometrium during 
the late-secretory phase (139). However, when pregnancy is initiated with an invading 
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blastocyst, the differentiation in the superficial layers extends throughout the entire 
endometrium accompanied by myriad physiological modifications that support the embryo 
growth until placentation ensues. In the absence of the blastocyst, the endometrium sloughs 
off along with the onset of a new menstrual cycle.  
 
    The contribution of E signaling in governing stromal differentiation has not been well 
explored during implantation. A recent study from our laboratory have shown that murine 
decidual uterus harbors the entire steroid biosynthetic machinery driving local E production 
that critically sustains decidualization (30). It has been reported that differentiating human 
endometrial stromal cells exhibits aromatase enzymatic activity, which is significantly 
potentiated by P and relaxin (140-146). However, the expression or the role of aromatase in 
human endometrial function has not been investigated. In this study we report for the first 
time that like rodents, the human endometrial stromal cells expresses the key enzyme P450 
aromatase, resulting in an optimal concentration of local E, which significantly contributes to 
endometrial stromal cell transformation. Furthermore, this endogenous E mediates ER 
action in bringing about the differentiation of stromal cells to decidual cells. Together, our 
findings revealed a pivotal contribution of E regulated factor(s) and signaling pathway(s) that 
play important role in sustaining decidualization of fibroblast uterine stromal cells across 
species.  
 
 
5.3. EXPERIMENTAL PROCEDURES 
 
Reagents-  
Progesterone, 17--estradiol and 8Br-cAMP were purchased from Sigma Chemical Co. (St. 
Louis, MO). Antibodies against P450 aromatase, ER and Calnexin were obtained from 
Abcam Inc. (Cambridge, MA) and Santa Cruz Biotechnology Inc. (Santa Cruz, CA), 
respectively.  
 
Human endometrial stromal isolation and cell culture-  
Human endometrial cell cultures and endometrial biopsies are procured according to the 
regulations directed for the protection of human subjects participating in clinical research and 
are approved by the Institutional Review Boards (IRBs) of Emory University and University 
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of Illinois. Endometrium samples from the early proliferative stage of the menstrual cycle 
were obtained at the Emory University Medical Center from fertile volunteers by Pipelle 
biopsy. Stromal cells from the endometrium were isolated by Dr. Taylor’s laboratory (147).  
 
Human endometrial stromal cell differentiation in vitro-  
Isolated endometrial stromal cells were cultured in complete medium along with 5% FBS. To 
induce differentiation cells were transferred to a 2% medium and incubated with 1M of P 
and 0.5mM of a membrane permeable analogue of cyclic adenosine monophosphate (cAMP), 
8Br-cAMP. Cells were cultured for an additional 4 days and gene expression was analyzed 
using markers of differentiation.  
 
siRNA transfection-  
siRNA corresponding to human ER (siERα forward sequence: 
UCAUCGCAUUCCUUGCAAAdTdT; and the reverse sequence: 
UUUGCAAGGAAUGCGAUGAdTdT.), human P450 aromatase (siAromatase forward 
sequence GUAUGUUCCACAUAAUGAAtt  and the reverse sequence 
UUCAUUAUGUGGAACAUACtt) and a scrambled negative control were obtained from 
Dharmacon (Dharmacon Inc., Lafayette, CO) and Ambion (Ambion Inc., Austin, TX), 
respectively. The oligos were transfected using the silentFect transfection reagent (Bio-Rad 
Inc., Hercules, CA) according to the manufacturer’s instruction. Briefly, the annealed 
oligonucleotide was complexed with the transfecting reagent in Opti MEM I reduced serum 
medium. The complex containing 20nM of siRNA in 5l of the reagent was dispersed into 
culture plates containing stromal cells at 70-80% confluency. 24hrs after transfection, cells 
were treated with a hormone cocktail containing 1M P and 0.5mM cAMP and cultured for 
an additional 5days before RNA extraction. For aromatase siRNA transfection experiments, 
cells were maintained in low serum conditions before gene silencing.  
 
Adenoviral transduction-  
Cultured human endometrial stromal cells were transduced with the human ER or the GFP 
expressing adenoviruses at a MOI of 50:1. Cells were treated with steroid hormones and 
cAMP for an additional 2 days to induce differentiation.  The extracted RNA was analyzed 
for the expression of various differentiation markers.  
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Estradiol ELISA-  
Estradiol levels were monitored by collecting the condition media of differentiating stromal 
cells after every 3 days of culture until 9 days. E level in the condition medium was 
determined using Estradiol ELISA kit (Calbiotech Inc., Spring Valley, CA) according to the 
manufacturer’s instruction. Briefly, equal volume of the concentrated condition media and 6 
estradiol reference standard solutions were added to wells coated with goat-anti rabbit IgG in 
triplicates and incubated with estradiol-HRP conjugate and rabbit anti-estradiol. Absorbance 
measured at 450 nm is a readout of the competitive binding between the HRP-labeled E and 
endogenous E in the condition medium. E concentration in the samples was then obtained by 
plotting the concentration of the standard versus the absorbance. 
 
Western Blotting-  
Whole cell extracts were prepared from mouse primary stromal cell cultures undergoing in 
vitro differentiation. Briefly, cells were washed with ice-cold balanced solution and lysed 
with the RIPA buffer (0.1% SDS, 0.5% Na-deoxycholate, 1% NP-40 in PBS) containing 
protease inhibitor cocktail, phenylmethylsulfonylfluoride (PMSF 0.1 mg/ml), and 
phosphatase inhibitor (1:1000; Sigma-Aldrich). This was followed by passing the cells 
through a 25G syringe and centrifugation at 12000 rpm for 10 mins to remove the cell debri. 
Typically 20-50g of the protein extract was analyzed by SDS-PAGE and transferred to 
polyvinylidene fluoride membrane (Amersham Biosciences Inc., Piscataway, NJ). The 
membrane was blocked with 5% milk in Tris buffered saline with 0.1% Tween 20 for 1 hr at 
room temperature, followed by incubation with a primary antibody against ER or calnexin. 
The blot was then incubated with HRP-conjugate secondary antibody for 45 mins at room 
temperature. The HRP was detected by chemiluminescence.  
 
Immunohistochemistry and immunocytochemistry-  
Polyclonal antibodies against Aromatase was used for immunohistochemistry as discussed 
before (100). Paraffin-embedded human endometrial tissues were sectioned at 4 µm and 
mounted on slides. Sections were washed in PBS for 20 min and then incubated in a blocking 
solution containing 10% normal goat serum for 10 min before incubation in primary antibody 
overnight at 40C. Immunostaining was performed using Avidin-Biotin kit for rabbit primary 
antibody (Vector Laboratories, Burlingame, CA). Sections were counterstained with 
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hematoxylin, mounted, and examined under bright field. Red deposits indicate the sites of 
immunostaining. For immunocytochemistry, cultured cells were fixed in 4% 
paraformaldehyde for 10 mins and permeablized using 0.25% Triton X before blocking and 
staining with the primary antibody.  
  
 
5.4. RESULTS 
 
5.4.1. Cytochrome P450 aromatase is induced in differentiating endometrial stromal cells 
To explore the mechanism of human endometrial stromal cell decidualization, we obtained 
undifferentiated stromal cells from healthy individuals undergoing endometrial biopsies 
during the proliferative stage of their menstrual cycle. Cells were cultured in complete 
medium and differentiation was induced by adding hormone cocktail containing P (1μM) and 
a membrane permeable analogue of cAMP, 8Br-cAMP (0.5mM). As shown in Fig 5.1A, 
administration of the hormone cocktail induced a visible transition of the cellular morphology 
from spindle like fibroblast appearance (panel a) to plump epitheloid shape (panels b and c), 
indicating differentiation of stromal cells to the decidual cell type. We further characterized 
decidualization by analyzing the mRNA expression profile of various decidual bio-markers 
like prolactin (PRL) (Fig 5.1B, panel A), insulin like growth factor binding protein-1 
(IGFBP-1) (panel B), cytokine interleukin-11 (IL-11) (panel C), and vascular endothelial 
growth factor (VEGF) (panel D). The expressions of these molecules were significantly 
induced as the differentiation progressed 4, 6 and 9 days after the hormone cocktail treatment.  
 
    The morphological transformation of the cultured cells along with the increased expression 
of factors actively involved in decidualization indicated a faithful in vitro representation of 
the cellular mechanisms functional in the late-secretory phase. We next monitored the 
expression of P450 aromatase in this cell culture model. Aromatase mRNA was induced 
within 2 days of P+cAMP treatment and progressively increased with differentiation, 
reaching the maximal levels around 6-9 days of culture (Fig 5.1C). Immunocytochemical 
analysis of aromatase protein in cultured stromal cells demonstrated prominent cytoplasmic 
expression of the enzyme in differentiating stromal cells. Consistent with the mRNA pattern, 
the protein expression was also significantly induced after 6 days and reached the maximum 
levels at 9 days of P and cAMP treatment (Fig 5.1D).  
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    The expression of aromatase in the endometrium was further confirmed by localizing 
aromatase protein in tissue sections obtained from endometrial biopsies of healthy individuals 
in the late secretory phase of menstrual cycle (Fig 5.1E). The cytoplasmic aromatase protein 
expression was restricted to the stromal cells surrounding the spiral arteries (panels A and B), 
while the epithelial cells were devoid of positive staining.  
 
5.4.2. Functional E biosynthetic machinery in differentiating endometrial stromal cells 
Induction of aromatase in differentiating stromal cells raised the possibility of a functional E 
biosynthetic machinery in the endometrium. We first examined the expression of enzymes 
responsible for steroid biosynthesis in cultured endometrial stromal cells. Consistent with the 
previous reports, strong induction of StAR (steroidogenic acute regulatory protein), P450scc 
(P450 side chain cleavage), P450c17 (17-lyase) and 3-HSD (3b-hydroxysteroid 
dehydrogenase) was observed in differentiating stromal cells in response to P and cAMP (Fig 
5.2A).  More importantly, to address the local steroid hormone biosynthesis in these decidual 
cells, the medium conditioned by stromal cells undergoing differentiation was collected every 
three days and subjected to E (17 estradiol) measurement using an ELISA kit as detailed in 
experimental procedures. While the steroid levels in the medium were very low to negligible 
prior to 3 days of hormone cocktail treatment, the estradiol level was significantly elevated 
after 6 days and reached the maximum concentration around 9 days of culture (Fig 5.2B). We 
were able to detect 30-40 pg/ml of E in differentiated stromal cells. Together these 
experiments indicated that induction of the key enzyme P450 aromatase along with other 
steroid biosynthetic components governed endogenous E production in differentiating human 
endometrial stromal cells.  
 
5.4.3. Endogenous E plays a major role in mediating stromal differentiation 
To explore the functional significance of local E biosynthesis in human endometrial stromal 
cells, we silenced aromatase expression in cultured cells by administering a siRNA targeted 
to its mRNA. Differentiation was induced 24 hrs after siRNA transfection by administering P 
and cAMP. Cells were cultured for an additional 6 days before analyzing the extent of 
decidualization. Administration of aromatase siRNA to cells led to more than 87% of gene 
silencing when compared to the cells transfected with a control scrambled siRNA (NC 
siRNA) (Fig 5.3A, left panel). The E levels, determined by subjecting the condition media to 
 117
ELISA assay, were also significantly down regulated in the aromatase siRNA treated cells, 
compared to scrambled siRNA transfection (right panel). To address the effect of aromatase 
knockdown on cell differentiation we analyzed the mRNA expression of the well established 
decidual bio-markers. IGFBP-1, PRL were significantly inhibited along with other markers 
like IL-11, VEGFa, FOXO1 and Wnt4. The expression of ER, however, remained unaltered 
after silencing of the aromatase gene. These experiments indicates that aromatase derived E is 
important in sustaining human endometrial decidualization.  
 
5.4.4. Optimal concentration of local E critically regulates stromal differentiation 
To address the fact that stromal differentiation defect observed after silencing aromatase 
expression is a consequence of impaired E signaling, we next performed a rescue experiment. 
Aromatase siRNA treated cells were cultured in a medium supplemented with 10nM of 
exogenous E along with the differentiating cocktail. As expected, cells transfected with 
aromatase siRNA exhibited a significant down regulation of PRL and IGFBP-1 when 
cultured in presence of P and cAMP (Fig 5.4A). However, administration of E to these 
differentiating cells restored the inhibition of the expression of the decidual bio-markers, 
indicating a critical role of endogenous E in mediating stromal decidualization.  
 
    Endometriosis, a pathological condition that results in impaired endometrial 
differentiation, is characterized by increased aromatase activity and E levels in both eutopic 
and ectopic stromal cells (148). To address this apparent contradiction with our observation 
in the healthy endometrium, we cultured fibroblast stromal cells with steroid hormones and 
cAMP for 5days and monitored expression of the decidual bio-markers. As indicated in Fig 
5.4B, in the presence of complete medium with FBS (None), there was no induction of 
decidualization. Culturing these cells with P and cAMP along with increasing concentration 
of E indicated that 10 and 50nM of E was capable of inducing a complete decidual response 
in stromal cells. However, E dosage 100nM and above impaired the induction of IGFBP-1 
and PRL mRNA expression, indicating that an optimal concentration of E is necessary to 
induce complete decidual response in the human stroma.  
 
5.4.5. ER plays a major role in stromal cell differentiation 
Nuclear steroid receptors play pivotal role in mediating the hormone action in reproductive 
tissues. E signaling is mediated via two receptor isoforms ER and ER. In order to 
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understand the signaling mechanism of endogenous E in human endometrium, we next 
studied the expression of ER, the predominant form of ER in the endometrium, during 
human stromal cell decidualization. Primary stromal cell cultures were subjected to 
decidualization in response to with P and cAMP. The expression pattern of ER mRNA (Fig 
5.5 upper panel) and protein (lower panel) was investigated on different days of hormone 
treatment. The expression of ER mRNA and protein was elevated in cultured stromal cells 
with progression of differentiation.  
 
    To address the role of ER in human decidualization, we employed the RNA interference 
strategy and silenced the endogenous transcript by administering ER siRNA. 24hrs after 
administration of siRNA to the fibroblast stromal cells, differentiation was induced by adding 
P and cAMP and cultured in the presence of hormone cocktail. As shown in Fig 5.6A, the 
expression of ER was significantly down regulated both at the transcript (upper panel) and 
protein levels (lower panel) after treating with the ER siRNA. While cells transfected with 
the NC siRNA underwent the usual cellular transformation after 6 days of culture in the 
presence of hormone cocktail, transfection of ER siRNA significantly impaired the 
morphological transition, indicating a severe impairment in stromal cell differentiation (Fig 
5.6B). We also measured the gene expression of the well characterized bio-markers of human 
stromal decidualization after silencing ER in cultured stromal cells. Our studies revealed 
that while the expression of MMP2 and GAPDH remained unaltered, the expression of PR, 
PRL, IGFBP-1, VEGFa, IL-11, Wnt4 and FOXO1 were significantly down regulated in these 
cells indicating a critical role of ER in regulating stromal cell differentiation program (Fig 
5.6C). 
 
    We further confirmed the above observation by over expressing ER in cultured stromal 
cells via viral transduction. Adenovirus encoding the ER (Ad-ER) and the GFP sequence 
(Ad-GFP) were transduced in cultured stromal cells at a multiplicity of infection (MOI) of 
50:1. 48 hrs after viral administration to the differentiating stromal cells, RNA was isolated 
and expression of the major decidual bio markers was analyzed by qPCR. Consistent with our 
previous observation, we found that over expression of ER in these cultured stromal cells 
accentuated the differentiation process resulting in the increased expression of factors that 
promote endometrial decidualization (Fig 5.6D).   
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5.5. DISCUSSION 
 
Although certain aspects of establishment of pregnancy in mouse and human are dissimilar, 
yet the orchestrations of steroid hormones in regulation of this event remain comparable in 
both the species. While E plays the major role in controlling cell proliferation to prepare the 
uterus for pregnancy, P critically regulates cell differentiation to sustain the blastocyst growth 
before placentation ensues. However in either case, the physiological response achieved is the 
consequence of a controlled interplay of these two steroids. The contribution of E in stromal 
cell differentiation remained ambiguous in the field of implantation biology until a recent 
study showed the induction of aromatase expression in mouse decidual uterus and the pivotal 
role of intrauterine E action in modulating the decidualization process. This raised an 
interesting possibility that perhaps endogenous E signaling is important in human stromal cell 
decidualization.  
 
    In previous studies Tseng et. al. reported aromatase enzymatic activity in cultured 
endometrial stromal cells in response to forskolin and MPA (141-143, 145). In a more recent 
study Aghajanova et.al, studied the comparative expression profile of the various 
steroidogenic enzymes in the endometrium of diseased and healthy individuals (149).  
Isolated stromal cells were cultured either in the presence of cAMP alone for 96 hrs or P for 
14 days. Although most of the biosynthetic enzymes were induced in either sample, the 
extent of induction was undoubtedly higher in the endometriotic cells. Our studies employing 
isolated human endometrial stromal cells cultured in the presence of P and cAMP showed a 
significant induction of aromatase expression both in the transcript and protein levels (Fig 
5.1). Additionally the expression of StAR, SCC, 3bHSD and lyase was also prominent in 
these differentiating stromal cells, similar to previous reports. Bulun and co-workers 
however, were unable to detect any aromatase transcript in the normal endometrial stromal 
cells (150). While our findings remain consistent with other previous observations, the 
difference could be accounted to the varying treatment parameters, experimental design and 
reduced sensitivity of the semi quantitative PCR compared to the real time PCR analysis 
performed in this study. To confirm the expression of aromatase in differentiating human 
endometrial stromal cells, we validated the amplified cDNA fragment by PCR-sequencing 
and identified a single band that shows 100% homology with human Cyp19A1 gene sequence 
(NCBI Acc no: DQ118405). Additionally, immunolocalization of aromatase protein 
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specifically to endometrial stromal cells further confirmed the expression of aromatase in the 
normal cycling individuals.  
 
    The hormone levels in stromal cells obtained from diseased and healthy individuals 
cultured in the presence of PGE2 was recently studied by Attar et.al (151). Stromal cells from 
the healthy endometrium exhibited low E levels and 48 hrs of vehicle or PGE2 treatment 
resulted in less than 10 pg/ml of E in the culture medium; a concentration significantly lower 
when compared to those from endometriotic cells. In our studies, we were unable to detect E 
in cultured medium in the absence of P and cAMP. After 3 days of hormone cocktail 
administration the E concentration was detected below 10 pg/ml. The prolonged treatment 
with P and cAMP for 9 days however resulted in almost 40 pg/ml of E in the condition 
medium.  
 
    In the human during menstrual cycle, E is primarily synthesized by the developing ovarian 
follicle and to a reduced extent by the corpora lutea in the early to mid-secretory phase of the 
endometrium. However, this circulatory steroid declines precipitously towards the late-
secretory phase while stromal cells are undergoing active differentiation. Following a 
successful implantation, the placenta becomes the predominant site of E biosynthesis 
throughout the first trimester of pregnancy. The decidua-parietalis, regarded as the gestational 
endometrium, maintains a close association with the fetal membrane throughout pregnancy. 
A complete differentiation of this maternal compartment is necessary to sustain pregnancy. It 
is thus possible that the presence of functional endogenous E biosynthetic machinery in the 
endometrial decidual cells probably acts as a functional bridge, to support the transition of the 
steroid source from the maternal tissue to placenta.  
 
    Administration of aromatase inhibitor letrozole to pregnant mouse results in embryo 
resorption and a significant reduction in the decidual cell mass. Molecular analysis revealed 
that the expressions of the major markers of mouse decidualization including PRP, Alkp, PR, 
BMP2 and Cx43 were significantly impaired after inhibitor treatment. Additionally, 
disruption of the intrauterine E biosynthesis severely impacted the development of mouse 
decidual angiogenesis and blood vasculature formation (30). The present study indicated that 
similar to its contribution in murine decidualization, aromatase derived intrauterine E also 
plays a critical role in human endometrial stromal cell differentiation. RNAi mediated gene 
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silencing of aromatase led to a severe defect in the expression of the various decidualization 
markers due to altered E biosynthesis in the differentiating stromal cells. 
 
    Endometriosis, a leading cause of infertility in women, leads to impaired stromal cell 
decidualization (152). It occurs due to retrograde menstruation during which endometrial 
fragments are implanted at ectopic sites on the pelvis and the ovary. As discussed before, 
individuals suffering from this pathological condition exhibits increased aromatase activity 
and endogenous E biosynthesis in the endometrial stromal cells (153). The heightened E 
action in these cells stimulates cell proliferation resulting in altered differentiation (154). 
Uterine tumors like leiomyomas, endometrial cancer and endometrial hyperplasia are 
additional diseased conditions with enhanced E activity (155). Thus, the significance of local 
E biosynthesis during decidualization in healthy diseased free uterine tissue was difficult to 
envisage. In our experiments, the concentration of E measured in the condition media varied 
from 20-40 pg/ml, which translates to 0.07 nM to 0.15 nM of E, a concentration significantly 
lower compared to cells obtained from endometriotic tissue (151). Because E is markedly 
elevated in endometriotic cells, we hypothesized that at an optimal concentration of E is 
needed to support the differentiation process. We further confirmed our hypothesis by 
culturing differentiating stromal cells with an increasing dosage of E. A significant reduction 
in the expression of decidual biomarkers in response to high E concentration explained the 
differentiation defect in the case of endometriosis.  
 
    Nuclear receptor action is the classical signaling pathway through which steroid hormones 
mediate their effect in reproductive tissues. Human endometrium displays expression of both 
ER and ER in the stromal and glandular epithelial cells (156, 157). While the role of ER 
is widely established in stromal cell regeneration and in regulating angiogenic factors in the 
proliferative phase, the role of ER remains unknown (158, 159). In the mouse, ER is the 
predominant E receptor playing pivotal roles in regulating epithelial receptivity and embryo 
attachment in pre-implantation phase. Studies from our laboratory have also revealed that 
conditional ablation of ER in endometrial stromal cells using a Cre-loxP technology renders 
the mouse absolutely unresponsive to any decidual stimulus, indicating a pivotal role of this 
nuclear receptor in decidualization (Laws MJ and Bagchi IC, unpublished observations). In 
this study, siRNA mediated ER gene silencing in human endometrial stromal cells also 
exhibited severe defect in cell differentiation. Silencing of ER impaired transformation of 
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the fibroblastic stromal cell morphology to the decidual structure, one of the characteristic 
features of cellular differentiation. Furthermore, many critical markers of human 
decidualization are down regulated in the absence of ER. Conversely, over expression of 
ER in endometrial stromal cells led to enhanced expression of the bio-markers, indicating 
that de novo synthesis of decidual E functioning via ER plays a critical role in regulating 
human endometrial stromal cell differentiation. 
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5.6. FIGURES  
 
Figure 5.1: Cytochrome P450 aromatase is induced in differentiating human stromal cells 
 
Figure 5.1: Cytochrome P450 aromatase is induced in differentiating human stromal cells 
 
Human endometrial stromal cells were isolated from cycling, healthy individuals during the 
late proliferative stage of the menstrual cycle and cultured in vitro in complete medium. 
Differentiation was induced by adding a hormone cocktail containing 1M P and 0.5mM 
cAMP and cultured for an additional 0-9days (n=3). A: Cell morphology was captured by 
phase microscopy in the absence (None) or 6 and 9 days after adding the hormone cocktail 
(middle and right panels). B: Cells were harvested at the 2, 3, 6 and 9 days after adding the 
hormone cocktail and the isolated total RNA was subjected to q-PCR analysis using gene 
specific primers for PRL (panel a), IGFBP-1 (panelb), IL-11 (panel c), VEGF (panel d) P450 
aromatase (Fig 5.1C). 
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Figure 5.1 (cont.) 
 
Figure 5.1: Cytochrome P450 aromatase is induced in differentiating human stromal cells 
 
D: Cultured stromal cells were fixed before (panel a and b), and after 6days (panel c and d) 
and 9days (panel e and f) days of hormone cocktail treatment and protein expression of 
aromatase was monitored.  E: Tissue sections obtained from healthy individuals undergoing 
endometrial biopsies in the late secretory phase was subjected to immunohistochemistry 
using anti-aromatase antibody. Strong cytoplasmic expression is observed in the stromal cells 
surrounding the spiral artery (panel a and b). Panel c shows the negative control, 
immunostained in the absence of a specific primary antibody. Str: stroma, SA: Spiral arteries, 
LE: Luminal epithelium, GL: Uterine glands. 
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Figure5.2: Functional E biosynthetic machinery in human endometrial stromal cells 
 
 
 
 
 
 
 
Figure 5.2: Functional E biosynthetic machinery in differentiating human endometrial 
stromal cells 
 
Human endometrial stromal cells isolated from cycling and healthy individuals during the 
late proliferative stage of the menstrual cycle were cultured in the presence of hormone 
cocktail to induce decidualization. A: Stromal cells were subjected to RNA isolation after 2, 
4 and 6 days of culture and subjected to q-PCR analysis using the primers specific to human 
StAR (steroidogenic acute regulatory protein), P450scc (P450 side chain cleavage), P450c17 
(17-lyase) and 3-HSD (3b-hydroxysteroid dehydrogenase). B: Steroid hormone levels 
were measured by ELISA in the conditioned medium on days 0, 3, 6 and 9 after 
administration of the hormone cocktail (n=3). 
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Figure 5.3: Endogenous E plays a major role in stromal cell differentiation 
 
 
 
 
 
 
 
 
Figure 5.3: Endogenous E plays a major role in stromal cell differentiation 
 
Primary human endometrial stromal cells were cultured in reduced serum conditions and 
transfected with aromatase and scramble (NC) siRNA. 24hrs after transfection, differentiation 
was induced by administering P and cAMP and cells were collected 5days after addition of 
the hormone cocktail. A: Down regulation of aromatase mRNA expression in cells treated 
with aromatase siRNA compared to control siRNA transfected cells, monitored by qPCR 
analysis (upper panel) and reduction of endogenous E concentration in the condition media 
of aromatase siRNA treated cells, assessed by ELISA (lower panel). B: Harvested cells were 
subjected to q-PCR analysis to monitor the gene expression of decidualization bio-markers 
like PRL, IGFBP-1, BMP2, Wnt4 and ER. (n=4, p<0.05) 
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Figure 5.4: Optimal concentration of E sustains decidualization 
 
Figure 5.4: Optimal concentration of E sustains decidualization 
 
Primary human endometrial stromal cells isolated from normal cycling individuals were 
cultured in vitro. A: Cells were transfected with aromatase siRNA and a control NC siRNA. 
24hrs after siRNA transfection cells were treated with a hormone cocktail containing 
P+cAMP (yellow bars) or E+P+cAMP (green bars). RNA was isolated after 6days of siRNA 
transfection and the expression of the decidual bio-markers PRL and IGFBP-1 was monitored 
by qPCR. B: Differentiation was induced in cultured stromal cells by administering 
increasing concentration of E (10nM, 100nM and 1M) along with P and cAMP. After 6 
days of culture, cells were harvested and the RNA isolated was subjected to q-PCR analysis 
using specific primers for PRL (upper panel) and IGFBP-1 (lower panel). (n=3, p<0.05) 
Fig 5.4A
Fig 5.4B
Figure 5.4  
Figure 5.4B 
*
*
*
*
*
 128
Figure 5.5: ER exhibits predominant stromal cell expression in cultured human 
endometrial cells 
 
 
 
 
 
 
Figure 5.5: ER exhibits predominant stromal cell expression in cultured human 
endometrial cells 
 
Human endometrial stromal cells isolated from cycling, healthy individuals during the late 
proliferative stage of the menstrual cycle were cultured in vitro. Differentiation was induced 
by adding a hormone cocktail containing 1M P and 0.5mM cAMP for 0-9days. A: RNA 
isolated from the differentiating cells after 0, 3, 6 and 9 days of culture were subjected to 
qPCR analysis using ER specific primers. B: 30g of whole cell protein extracts isolated at 
the same time-points from the cultured cells were resolved on a 10% SDS-PAGE gel and the 
protein level of ER was monitored by Western blot analysis. An equal amount of whole cell 
extract from ovary was loaded as positive control. The expression level of Calnexin, a 
calcium binding protein, was also monitored to ensure equal loading of the protein extracts. 
(n=3, p<0.05) 
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Figure 5.6: Endogenous E acts through ER in mediating the stromal decidualization 
process. 
 
 
 
 
 
 
 
Figure 5.6: Endogenous E acts through ER in mediating the stromal decidualization 
process. 
 
Primary human endometrial stromal cells were transfected with ER and NC specific siRNA. 
24hrs after transfection, differentiation was induced by administering P and cAMP and cells 
were isolated 5days after addition of the hormone cocktail. A: Down regulation of ER 
mRNA (upper panel) and protein (lower panel) was assessed by qPCR and WB respectively. 
B: Morphology of cells cultured in the presence of hormone cocktail, transfected with NC 
siRNA (upper panels) and the ER siRNA (lower panels) at similar concentrations.  
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Figure 5.6 (cont.) 
 
 
 
 
 
 
 
Figure 5.6: Endogenous E acts through ER in mediating the stromal decidualization 
process 
 
C: Relative level of expression of the decidualization markers like PRL, IGFBP-1, BMP2, 
Wnt4 in ER silenced cells compared to the NC siRNA treated cells was assessed by qPCR. 
D: Fibroblast stromal cells were transduced with an adenovirus encoding ER or a control 
virus expressing GFP at a multiplicity of infection (MOI) of 50:1. Differentiation was then 
induced by adding P+cAMP. Cells were harvested 48hrs following viral administration. The 
RNA isolated was analyzed by qPCR to monitor the expression level of the different decidual 
bio markers after ER over expression compared to the control virus infected cells. (n=3, 
p<0.05) 
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Summary  
 
Implantation is initiated upon attachment of the embryo to the uterine luminal epithelium, 
which in mouse occurs on day 4 of pregnancy. This event is followed by proliferation and 
differentiation of uterine stromal cells into morphologically distinct secretory decidual cells, 
which control trophoblast invasion and embryonic growth until placentation ensues. As the 
blastocyst invades though the maternal wall, the decidualized stromal cells at the immediate 
vicinity of the embryo migrate away to accommodate the growing embryo. It is well 
established that ovarian steroids, estrogen (E) and progesterone (P), are essential to prepare 
the uterus for embryo implantation. While P plays a critical role in decidualization, the role of 
E in stromal differentiation and remodeling is less clear. Studies in our labiratory revealed 
that the decidual uterus expresses all the enzymatic components of the steroid hormone 
biosynthetic machinery, including the key enzyme P450 aromatase, which converts 
testosterone to E. The overall finding of this dissertation is focused on identifying the role of 
E signaling during decidualization. Importantly, we identified that this pathway is 
phyllogenetically conserved in both mouse and human endometrium. 
     
    In the preimplantation phase, while the ovarian source of E critically regulates epithelial 
receptivity by mediating the action of ER, with the initiation of stromal differentiation, 
P450 aromatase, which is induced in the decidualizing stromal cells, along with the other 
critical steroid biosynthetic enzymes regulates the de novo synthesis of E. Interestingly, we 
have further observed that induction of aromatase in the decidualization phase is regulated by 
the transcription factor C/EBPbeta. The intrauterine E plays a major role in modulating the 
differentiation of stromal cells by regulating down stream target molecules like PR, Wnt4, 
Bmp2. In addition to this PR dependent pathway, it also governs the expression of some 
known targets of E signaling constituting the PR independent pathway, including Cx43 and 
CYR61. Altered differentiation consequently impairs the release of several cytokines which 
through a paracrine mechanism act on the neighboring endothelial cells governing the growth 
and maturation of the uterine angiogenic networks. Again, local E regulated the expression of 
endothelial cell specific molecules which contributed to the development of angiogenesis. 
Finally, we identified the transcription factor FRA-1 as a direct target of E-ER signaling 
during decidualization. While FRA-1 is regulated by ER at the transcription level, the 
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activation and nuclear stabilization of FRA-1 is governed by the ERK1/2-MAPK pathway. 
FRA-1 has major contributions in governing stromal differentiation. Our studies showed that 
inhibition of FRA-1 expression in stromal cells blocked the decidualization process as 
indicated by the down regulation of well-known biomarkers of stromal differentiation. 
Interestingly, we also observed that down regulation of FRA-1 expression impaired the 
migration of stromal cells in an in vitro wound-healing assay. This defect in stromal cell 
mobility is mediated through extra cellular matrix modulators like MMP, TIMPs and CD44. 
Our study, therefore, established that biosythesis of local E acting through ER is a major 
signaling pathway that critically regulates stromal cell differentiation and migration by 
regulating the expression of FRA-1 and contributes to the neo-angiogenic networking by 
modulating the expression of various paracrine signaling factors. Most importantly, we 
observed that this signaling mechanism remains conserved during human decidualization, 
playing pivotal roles in stromal differentiation. Fig. 6 summarizes these E mediated 
transcriptional networks that critically modulate the success of decidualization during early 
pregnancy. 
     
    The specific regulation of aromatase in the differentiating uterus still remains unknown. 
Aromatase expression is regulated by various tissue specific promoters. Some of the plausible 
candidates involved in regulating aromatase expression in the decidual uterus include 
members of the monomeric orphan nuclear receptor family, which are key aromatase 
transcription regulators in other E-producing tissues. Steroidogenic factor 1 (SF-1) and liver-
receptor homolog-1 (LRH-1) were the two major factors studied. While some of the 
preliminary experiments suggest that the expression of aromatase can be regulated by the 
orphan nuclear receptor LRH-1, extensive studies require further characterization of the 
molecular details.  
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Figure 6: Summary: Estrogen mediated transcriptional network in the decidual 
endometrium 
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A1. ER critically regulates stromal cell decidualization 
 
Stromal cells isolated from day 4 pregnant, pre-implantation mouse uterus were cultured and 
differentiation was induced by adding P. The cells were then transfected with mouse ER 
specific siRNA (sense sequence GGGAGAAUGUUGAAGCACAtt and anti sense sequence 
UGUGCUUCAACAUUCUCCCtc) and the scrambled (NC) siRNA. Cells were cultured for 
an additional 48 hrs, and subjected to RNA isolation or fixed with 4 % formaldehyde to 
monitor the expression of ER (Fig A-1). Silencing of ER indicated almost 80% 
knockdown of the gene both at the transcript and protein levels. Phallodin staining, 
demarcating the F-actin filament of the cells revealed a significant alteration of the cellular 
architecture when treated with ER siRNA compared to the scrambled siRNA transfected 
cells (Fig A-2). RNA isolated from ER siRNA transfected stromal cells was subjected to q-
PCR analysis to monitor the expression of well known targets of stromal differentiation. As 
shown in Fig A-3 knockdown of ER expression, significantly down regulated the 
expression of Alkp, a known bio-marker of decidualization. In addition, the expression of 
several other important regulators of stromal cell differentiation like PR, CEBP, CX-43, 
BMP2 and CYR-61, were also significantly inhibited while the expression of GAPDH 
remained unaltered. This experiment indicated that ER signaling plays a major role in 
mediating stromal differentiation.   
 
Figure A-1: Silencing of ER expression in mouse stromal cells 
 
siRNA specific to mouse ER and scrambled (NC) was transfected to primary stromal cells 
undergoing differentiation in the presence of steroid hormones. RNA isolated after 48hrs of 
transfection was subjected to qPCR analysis to monitor the gene expression of ER (left 
panel). The efficient silencing of the target gene was further confirmed by immunostaining 
siRNA transfected cells with anti ER antibody (right panel).  
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Figure A-2: Cellular architecture of cells transfected with ER siRNA 
Primary stromal cell cultures were transfected with ER or scrambled siRNA. Cells were 
fixed and stained for F-actin expression. Control siRNA treated cells revealed characteristic 
decidual morphology (left panel) which was significantly impaired after ER silencing (right 
panel).  
 
Figure A-3: ER critically modulates stromal cell decidualization 
 
siRNA treated cells were subjected to RNA isolation and was subjected to qPCR analysis to 
monitor the expression of several molecules involved in decidualization. Silencing of ER 
significantly impaired the expression of these genes. (n=3, p<0.05) 
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A-2. C/CAAT enhancer binding protein beta (C/EBP regulates P450 aromatase 
expression in differentiating stromal cells 
 
The pivotal contribution of aromatase derived E in the decidual phase has been the key focus 
of this dissertation research. However, the regulator of aromatase expression in the uterus 
during implantation is currently unknown. In the gonads it has been shown that cAMP and 
gonadotrophins regulate aromatase expression (160). In human adipose fibroblasts, aromatase 
expression is up-regulated by the binding of C/EBP to the promoter (161). The transcription 
factor C/EBP is a critical mediator of steroid hormone action in the decidual uterus. It 
belongs to the family of basic leucine zipper domain proteins that is important in regulating 
cellular processes like proliferation, differentitation, inflammation and apoptosis. C/EBP 
null mouse do not undergo implantation and exhibits a severe defect in endometrial cell 
proliferation and differentiation of stromal cells to decidual cells. To investigate whether 
C/EBP in the mouse stromal cells were involved in regulating P450 aromatase expression, 
the transcriptional activity of C/EBP was impaired by the administration of a dominant 
negative C/EBP(ACEBP) in primary mouse stromal cell cultures. ACEBP heterodimerizes 
with the endogenous C/EBP and prevents its DNA binding, thereby disrupting its 
transcriptional activity. As shown in Figure A-3, cells transduced with the adenovirus 
expressing ACEBP exhibited almost 80% reduction in aromatase expression compared to the 
GFP expressing adenovirus, indicating that aromatase expression in the decidual uterus is 
regulated by this C/CAAT box binding transcription factor. The observation was further 
confirmed by analyzing the gene expression level in the wildtype and CEBP KO mouse 
uterus (data not shown). As anticipated, aromatase expression was significantly inhibited in 
the null uterus. Currently, studies are undergoing to address the functional promoter region 
and CEBP binding sites in the aromatase promoter during early mouse pregnancy. 
 Figure A-4 
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Figure A-4: Aromatase expression in the differentiating stromal cells is regulated by 
C/EBP 
Primary stromal cells isolated from day 4 pre-implantation mouse uterus were cultured in the 
presence of P to induce differentiation. The functional activity of C/EBP was impaired by 
the administration of a dominant negative CEBP. P450 aromatase expression was 
significantly downregulated in the ACEBP transduced cells, while the expression of CEBP 
remained unaltered. (n=3, p<0.05) 
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A.3.Generation of mouse ERG-1 plasmid 
 
The full length ERG-1 or Itmap-1 and the truncated ERG-1 cDNA excluding the membrane 
spanning domain (NCBI accession no: U69699) was PCR amplified from pregnant day 1 
mouse uterus mRNA using Pfu DNA polymerase (Stratagene), with the following conditions: 
95°C for 5 min, 1 cycle; 94°C for 30 s, 61°C for 120 s, 72°C for 120 s for 30 cycles, followed 
by 1 cycle at 72°C for 10 min. The full-length cDNA construct was gel extracted (Qiagen Gel 
Extraction Kit), followed by cloning to the pPCR-Script Amp SK+ cloning vector (pPCR-
Script Amp cloning Kit, Promega). Positive colonies were identified by blue-white selection 
subjected to plasmid isolation.  For the expression of FLAG epitope-tagged mouse ERG-1, 
DNA encoding the full-length ERG-1 was cloned into the NotI and BglII sites of pCMV-
FLAG-MAT2 vector (Sigma Algrich) upstream of a FLAG-MAT peptide sequence. The 
clones obtained from bacterial transformation were confirmed by restriction enzyme 
digestion and DNA sequencing. Confirmed sequences were then further purified using the 
Endo Free Maxi Kit (Qiagen) to get transfection-quality cDNA. The fusion protein was 
expressed in mammalian HEK-293 cells, denatured in SDS-sample buffer, resolved on an 
SDS-PAGE, stained with Coomassie Blue, blotted with anti-FLAG M2 antibody and 
visualized by autoradiography. 
Figure: A-5: Map of ERG-1 clone 
 
ERG-1
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A.4. Primer Sequences 
Table A-1. Mouse primer sequences 
Mouse Primers  
Primer Name Sequence 
36B4-F 5'- CATCACCACGAAAATCTCCA 
36B4-R 5'- TTGTCAAACACCTGCTGGAT 
Adrmdln Fwd 5'- ACATTCGTGTCAAACGCTACC 
Adrmdln Rev 5'- ATGCCGTCCTTGTCTTTGTCT 
Caveolin-F 5'- GAGTACCAACAACCTCAACTGC 
Caveolin-R 5'- GTTAAGAGTGAGGACAGCAACC 
CD44 Fwd 5'- GAACAAGGAACCATCAGAGACC 
CD44 Rev 5'- AATGGCGTAGGGCACTACAC 
cebpb asense 5'- CTGCTCCACCTTCTTCTG 
cebpb sense 5'- AGCGACGAGTACAAGATG 
c-Fos-Fwd 5'- ACAGTTGGACCCAAGACAAAC 
c Fos-Rev 5'- TGAAACTGGCTCCTACAGCA 
Claudin5 Fwd 5'- ATGCAGTGCAAGGTGTATGAA 
Claudin5 Rev 5'- AGGTAACAAAGAGTGCCACCA 
COUP-TF-Fwd 5'- CGG AGG AAC CTG AGC TAC AC -3' 
COUP-TF-rev 5'- CAG GTA CGA GTG GCA GTT GA -3' 
Cx43 #1 5'- CTATCGTGGATCAGCGACCTTC 
Cx43 #2 5'- CACGGGAACGAAATGAACACC 
Endothelin-1 Fwd 5'- ACTTCTGCCACCTGGACATC 
Endothelin-1 Rev 5'- GGTGAGCGCACTGACATCTA 
erk1-fwd 5'- TAAAAGCCAGCAGCTGAGCAA 
erk1-rev 5'- AAGCAGATTGGAAGGCTTCA 
Fra-1F 5'- CAAGCATCGACAGCAGCA 
Fra-1R 5'- AGAAAGGGAGATGCAAGGCA 
Fra2- Rev 5'- CACAGGGTTACAGGGCTAGAA 
Fra2-Fwd 5'- ATCACTCCCGGCACTTCAAA 
FraKpn1R 5'- CCAGCCGGTACCTCACAAAGCCAGGAGTGT 
FraXba1F 5'- CCAGCCTCTAGAATGTACCGAGACTACGGG 
Gcebp as 5'- GCGCAGGGCGAACGGGAAACCG 
Gcebp sen 5'- AGCCCCTACCTGGAGCCGCTCGCG 
h-arom PII Fwd 5'- GAGGAGGAGGAGGAAAAAGGA 
h-arom PII Rev 5'- AAGGCTGGATGGTTTCTGGT 
ITF-2-Fwd 5'- CTC CAA TCC TTC AAC TCC TGT G -3' 
ITF-2-Rev 5'- GTC CAG TCT TTC CAA ACG GTC T -3' 
JunB- Fwd 5'- ACGACCTGCACAAGATGAACC 
JunB-Rev 5'- TATGAGCTCCCAGTCCCGA 
LRH-1F 5'- ACAGAAGTCGCGTTCAACAA 
LRH-1R 5'- GAAGTAGCTGTCCGAATTTCTCA 
ltmapF 5'- CTGAGGACCCTGCGAAGAT 
ltmapR 5'- AGGCCTTTCTTGGGGTCCA 
m-17bHSD1 F 5'- TTGGGACCATTCGGATGCT 
m-17bHSD1 R 5'- GCCCACCAGCTTTTCATAGAA 
m-17bHSD2 F 5'- TGGAGTGCTGGACAAAGAGG 
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m-17bHSD2 R 5'- AGTTCACGGCCATGCATTTT 
Maromatase asen2 5'- AGCTCTGCGCATGACCAAGT 
Maromatase sen1 5'- TAACATGCTCTTCCTGGGGAT 
Maromatase asen 5'- CACGCCACCTACTCGATAAAA 
Maromatase sense 5'- TGAACATCGGAAGAATGCAC 
MMP-13 fwd 5'- CCCTATCCCTTGATGCCATT 
MMP-13 rev 5'- TGGGATAACCTTCCAGAATGT 
MMP-2 fwd 5'- CCCTCAAGAAGATGCAGAAGT 
MMP-2 rev 5'- TGTGATCTGGTTCTTGTCCC 
MMP-7 fwd 5'- ATGCAGAAGTTCTTTGGCCTG 
MMP-7 rev 5'- CTCTCCTTGCGAAGCCAATT 
MMP-9 fwd 5'- TCTTCCCCTTCGTCTTCCTT 
MMP-9 rev 5'- TATACAGCGGGTACATGAGCG 
mStarF 5'- TCACAAAAGGGGACAAAACG 
mStarR 5'- TGTCACCATTTGCAGTGTTG 
mus Cyr61 Fwd 5'- ATTAAGGACTCCCTGGACGA 
mus Cyr61 Rev 5'- ACGATGCATTTCTGGCCATG 
PDGF-I Reverse 5' AGGTATGATGGCAGAGTCATCC  3' 
PDGF-II Forward 5'  TGCGATCTGAACTCACAGTG  3' 
SCC-F 5'- AGTCCCAGGAACACAGGAAA 
SCC-R 5'- CATTCCTTGCGGGTTTTG 
SF-1F 5'- CTCCAAAAGACTCCTTGCATT 
SF-1R 5'- TGATGGAGGAAGGAATGGTT 
erg 570 reverse 5'- GCC TGG ATC CAA CTT GAT GT -3' 
FraflF 5'- CAGGGCATGTACCGAGACTA 
FraflR 5'- CCTCACAAAGCCAGGAGTGTA 
  
  
Gel shift Assay oligo  
AP 2 5'- TTCCGGCTGACTCATCAAGCG 
AP 1 5'- CGCTTGATGAGTCAGCCGGAA 
AP 5- Bio 2 TTCCGGCTGACTCATCAAGCG 
AP 5- Bio 1 CGCTTGATGAGTCAGCCGGAA 
AP 3- Bio 2 TTCCGGCTGACTCATCAAGCG 
AP 3- Bio 1 CGCTTGATGAGTCAGCCGGAA 
 
Chip assay primers  
Pgr ERE Rev 5'-TCCTCGCACCCGTAAATACT 
Pgr ERE Fwd 5'-GAATTCCAACGCCAGAGATT 
ADM ERE Fwd 5'-ATCCTCACGTTTATGATGGA 
ADM ERE rev 5'-CGGATTTCGTAATAAGGGCA 
RAMP ERE Rev 5'-CTGTGACAGCAGGAGGACAG 
RAMP ERE Fwd 5'-AGAGTGTACGTGTGGACAGG 
Pgr distal Rev 5'-ATCACCAGGGAGGTGCTACA 
Pgr distal Fwd 5'-ACTGTCCAGAATGCCTCCAC 
Fra 171 Rev 5'-ATTTGTGAACTGGGGGCA 
Fra 171 Fwd 5'-CCATCTCTGCAGCCTTGATTT 
Fra 323 Fwd 5'-TGGATTCACAGTGGATGGTCA 
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Fra 323 Rev 5'-GGCTCTAGGGCTCTTTCCTTA 
Fra 592 Rev 5'-TCTCCTTCCTGAGTCTGGGGT 
Fra 592 Fwd 5'-GGAAAGAGCCCTAGAGCCCTA 
Fra 886 Fwd 5'-CAGAGAAAGAGTTTTGGGACC 
Fra 886 Rev 5'-TGAGGCTGACAGGTATTGAAA 
Fra 1006 Fwd 5'-TTTCAATACCTGTCAGCCTCA 
Fra 1006 Rev 5'-ACTATGTGTGTCACCAGCCCA 
Fra 1842 Fwd 5'-TCACTTCCCAGCTTTCAGACA 
Fra 1842 Rev 5'-ACGCACCTTGCCGAAGTT 
 
Table A-2: Human Primer sequences 
 
Primer name Sequence        
17bHSD1 Fwd AAGGGACTCAAAATCCGTGGC     
17bHSD1 Rev AGCATCCGCACAGTCCCTACT     
17bHSD2 Fwd CTTGGCCATGCTTTGTGCAA     
17bHSD2 Rev TGCTGCAACCTTGCTGTAAGC     
h-17a lyase F CCAATCTCAGCTCACTGCAA     
h-17a lyase R GATCGAGACCATCCTGGCTA     
h36B4 F GTGTTCGACAATGGCAGCAT     
h36B4 R GACACCCTCCAGGAAGCGA     
h-3HSD F TATGGGGAAGGAAGCCGATT     
h-3HSD R CAGGCCACATTGCCAACATA     
h-Aromatase-F CCTGAATATTGGAAGGATGCA     
h-Aromatase-R TACTTTCCTGCACAGCCACG     
hCYCLIN D1 asense AAACCTTCCGGTGTGAAACA     
hCYCLIN D1 sense TTGCATTCTCACATTGCCAG     
h-decorin fwd TGGAGCATTTACACCTTTGG     
h-decorin rev TGATCTCATTCTCATGGGCA     
hFOXO1-asense TTGGGTCAGGCGGTTCA     
hFOXO1-sense TGGACATGCTCAGCAGACATC     
hFra1Fwd AAGGAACTGACCGACTTCCTG     
hFra1Rev GCTTCCAGCACCAGCTCTA     
hMMP2-asense AAGACACAGGGGGCACCTT     
hMMP2-sense AAGGATGGCAAGTACGGCTT     
h-PR Fwd TGTATTTGTGCGTGTGGGTG     
h-PR Rev TACAGCCCATTCCCAGGAAG     
h-scc F GTGATGACCTGTTCCGCTTT     
h-scc R AACAGGTCTGGGGGAAGGT     
h-StAR F CCCAATGTCAAGGAGATCA     
h-StAR R ACAGCGCACGCTCACAAA     
IGFBP-1 sense GTAGACGCACCAGCAGAG     
IGFBP-1asense CCAAACTGCAACAAGAATG     
PRL antisense GGGCTTGCTCCTTGTCTTC     
PRL sense CTACATCCATAACCTCTCCTCAG     
 
